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ABSTRACT
Nuclear magnetic resonance (NMR) spectroscopy has been successfully used in the
analysis of biological fluids. Analytical NMR studies of biofluids have been concerned
primarily with the collection, assignment and quantitation of NMR spectra and their
interpretation in biochemical terms.
'H NMR Spectroscopy has been used over the years to study low molecular
weight substances in a variety of biological fluids such as urine, plasma, bile and
cerebrospinal fluid in normal controls and in the context of diseases. Many studies
have shown the usefulness of the technique in identifying abnormal substances. Few
studies have been undertaken to try and quantitate low molecular weight substances in
biological fluids.
The aim of this thesis was twofold. First we wanted to validate the use of LH
NMR spectroscopy as a reliable technique to observe and quantitate low molecular
weight substances in the context of liver disease. We then wanted to provide some
insight into the performance of key metabolic pathways in hepatocytes that are either
cultured or failing in the native liver of patients .
We validated our technique by comparing concentrations of low molecular
weight substances measured by NMR with results from standard biochemical assays
and HPLC. We used primary porcine hepatocytes and studied the effect of different
culture conditions and modalities on the metabolism of those cells by looking at the
supernatant of the cell cultures. We have shown in this thesis that culture conditions
and culture media are factors that greatly influence the performance of key metabolic
pathways of cultured hepatocytes and this in turn, influences the life span of cell in
culture.
We then investigated the changes in key metabolites in the plasma from
patients suffering from chronic liver failure and its complication chronic hepatic
encephalopathy and from patients with acute liver failure and compared those
concentrations with controls. Key metabolic pathways were impaired in patients with
chronic liver failure compared to controls. Further impairment of branch chain amino
acids and ketone bodies metabolism was noted in chronic hepatic encephalopathy. In
acute liver failure gluconeogenesis was greatly impaired along with ketogensis at the
early stages of the disease.
In conclusion NMR spectroscopy is capable of providing accurate estimations of
concentrations of low molecular weight substances in biofluids and thus can give us an
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AIM OF THE THESIS
The aim of this thesis was twofold. First we wanted to validate the use of !H
NMR spectroscopy as a reliable technique to observe and quantitate low molecular
weight substances in the context of liver disease. We then wanted to provide some
insight into the performance of key metabolic pathways in hepatocytes that are either
cultured or failing in the native liver of patients.
We have used primary porcine hepatocytes and studied the effect of different
culture conditions and modalities on the metabolism of those cells by looking at the
supernatant of the cell cultures. We have studied different culture and preservation
conditions and have investigated the activity of primary porcine hepatocytes, in an
effort to provide accurate data on the function of those hepatocytes in culture.
We have studied biochemical pathways of liver cells in patients suffering from
acute liver failure from different aetiologies and we have studied key intermediate
metabolites in an effort to link the observed clinical course of the patients with the
underlying biochemical abnormalities.
We have also studied biochemical pathways of liver cells in patients suffering
from chronic liver failure and chronic hepatic encephalopathy and we have studied
differences between key intermediate metabolites in an effort to provide an
explanation for the observed symptoms in chronic liver failure and encephalopathy.
Interesting data were accumulated and they are looked into in detail in the
experimental chapters of this thesis.
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CHAPTER 1
INTRODUCTION TO NMR SPECTROSCOPY AND LIVER DISEASES
1.1 NMR Spectroscopy of biological fluids.
Biofluids have been regarded for a long time as important tools to study the
biochemical status of a living organism. It is well known that the composition of
these fluids is dependent on the function of the cells that are responsible for their
manufacture. In the case of blood, abnormalities in its composition can reflect the
function of many internal organs. Nuclear magnetic resonance (NMR) spectroscopy
has been used successfully in the analysis of biological fluids (Nicholson et al, 1989).
Analytical NMR studies of biofluids have been concerned primarily with the
collection, assignment and quantitation of NMR spectra and their interpretation in
biochemical terms.
Even the advent of powerful spectrometers has not made possible so far the
complete assignment of the 'H NMR spectrum of most biofluids. This is due to the
enormous complexity of the fluid itself, although some well regulated fluids like
seminal fluid, with relatively few metabolites have been almost completely assigned at
750MHz. Others like urine are difficult to interpret even at 1GHz due to the
enormous variability of their composition (Lindon et al, 1999). Things are made
more difficult with the presence of many metabolites in concentrations close to the
limit of detection. All biological fluids have their own characteristic physicochemical
properties and that restricts the type of NMR experiments that can be performed on
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them and the information that can be gathered from each one. It is generally accepted
though that NMR studies of biological fluids should be performed at the highest
available field to obtain maximal dispersion and sensitivity and to minimise the noise
(Nicholson et al, 1995).
Two types of noise may be evident in the 'H NMR spectra of biological fluids.
The most common is the instrument noise which is an inherent property of the
apparatus. There is also the chemical noise which is related to the sample itself.
(Lindon et al, 1999). Chemical noise is the result of overlapping of signals that are
low in abundance in the matrix and close to the detection limits of the spectrometer.
Chemical noise is the factor limiting the information recoverable from the spectra of
most biofluids. Increasing the frequency can allow recovery of information that was
in the chemical noise at lower frequencies.
Information in a spectrum can be classed as patent or latent (Nicholson et al,
1995). Patent information can be recovered from a single pulse experiment in a
quantitative fashion. Latent information in an NMR spectrum measured at a
particular field is not readily extractable from a single pulse experiment. The
biochemical data contained therein can be extracted by carefully selecting the
appropriate multiple pulse sequences. If we increase the field strength then
information latent in the chemical noise can become patent. Arguably, NMR
spectroscopy of biological fluids has become a field of exciting developments and one
that has gained a lot from the recent technological advances in spectroscopic methods
and instrumentation.
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1.2 History of NMR Spectroscopy
NMR Spectroscopy is one of the most important tools for obtaining detailed
information on chemical systems at a molecular level. Nuclear magnetic resonance is
a nuclear phenomenon related to the magnetic properties of the nuclei. It is based on
the ability of some atomic nuclei oriented by a magnetic field (0.70 -20.0 T ) to absorb
electromagnetic radiation at particular frequencies in the radiofrequency part of the
spectrum.
It was first described as a phenomenon in 1946 by two groups. Purcell's
group was working at Stanford University (Purcell et al, 1946) and Bloch's group
was working at the MIT (Bloch et al, 1946). Purcell and Bloch shared the Nobel
Prize for Chemistry in 1952 for this discovery. Useful chemical applications of NMR
became possible only after the discovery of the chemical shift effect in 1949
(Dickinson, 1950).
The first high resolution NMR spectra were recorded by the continuous wave
(CW) technique. In this method the spectra is recorded either by continuously
altering the transmitter frequency whilst the applied magnetic field (B0) is held
constant or more commonly, vice-versa. The first commercial CW proton NMR
spectrometer was produced in 1953. As a consequence to this achievement the use of
NMR as a chemical tool has increased
, but the CW method was only suitable for the
recording of spectra of sensitive and high abundance nuclei such as 'H, 31P and 19F.
The introduction of the Fourier Transform (FT) method in 1966 by Ernst and
Anderson, (Ernst et al, 1966) revolutionised the field. It allowed for the accurate
observation of low abundance nuclei such as 13C and 15N. It also allowed for a
significant gain in sensitivity. In 1971 Jeener introduced the idea of two dimensional
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FT NMR (Jeener, 1971). Around the same time the first commercial FT NMR
spectrometers were made available by the Bruker company.
Since then there has been an enormous progress in the instrumentation and
methods of NMR Spectroscopy. The construction of high field spectrometers, the
introduction of multi-dimensional NMR techniques and the huge advance in computer
technology have made some enormous advances in NMR spectroscopy possible.
In the first publication on NMR spectroscopy of biofluids in 1979, Ohsaka et
al. reported that 100 MHz *H NMR spectra of blood serum from patients with
malignant tumours showed high lactate levels (Ohsaka et al, 1979). Since then NMR
spectroscopy of biofluids has progressed a great deal and the advent of new powerful
instruments has allowed for this technique to be used for the investigation and
measurement of subtle biochemical processes in complex fluids and cell extracts.
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1.3 Theory of NMR Spectroscopy.
NMR Spectroscopy is based upon the magnetic properties of the atomic
nucleus. All atomic nuclei possess nuclear spin angular momentum (P). The spin
angular momentum P is in units h/2p where h is Planck's constant. According to the
quantum theory the angular momentum is quantized:
| P | = hV 1(1+1) /2tt (1)
The associated quantum number (I) takes a value of 0, V2, 1, 1V2, 2 up to 6. For
nuclei with even mass numbers and even charge, 1=0 and these nuclei e.g. 12C, 160,
show no magnetic behaviour. Nuclei that have even mass numbers and odd charge
e.g. 2H, 14N, have integral values of I. Nuclei with odd mass numbers have half-
integral values of spin. Such nuclei are 'H, 13C, 15N and 19F.
The spin angular momentum P has associated with it a magnetic moment (p).
These two vector quantities are proportional to each other and the proportionality
constant ? is called the gyromagnetic or magnetogyric ratio.
p = y P (2)
By combining (1) and (2), the magnetic moment p also quantized can be
obtained.
| p | = y h Vl(I+l) /2 k (3)
In a magnetic field ( B0 ) the orientation (?) of the magnetic moment (p) to
the field direction ( z-axis ) is also quantized and depends on I. The orientation to the
x- and y- axes is not quantized and is undefined. When a magnetic field ( B0 ) is
applied, the angular momentum component P along the direction of the field,
conventionally defined as the z-direction, takes values equal to a multiple of mih/2p
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where mi is the magnetic quantum number which characterises the corresponding
stationary states of the nucleus.
| Pz | = mi h/271 (4)
As the energy of the nucleus is quantized then mi can take any of the values mi
= I, 1-1, 1-2 .... -I giving 21+1 possible orientations (Figure 1.1) (Purcell et al, 1946).
From equations (2) and (4) the component of the magnetic moment along the applied
field direction z (pz) can be obtained.
|pz| = mIyh/27r (5)
The magnetic moment p never lines exactly with the field direction but is at an
angle
{cosG = m a/I(I+1)}
and it behaves as if it precesses about the field direction with an angular velocity (?)
which is given by the equation ? = -? B(, (Figure 1.2) where ? is referred to as the
Larmor frequency (Bloch et al, 1946).
The energy (E) of a magnetic dipole in an applied field (B0) is the dot product of two
vectors the magnetic moment (p) and the applied field (B).
E = -fiB = -|i cos 0 Bo = - gz B0 (6)
E = - mi y h B0 /2k (7)
Thus the energy difference between the two adjacent energy levels can be
given as
A E = y h B0 /2k (8)
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1= 1/2 1= 1
'h l3c 2h, l4n
m = -1/2 (b) Eb =+1/2 y h B0 ^m=-1 E.i= y h B0
0 fe- m=0 E0=0
\
m = +1/2 (a) Ea= -1/2 y h B0 ^m=+1 E+1=-YhB0
Figure 1.1 Energy level schemes for nuclei l= 1/4 and 1=1
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The selection rule for NMR transitions between orientations is Am = ± 1.
Transition between the two adjacent energy levels may be induced by electromagnetic
radiation of frequency v where AE = h v and thus the absorption frequency is given by
v = (y/27c) B0 (9)
Thus there are two possible orientations of the nuclear spin for protons and all
of the spin Vi nuclei.
The ratio of the populations between these two energy states is given by the
Boltzmann equation.
Nfi/Na = exp (-AE/k-r)
= 1- AE/kT (as AE« kT) ( ca. 1 to 105 for 'H) (10)
where Na and No are the numbers of nuclei in the ground and excited states
respectively. Since these energy differences are small, there is only a small excess of
nuclei in the a state compared to the 13 state. When Na > Nu an NMR signal can be
observed due the net absorption of energy.
1.3.1 The NMR experiment.
In an NMR experiment we observe the behaviour of an ensemble of spins in a
magnetic field. Consider a sample containing only a single type of spin 1/2 nucleus
(e.g. the proton in CHCI3). In pictorial vector diagrams the z-axis points along the
static magnetic field (B0) direction. The net magnetisation M arises from the net sum
of all the individual nuclear magnetic moments precessing about the magnetic field
direction (z-axis). This net magnetisation is aligned with the applied magnetic field
and remains undisturbed (Figure 1.2), in the absence of electromagnetic radiation.
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Once this Boltzmann population distribution has been established M reaches a
stationary equilibrium value M0.
The second magnetic field Bi, which oscillates at the appropriate
radiofrequency in the plane perpendicular to B0 displaces the magnetisation M0 away
from the z-direction. After the pulse generates Bi, B0 generates a force on M which
is a torque that will cause M to precess about B0 at a frequency (?/2p) B0 Hz. This
motion is known as Larmor precession. The component of the precessing
magnetisation in the xy-plane will be detected as an NMR signal. The final position of
the magnetisation M depends upon the length of time (ps) for which the
radiofrequency is applied. The angle (?) by which the magnetisation is tipped from
the z-axis is called the flip angle or pulse angle.
The orientation of the magnetisation vector M can be specified in the
coordinate system by the three axial components Mx, My and Mz. The spin system
returns to its equilibrium state by relaxation when the pulse Bi is switched off. The z
component Mz returns to its original position while the x and y components Mx and
My approach zero (Figure 1.3). The motion of the magnetisation vector is described
by two different relaxation times Ti (spin-lattice or longitudinal relaxation time) and
T2 (spin-spin or transverse relaxation time).
At "t - 0"
Bo (Np/Na = 1)
At "thermal equilibrium"
Np/Na = exp (-AE/kT)
Longitudinal Relaxation














Figure 1.2 Growing of the net magnetisation M (a), the M at equilibrium
(b) and at precession ( c ).
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Ti is a measure of the rate at which the Boltzmann population distribution is
established from any non-Boltzmann situation.
dMz = - (Ml -M ) (11)
dt T,
T2 is a measure of the rate of decay of the generated NMR signal.
dMx = - Mx (12)
dt dt
dMv = - My (13)
dt dt
resonance on pulse
Longitudinal Relaxation Transverse Relaxation




The chemical shift is an inherent property of the molecule. It is caused by the
distribution of the electrons in the chemical bonds in the molecule. In a fixed eternal
magnetic field B0 the exact resonance frequency of a nucleus depends on its
environment in the molecule. When a molecule is placed in the magnetic field B0, the
magnetic field induces motion in the electron cloud surrounding the nuclei in such a
way that a magnetic field opposed to the original B0 is induced. Thus the electrons
shield the nuclei from the applied field B0. This magnetic shielding is equal to gB0
where a is known as shielding constant which is dependent on the electron density
surrounding the nucleus. Although the shielding is molecule orientation dependent,
molecule reorientation in solution is sufficiently fast for the orientation effect to be
averaged.
The chemical shift (5) as defined below is quoted in units of parts per million
(ppm) and will be the same whatever the strength of the field used. The resonance
frequency of the signal is measured relatively to a reference or standard compound.
Chemical shift 5 = vx - x 106
vstd




Often, the individual resonance signals from different atomic nuclei are split
into a number of lines. This arises from interactions between magnetic nuclei
transmitted through bonding electrons. The splitting of signals can normally be seen
in nuclei separated by no more than three bonds but in some cases depending on the
geometry of the molecule it can be seen through four or five bonds. The fact that
spin- spin coupling is transmitted through chemical bonds makes the coupling
constant J, a sensitive indicator for the types of bonds involved and for their spatial
orientation in the molecule. The coupling constant is therefore geometry dependent.
In complex molecules it can be seen that each nucleus can interact with many others
and this can lead to very complicated spin patterns. The spin-spin coupling is field
independent and is measured in Hertz (Hz).
When the frequency separation between the signals of the interacting nuclei is
large compared to the value of J the appearance of the signal can be predicted by
simple rules. A nucleus of spin I splits the resonance of another nucleus (any nucleus)
into 21+1 lines. The number of lines in multiplet, which is called multiplicity M, can
be obtained from the following equation:
M= 2nl+l (14)
Here n is the number of equivalent neighbouring nuclei. For nuclei with a magnetic
quantum number 1=1/2, which include 'H and l3C we can deduce from (14)
M=n+1 (15)
For couplings to nuclei with 1=1/2 the signal intensities within each multiplet





n=2 1 2 1
n=3 1331
n=4 1 4 6 4 1
1.3.4 Solvent suppression
All biofluids have very low concentrations of components. This makes
obtaining the Fourier transform 'H NMR spectra of biofluids difficult because the
weak solute signals (0.001 - 0.1 M) have to be detected in the presence of a huge
signal from the water protons (-110 M). A technique widely used to overcome this
hurdle is water suppression. The simplest suppression method is continuous weak
radiofrequency prior to excitation and acquisition to eliminate the water magnetisation
(Hoult, 1976). Irradiation should be gated off during acquisition of data avoid Bloch -
Siegert shifts despite the reduction in the level of suppression this entails. The
decoupler power should be carefully selected as high decoupler power will give
efficient elimination of the solvent resonance but will also saturate protons with
nearby chemical shifts. The same applies to irradiation time as long irradiation times
will give good saturations but will reduce the efficiency of signal averaging.
Saturation of the solvent peak although highly successful does not achieve
total suppression of the peak. Inevitably some protons lie directly under the water
signal or are sufficiently close to it in frequency that they do not escape saturation.
Any protons bleached in this way are completely invisible in both one and two
35
dimensional experiments but can sometimes be revealed by applying specific
techniques to the spectrum acquisition and editing (Hewage , 1995).
1.4 One dimensional (ID) and two dimensional (2D) NMR experiments
Simple ID NMR experiments are usually adequate for the study of similar
samples from biofluids. The study of biofluids has mostly concentrated in ID NMR
experiments which are simple and have the advantage of acquiring significant amounts
of data in high speed. One can resort to 2D experiments in some biofluids like plasma
and urine where there is a need for assignment of peaks overlapping in ID
experiments.
The simple presaturation technique is mostly used if all substances have similar
molecular weights and similar relaxation times. Single pulse proton NMR spectra are
acquired using the pulse sequence D1 - 90° - AQ with D1 being a relaxation delay
during which the saturation frequency is applied and AQ the acquisition time. In all
ID NMR experiments a preparation time is immediately followed by the data
acquisition period.
All ID NMR spectra have two dimensions: the abscissa which correspond to
the frequency axis from which one reads off the chemical shifts and the ordinate which
gives the intensities of the signals. In ID NMR a short intense pulse at a single radio
frequency serves to excite all spins from a particular radiofrequency. The response of
the sample following the pulse as manifested by the current generated in the receiver
coil, is amplified, detected against the frequency of the transmitter, converted from
analogue to digital form and then stored in computer memory as amplitude vs time
(t2). The sequence can be repeated after a suitable delay which allows the spins to
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return towards equilibrium. FIDs digitised during the acquisition period are combined
to improve the signal to noise ratio. Weighting of the averaged time - domain signal
with appropriate mathematical functions can be used to increase resolution or signal
to noise ratio. The frequency components of the FID are separated by Fourier
transformation to give spectral peaks at their characteristic frequencies.
In cell culture media where all molecules are of similar molecular weight and
signals are not overlapping the simple presaturation technique is widely used. In the
case of more complex biological fluids such as plasma where there are substantial
amounts of albumin and lipoproteins, the spectral profile is more complex with broad
signals from macromolecules overlapping with sharp signals from small molecules.
The use of specific pulse sequences can simplify the spectrum by attenuation of the
broad proton signals (Nicholson et al, 1995).
One such sequence which is very useful is the Carr- Purcell- Meiboom-Gill
(CPMG) spin echo pulse sequence. This is based on a method for determining T2
whereby the inhomogeneity contribution is eliminated. In this pulse sequence the 90°
excitation pulse is not followed by another 90° pulse but by a 180° pulse. The
complete pulse sequence is
90° - x - 180° - x (1st echo) - x -180° - x (2nd echo)
The CPMG spin-echo pulse sequence does not J-modulate the pulse sequence.
Any loss of signal intensity, during the T2 relaxation delays by diffusion through field
gradients, is minimised by virtue of the short delays employed. In a spin-echo
experiment, total spin-spin relaxation delays of < 120ms are usually sufficient to
attenuate protein resonances by factors of 1000 and hence allow low molecular
weight substances to be measured without interference ( Lindon et al, 1999).
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The use of 2D NMR methods is important as mentioned earlier for spectral
assignment purposes. A 2D NMR experiment is recorded in a 2D time space. It
differs from ID by the addition to the pulse sequence of one or more transmitter
pulses and one delay (ti) that is incremented from one acquisition or set of
acquisitions to the next. The time span is divided into four periods, (a) a preparation
period in which the desired order of coherence is generated, (b) an evolution period
during which the spin system evolves under the influence of the chemical shift and
scalar couplings. ( c ) a mixing period during which there is some transfer of
coherence and (d) a detection period when the NMR signal is recorded.
As in ID NMR spectra, the data are digitised as a function of time t2. The raw
data of a 2D NMR experiment consists initially of a series of these FIDs stored in
different files each having a different evolution time ft. FTs are carried out with
respect to both time axes ft and t2. The result is spectral intensity as a function of two
frequencies m (Fi, F2 ). Any signal in the 2D spectrum is defined by two frequencies;
mjj(Fii ,F2j ), m being the magnitude of signal at any data point and Fx being the
chemical shift dimension. The additional frequency axis allows the correlation of
magnetic properties of one nucleus with those of one or more other nuclei that
interact with it during the mixing time. Resolution in the F2 dimension is determined
by the digitisation during the t2 period: resolution in the Fl dimension is limited by the
number of incremented ft values. Quadrature detection is normally used in acquiring
in the t2 dimension to enhance sensitivity. By obtaining pure-phase spectra, one can
avoid the degraded resolution characteristic of peaks in absolute value experiments
(Hewage, 1995).
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J-resolved (JRES) spectra have been used to simplify the spectra of complex
biofluids like plasma and urine (Foxall et al, 1993a). Homonuclear 2D J-resolved
spectroscopy is frequently the first 2D experiment to be used in biofluids analysis.
The spin-echo pulse used is as follows:
90° - ti/2 - 180° - ti/2 - AQ(t2).
In practice one records FIDs for a range of different ti- values at constant
increments of a few ms. FT of an individual FID gives a frequency spectrum F2
which contains information on chemical shifts and coupling constants. A second FT
with respect to ti yields another frequency spectrum Fl. This only contains multiplets
produced by the couplings and thus gives the coupling constants. All multiplets are
tilted relative to the F2-axis by 45°. All signals of a multiplet belonging to one proton
with a chemical shift 5 can be made to appear on a line perpendicular to the F2-axis.
If this 2D spectrum is then projected onto the F2-axis the resulting spectrum consists
only of singlets. The overlapped regions of ID plasma spectra can be thus more
clearly defined (Lindon et al, 1999).
Another helpful 2D experiment used to further define the presence of a
number of substances is 2D Homonuclear Correlated Spectroscopy (COSY). COSY
provides similar information to the single frequency decoupling experiment which
identifies spins that are scalar coupled to one another. In a COSY spectrum, the ID
spectrum lies along the diagonal which runs from bottom left to top right and the off-
diagonal elements are present at the intersection of chemical shifts of groups that are J
coupled. The pulse sequence used is as follows:
90° - ti - 90° - AQ( t2 )
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In practice a single COSY spectrum presents a map of the complete spin-spin
coupling network in a substance (Nagayama et al, 1980).
1.5 Resonance assignment and quantitation in NMR spectra of biofluids
Usually in order to make assignments in 'H NMR spectra of biofluids
comparison is made with authentic materials or by adding pure substances to the
biological fluid. This has served to assign the major peaks in biofluids. Additional
confirmation of assignments is sought from the application of 2D NMR methods such
as COSY and HMQC (Lindon et al, 1999). The application of 2D J-resolved spectra
pulse sequence is important to spread out the coupling patterns of the high number of
substances of small molecular weight in a biofluid. But even this often results in a lot
of overlapping and further editing is often desirable. This can be achieved by
relaxation editing, diffusion editing and multiple quantum filtering (Liu et al, 1998).
One major advantage of NMR spectroscopy as a tool to study biofluids is that
measurements can often be made with minimal sample preparation (usually only with
the addition of 5- 20% D20 ) and a detailed analytical profile can be obtained on the
whole of the biological sample. Minimal preparation also ensures minimal
perturbation to the sensitive compounds in the biofluid (Nicholson et al, 1989). Other
advantages are that it can be fast with spectra being obtained in 5 to 15 minutes and
also that it can provide detection of all the substances in the biofluid providing that
they are present above the detection limit.
Detailed 'H NMR spectroscopic data exist for most biological fluids and have
been obtained using the above mentioned methods (Lindon et al, 1999, Fan et al,
1986, Sze et al, 1994). Table 1.1 gives data for the substances detected in plasma.
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Most work done in this thesis was based on reconfirming data from that Table and
then proceeding with the quantitation of the concentrations in the biofluids.
Table 1.1
Assignment of peaks to substances from spectra of human plasma. The peaks marked
with an asterisk (*) were used for quantitation of the corrresponding analyte.
Assignment dCn) m
Isoleucine 5-CH3 0.94 t
Leucine * 5-CH3 0.96 t
Leucine 5-CH3 0.97 t
Valine ch3 0.99 d
Isoleucine* p-CH3 1.01 d
Valine * ch3 1.04 d
Ethanol * ch3 1.11 t
Isobutyrate ch3 1.13 d
P-Hudroxybutyrate * ch3 1.20 d
Isoleucine y-ch2 1.26 m
Fucose ch3 1.31 d
Lactate * ch3 1.33 d
Threonine * ch3 1.34 d
Alanine * ch3 1.48 d
Lysine y-ch2 1.48 m
Isoleucine y-ch2 1.48 m
tt-Butyrate ^-ch2 1.56 d
Adipate ch2 1.56 m
Leucine ch2 1.71 m
Lysine 5-CH2 1.73 m
Ornithine y-ch2 1.81 m
Citrulline * P-CH2 1.88 m
N-Acetylglutamate P-ch2 1.89 m
y-Amino-n-butyrate P-ch2 1.91 m
Lysine P-ch2 1.91 m
Arginine * P-ch2 1.93 m
Acetate* ch3 1.95 s
Isoleucine P-CH 1.98 m
N-Acetyl groups ch3 2.02 s
N-Acetyl groups ch3 2.05 s
Glutamate P-ch2 2.10 m
Glutamine * P-ch2 2.14 m
Methionine * S-ch3 2.14 s
n-Butyrate a-CH2 2.16 t
Methionine P-ch2 2.16 m
Acetone * ch3 2.23 s
Valine p-CH 2.28 m
Acetoacetate * ch3 2.29 s
(3-Hydroxybutyrate ch2 2.31 ABX
Glutamate * y-ch2 2.36 m
Oxalacetate ch2 2.38 s
Pyruvate * ch3 2.38 s
P-Hydroxybutyrate ch2 2.41 ABX
Succinate CH 2.43 s
Carnitine CH2(COOH) 2.44 dd
a-Ketoglutarate y-ch2 2.45 t
Glutamine y-ch2 2.46 m
Glutamate yCH2 2.50 m
Methylamine * ch3 2.54 s
Citrate * 1/2CH2 2.67 AB
Methionine s-ch2 2.56 t
Aspartate * P-ch2 2.68 ABX
Dimethylamine * ch3 2.72 s
Dimethyglytcine ch3 2.78 s
Citrate 1/2CH2 2.80 AB
Aspartate P-ch2 2.82 ABX
Asparagine P-ch2 2.86 m
Asparagine P-ch2 2.96 in
a-Ketoglutarate P-ch2 3.01 t
Lysine s-CH2 3.03 t
Creatine * ch3 3.04 s
Creatinine * ch3 3.05 s
Tyrosine ch2 3.06 ABX
Phenylalanine P-ch2 3.13 m
Histidine P-ch2 3.14 ABX
Tyrosine ch2 3.20 ABX
Choline N(CH3)3 3.21 s
P-Glucose C-H2 3.24 dd
Histidine P-ch2 3.25 ABX
Trimethylamine-N-oxide * N(CH3)3 3.27 s
Taurine ch2so3 3.25 t
Betaine N(CH3)3 3.27 s
Phenylalanine P-ch2 3.28 m
Myo-Inositol H5 3.28 t
Tryptophan ch2 3.31 ABX
Proline 5-CH2 3.33 m
P-Glucose C-H4 3.40 t
a-Glucose C-H4 3.41 t
Proline 5-CH2 3.42 m
Carnitine nch2 3.43 m
Taurine * nch2 3.43 t
































































































1-Methylhistidine H4 7.05 s
Tyrosine H2/H6 7.20 d
Phenylalanine * H2/H6 7.33 m
Phenylalanine * H4 7.38 m
Phenylalanine * H/H5 7.43 m
3-Methylhistidine H2 7.61 s
1-Methylhistidine H2 7.77 s
Histidine * C2H 7.83 s
Formate CH 8.46 s
We have used 'H NMR spectroscopy to quantitate the amounts of different
substances present in the biological fluids studied. To ensure that this analysis is
quantitative some assumptions were made. All spectral lines of the compounds
studied were narrow compared to chemical shift differences. To obtain quantitative
results we integrated the areas under the lines bearing in mind that electronic
integrators under the best conditions are accurate to 2% of full scale measurement.
The lines studied were clearly defined and the signal to noise ration was high. There
were no major satellite peaks present and those seen did not overlap with peaks that
were studied. Spinning side bands were added to the main line band for the
integration. By gating the decoupler off during the delay period the Nuclear
Overhauser Effect (NOE) was eliminated. Finally the lines studied for the quantitative
measurements were not produced by quickly exchangeable protons.
Chemical shifts were referenced internally to the singlet methyl resonance of
Sodium 3-(trimethylsilyl 2,2,3,3-2H4) -1 propionate (TSP) at zero ppm. Quantitation
of compounds present in the samples was achieved by two alternative means, (a)
integrals were measured relative to that of a known quantity of TSP (10 mg/ml )
present as an internal standard to the solution (Foxall et al, 1993b). (b) When signals
were partially overlapped, peak height measurements were used, taking into account
the appropriate coupling pattern of intensities of the non-overlapped lines.
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1.6 NMR Spectroscopy of blood plasma
Blood plasma is a constituent of normal blood which is obtained from
untreated whole blood after the addition of an anticoagulant (trisodium EDTA or
lithium heparin) and after centrifugation in order to discard all the cellular constituents
of blood. Plasma consists mainly of water in which there are several distinct domains.
These include an essentially isotropic, free-solution environment, which contains
colloidal structures and aggregates of macromolecules such as lipids and proteins. It
also contains a large number of inorganic and low molecular weight solutes.
The physicochemical complexity of plasma is expressed in its 'H TMMR spectra
by the range of linewidths of the signals. This means that biochemical information is
difficult to extract and most of the previously mentioned techniques are routinely used
to extract maximum information from the spectra. Eventually, 'H NMR spectra of
plasma can provide a plethora of biochemical information on both low molecular
weight metabolites and macromolecular structure and organisation. The usefulness of
'H NMR spectra of plasma has been the central theme of recent reviews (Nicholson et
al 1995; Lindon et al, 1999). It has been noted that there are difficulties in obtaining
quantitative determinations in blood plasma but new techniques have shown that there
is potential to overcome that, if every substance is considered separately. For
example protein binding of lactate makes about 30% of its concentration NMR
invisible initially but after addition of ammonium chloride this can be overcome. A
similar effect is reported for acetoacetate. (Bell et al, 1988a).
Although 'H NMR spectra of plasma have been used to study metal
complexes (Nicholson et al, 1983), protein - ligand binding (Bell et al, 1988a),
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lipoproteins (Ala-Korpela 1995) and to evaluate the molecular diffusion coefficients
of plasma substances (Liu et al, 1995), their main role is to characterise different
pathological states.
1.7 NMR spectroscpy of plasma in pathological states
1.7.1 Malignant diseases
Excitement was generated when a paper reported that by using *H NMR
spectra one could differentiate between patients with malignant tumours and normal
subjects. (Fossel et al, 1986). This was based on the study of specific signals arising
from lipoproteins. Although numerous researchers have attempted to reproduce the
original findings, they have been unable to do so. Other factors, including diet (Bell et
al, 1988b), age and gender (Engen et al, 1991) and hyperlipidaemia (Mims et al,
1989) have been found to cause similar changes in this signal pattern. Other
lipoprotein bands especially from fucosilated moieties have also been studied by *H
NMR spectroscopy (Mountford et al, 1987). Other studies of 'H NMR spectra of
blood plasma in malignant disease have included general studies (Otvos et al, 1987),
testicular cancer ( Hofeler et al, 1989) and lung cancer ( Schumacher et al, 1990),
comparison of NMR and chromatographic methods (Chmurne et al, 1988), the effects
of plasma sialic acids (Kriat et al, 1992) and the effect of dyslipoproteinaemias
(Herring et al, 1989).
1.7.2 Transplantation
Heart transplantation has been studied most. Most studies concentrated on
providing evidence of rejection after transplantation. Studies on the same signals of
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lipoproteins reported accurate identification of rejection (Eugene et al, 1988, 1991).
Another study found a correlation between the areas of two glycoprotein signals and
the isovolumetric left ventricular relaxation time post transplantation (Pont et al,
1991). In kidney transplantation a study was performed to look at these same
lipoprotein signals but the results were negative (Eugene et al, 1989) .
1.7.3 Malaria
One study exists looking at inpatients seropositive to Plasmodium which
showed higher lactate concentrations than controls. It also showed that there were
significant differences in the same signals of lipoproteins as previously (Nishina et al,
1988).
1.7.4 Diabetes mellitus
In NMR spectra there are marked elevations in the concentrations of all
three ketone bodies i.e. acetoacetate, acetone and B-hydroxybutyrate and glucose in
diabetic patients. The levels of lactate, valine and alanine were also measured and
there was a good correlation in concentrations measured by NMR and standard
biochemical methods. Concentrations of VLDL lipoproteins and chylomicrons were
found to be decreased. In non insulin dependent diabetics the level of triglycerides
observed was high, decreasing after better diabetic control (Bell et al, 1989).
1.7.5 Renal diseases
There has been a study comparing plasma from patients on dialysis, patients
with early renal failure and controls (Grasdalen et al, 1987). Acetate accumulation
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was seen in patients in dialysis when plasma components were monitored. TMAO
was high in patients with renal failure. In another study TMAO concentrations
correlated with the degree of renal failure (Foxall et al, 1993c). Dimethylamine and
trimethylamine were shown to be elevated along with lactate and creatinine. In the
same study, plasma from patients with chronic renal failure and controls were
compared and metabolic abnormalities were seen (Foxall et al, 1993c). Metabolic
abnormalities were also seen in the plasma of patients with uraemic syndrome in
another study (Foxall ,1993 d).
1.7.6 Liver diseases
Liver diseases have been the centre of many NMR studies. Most of them were
performed in what is known as the in vivo setting. This means that instead of using
body fluids as samples to look at metabolites, whole organisms are placed in an NMR
scanner. The resulting spectra have the advantage of looking at the structure of a
whole organ and identify differences in metabolic activity between parts of the organ.
The biggest disadvantage of this technique has been its limitation by the study of a
living organism and the subsequent use of low power magnets normally less than 3.0
T. The spectra acquired have a very low resolution and a lot of overlapping and it is
almost impossible to quantitate concentrations directly from the spectrum. Another
setback of the method is that, as it uses small voxels to acquire spectra, a considerable
amount of time is spent for one experiment and this can be up to 2 hours.
A number of in vitro studies have been conducted looking at other nuclei than
hydrogen in particular carbon and phosphorus. Phosphorus NMR spectroscopy has
an advantage in producing data reflecting the bioenergetics of the cell studied but
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apart from that it is difficult to obtain information about other key metabolic pathways
which do not contain high energy phosphorus bonds. Carbon NMR spectroscopy can
be effective but the mean time for the acquisition of one set of spectra is a lot higher
than with hydrogen and the spectra are a lot more complex to analyse.
There are few studies in liver disease that have used 'H NMR Spectroscopy.
Although most of them were set out to answer specific questions in a general context
of research they definitely show the potential of the technique. Two studies have used
hydrogen and carbon NMR to study the performance of specific reactions in the
Kreb's cycle in rat livers (Petersen et al, 1994, 1995). Other studies have looked at
liver metabolism in the context of cold hypoxia (Lockett et al, 1996; Churchill et al,
1997; So et al, 1998). One study has looked at the intracellular metabolites of
cultured liver cells (De Loecker et al, 1993) and another study has looked at liver
slices from animals of different species (Fuller et al, 1994). One study still in abstract
form has looked at some metabolites in the plasma of patients suffering from cirrhosis
caused by primary biliary cirrhosis before and after Transjulular Intrahepatic
Portosystemic Stent Shunt (TIPSS) and concluded that there were differences
between controls and patients before and after TIPSS (Jalan et al, 1995a). No
systematic study was performed before in either the area of cultured primary
hepatocyte by NMR and how culture conditions affect their performance or in
patients suffering from acute of chronic liver failure.
49
1.8 Liver anatomy
1.8.1 Gross clinical anatomy.
The liver is the largest internal organ in the body. It weighs about 1.5 (1.2-1.8)
kg and is roughly wedge-shaped. It is situated in the right hypochondrium and
occupies most of the right upper quadrant of the abdomen. Its upper border lies
between the fifth and sixth ribs and its inferior border extends from the left extremity
of the upper border to the tip of the tenth rib.
The liver has a diaphragmatic surface to which the falciform ligament is
attached, and a visceral surface which contains the porta hepatis where the hepatic
artery and portal vein are entering the liver and the common hepatic duct leaves the
liver, the gallbladder fossa and the inferior vena cava (Figure 1.5).
The parenchymal mass of the liver is divided into two main lobes, the right
which is larger and the left. The right lobe also contains the quadrate, the caudate and
Riedel's lobes (Figure 1.5).
The blood supply to the liver is via the hepatic artery which supplies 25% of
the total blood flow and 50% of the oxygen and the portal vein which supplies 75% of
the blood flow and the other 50% of the oxygen supply (Figure 1.5).
1.8.2 Microscopic anatomy and function
The functional unit of the liver is the hepatic acinus (Rappaport, 1958). This
is defined as a mass of parenchyma that has a single blood supply by hepatic arterial
and portal venous branches in the smallest portal tract. The portal tracts are well
defined and contain a portal vein radicle, an hepatic arteriole and a bile ductule. A
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simple acinus contains a portal triad, hepatocytes that are the predominant liver cells,
sinusoids which are the capillary vessels of the liver and two hepatic veins situated at
the edges of the acinus. The acinus looks superficially homogeneous but in fact it is
heterogeneous in respect of the hepatocytes, the sinusoids, the perisinusoidal cells and
the extracellular matrix.
The hepatocytes near the portal triad are said to belong to zone 1. They are
well supplied in oxygenated blood, and in the normal well fed state their enzymatic
armoury is geared towards catabolism of fatty acids and gluconeogenesis. They are
thought to be more resistant to injury that the cells in zone 3 which is near the hepatic
vein.
Hepatocytes in zone 3 are not well supplied in oxygenated blood and their
main source of energy is glycolysis. They are also more active in drug metabolism
(Jungermann et al, 1982) (Figure 1.6).
Kupffer cells, the liver macrophages are found in the sinusoids particularly in
zone 1. Hepatic stellate cells found in the space of Disse, in the perisinusoidal space
are most numerous in zone 3. They are important in the production of connective

































Figure 1.4 Liver lobes shown from the diaphragmatic surface (A) and
the peritoneal surface (B), and a schema of the hepatic
vascularisation (C)
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Figure 1.5 The zonal subdivision of the hepatic acinus. TPT= terminal
portal tract, THV=terminal hepatic vein
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1.9 Liver physiology and biochemistry
1.9.1 Carbohydrate metabolism.
The liver acts as the glucostat of the body. The maintenance of the blood
sugar is one of the most important functions of the liver. All hepatocytes are capable
of metabolising glucose. In the well fed state glucose is stored in the form of
glycogen. If the glycogen stores are full and glucose is still coming into the liver from
the portal blood then glucose is diverted into fatty acid synthesis. Fatty acids are then
esterified and stored as triacylglycerols in the liver itself or in the adipose tissue.
In starvation or simply in between meals the liver uses Cither glucose or fatty
acids to extract energy. Glucose can be oxidised either aerobically or anaerobically.
Both paths have a common metabolic pathway known as glycolysis. One molecule of
glucose is transformed to two molecules of pyruvate.
If enough oxygen is present then the aerobic metabolism is active. Pyruvate is
fed into the Krebs cycle and it is completely oxidised to form three molecules of
carbon dioxide. Energy is conserved in ATP molecules and water is also formed.
ATP can then be used to provide energy for biological work. The net yield from one
molecule of glucose is 38 molecules of ATP (Figure 1.7).
If the hepatocytes are operating under hypoxic conditions then the anaerobic
metabolism becomes active. Pyruvate is transformed to lactate which is the end
product of the pathway. Anaerobic oxidation of one molecule of glucose provides
only 3 molecules of ATP. Lactate as a by-product of anaerobic metabolism is
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excreted from the hepatocytes as it can cause rapid changes in their physiological pH
(Figure 1.7).
Hepatocytes are capable of metabolising all the simple sugars. Galactose can
be metabolised to glucose with consumption of ATP. Fructose can also be
phosphorylated with consumption of ATP and can enter the pathway of glycolysis.
Hepatocytes are not only capable of breaking down glucose, they are also
capable of synthesising glucose. Gluconeogenesis is unique to the liver and kidney
cortex. The main substrates for gluconeogenesis are lactate and amino acids but
glycerol can be used as well. The bulk of lactate would normally be imported from
the muscles who tend to use quite extensively glucose anaerobically for their energy
requirements (Figure 1.7).
Glycogen is a unique form of glucose storing molecule. Approximately 80 g of
glycogen can be stored in the liver. This is stored very temporarily as the glycogen
would be the first line of energy storage that would normally be used if need arises.
Glucogenolysis is a quick and efficient way to extract energy from stored glucose.
Glycogen molecules are cleaved to their individual glucose molecules and they then
enter glucolysis (Figure 1.7).
























CH3(CH2)12-- j--SCoA HL-bydroxyacyiC A






















The liver plays a pivotal role in lipid metabolism. It can form de novo
triglycerides and it can also oxidise fat. It also plays a major role in the metabolism of
the lipoproteins which carry the esterified lipids into the blood stream. The liver
produces very low density lipoproteins (VLDLs) and high density lipoproteins
(HDLs). It also degrades intermediate density lipoproteins (IDLs) and low density
lipoproteins (LDLs)
Triglycerides are the final product of fat synthesis. They are composed of
three molecules of free fatty acids and a molecule of glycerol. Fatty acids are
produced in the liver from the excess of glucose. They are esterified with glycerol in
the cytoplasm of the hepatocytes and are then incorporated into the lipoproteins to
form very low density lipoproteins (VLDLs). Oxidation of triglycerides is also taking
place in the hepatocytes when the cells need energy. Triglycerides are cleaved in the
cytoplasm to form glycerol and free fatty acids. The latter move then into the
mitochondria of the cells and they undertake there (3-oxidation which produces ATP
and acetyl-CoA. Acetyl-CoA can then enter the Krebs cycle and produce more ATP
(Figure 1.8).
During starvation, severe prolonged exercise or uncontrolled diabetes acetyl-
coA cannot enter the Krebs cycle. It is then diverted into ketogenesis to form the
ketone bodies acetoacetate, P-hydroxybutyrate, and acetone which is spontaneously
produced from acetoacetate. All three are collectively known as the ketone bodies.
The liver is particular at that point as it normally has an excess of acetyl-CoA which
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is coming mainly from the adipose tissue. The liver tissue then forms ketone bodies,
mainly acetoacetate which then exports to other tissues (Figure 1.8).
1,9.3 Protein and amino acid metabolism.
The liver is the principal site of synthesis of all the circulating proteins apart
from the y-globulins. It receives amino acids from the intestine and the muscle and
uses them to form proteins. By controlling gluconeogenesis and transamination , the
other two metabolic pathways that can consume amino acids, it regulates the level of
protein in the plasma.
Albumin is the major protein contained in the plasma. It has a half-life of 16-
24 days and 10-12 g are synthesised daily. Reduced synthesis of albumin over
prolonged periods of time results in hypoalbuminaemia which is a characteristic of
chronic liver disease.
Transport or carrier proteins such as transferrin or ceruloplasmin and other
proteins like ai-antitrypsin and a- fetoprotein are also synthesised by the liver. It can
also produce all coagulation factors apart from factor VIII and components of the
complement system.
The liver also breaks down proteins, into their constituent amino acids that
can either be rearranged to form new types of proteins or can be further degraded to
produce urea which is then transported to the kidneys for excretion.
Amino acid metabolism is an essential element of hepatocyte physiology.
Liver cells can synthesise all the non-essential amino acids. Tyrosine is formed from
the essential amino acid phenylalanine. Serine, glycine and cysteine are made from
intermediates formed in the glycolytic pathway. Glutamate, glutamine, proline and
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arginine are formed from the Krebs cycle intermediate a-ketoglutarate. Aspartate is
formed from oxaloacetate, another intermediate of the Krebs cycle and asparagine is
synthesised by transamidation from glutamine (Figure 1.9).
Amino acids play a pivotal role in the production of substrates in the
hepatocyte. As well as being the building blocks of proteins they can be used in
starvation by the hepatocytes to produce glucose. Amino acids can be transformed to
pyruvate (i.e. methionine, alanine, tryptophan), a-ketoglutarate (i.e. glutamate,
arginine) or 2- phosphoglycerate (i.e. phenylalanine, aspartate, serine) and those
substrates can be incorporated into the gluconeogenetic pathway (Figure 1.10).
Oxaloacetate and pyruvate formed from amino acids can be intermediates in
the fatty acid synthesis, so amino acids can be used for triglyceride synthesis. Via the
1-carbon pool and folate metabolism amino acids can be used for the synthesis of
purines and pyrimidines which are the building blocks for nucleotides.
Overall each amino acid in the hepatocyte can be broken down and the
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1.10 Liver cirrhosis
Cirrhosis is the final common pathway of most chronic liver injuries. It is a
combination of hepatic fibrosis and nodular regenerative hyperplasia. Although there
are many causes of chronic liver injury only a small number of those, account for the
majority of cases. In the developed world alcohol accounts for 50 -60% of all cases
and is the most important cause. In Africa and Asia the most important cause is
hepatitis B infection which accounts for around 10% of cases in the Western world.
In recent years hepatitis C is increasingly recognised as an important cause of
cirrhosis world-wide and accounts for more than 10% of cases of cirrhosis in the
developed world. Primary biliary cirrhosis and autoimmune hepatitis are important
although infrequent causes of cirrhosis as the patients suffering from them are very
good candidates for liver transplantation. Metabolic causes such as Wilson's disease
and haemochromatosis are important causes since early recognition can lead to
effective treatment. Although our understanding of the pathogenesis of cirrhosis has
improved and new causes are increasingly recognised, a significant minority (5-10%)
are still labelled as cryptogenic cirrhosis (Hayes, 1995).
The incidence of cirrhosis in most parts of the world is not known and
must vary considerably. In the Western world it is estimated that the incidence of
cirrhosis is around 15 -25 in 100000 population (Saunders et al, 1982). During the




Chronic liver injury resulting in the development of inflammation and
subsequent progression to cell death is the common path for the development of
fibrosis. The mechanisms that result in death of hepatocytes are complex and differ
depending on the etiologic agent. Direct cytotoxic effect of the causative agent,
immunological mechanisms with neoantigen formation and free radicals production
are some examples.
It has emerged that the role of stellate cells in the process of fibrosis is
pivotal. These cells are possibly activated by cytokines, start to proliferate and
synthesise collagen and laminin. This results in production of extracellular matrix
around the sinusoids and as a result the hepatic sinusoids are capillarised. Increases of
all types of collagen occur but it seems that type I and type IV collagen are
preferentially produced. (Friedmann et al, 1993).
Simultaneously, hepatocytes lose their microvilli and the sinusoidal
fenestrations are occluded. This results in reduced hepatic uptake of water and solute
from the circulation aggravating the liver function as cirrhosis progresses (Villeneuve
et al, 1996)
The production of collagen leads to production of large bundles of fibrous
tissue and fibrosis of the liver. This causes disruption of the liver framework and
simultaneous hepatocellular regeneration causes formation of nodules.
1.10.2 Pathology
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The whole mass of the liver should be involved in fibrosis and
regeneration in order for the liver to qualify as cirrhotic. Regenerated nodules are
surrounded by connective tissue. But in the nodule, the normal liver appearance is
preserved. Other features that can be encountered in the parenchyma of a cirrhotic
liver are, variation in the size of hepatocytes, increased thickness of the liver cell
plates and abnormal vasculature.
Two main categories of cirrhosis have been traditionally laid out depending
on the nodule size. In micronodular cirrhosis the size of the nodules is less than 3mm
in diameter, while in macronodular cirrhosis it is typically more than 3mm in diameter.
When both sizes are present cirrhosis is then described as mixed (Anthony et al,
1977).
1.10.3 Clinical Features
These are divided in hepatic and portal venous features and extrahepatic
features (Hayes, 1995). Abdominal pain, palpable liver and hepatomegaly, palpable
spleen and splenomegaly together with dilated superficial collaterals radiating from
the ombilicus are the commonest hepatic and portal signs and symptoms.
The commonest extrahepatic features are manifested on the skin and in the
circulation. Skin signs include jaundice which is a sign of advanced cirrhosis,
pigmentation, finger clubbing, Dupuytren's contractures, bruising and purpura.
Vascular abnormalities include spider telangectasias and epistaxis. A
hyperdynamic circulation is characteristic of cirrhosis. Patients have tachycardia,
increased cardiac output, low blood pressure and low peripheral vascular resistance.
Splanchnic circulation is also affected on top of the abnormalities in the systemic
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circulation. There is increased splanchnic blood flow, portal hypertension and
increased flow in the portosystemic collaterals.
Another clinical feature of cirrhotic patients is hypogonadism manifested
with impotence and small testes in males and dysmenorrhea, infertility and benign
cysts of the breast in females. Feminisation of male patients occurs characterised by
gynaecomastia and loss of body hair. Finally parotid enlargement is frequent in
patients with cirrhosis
1.11 Complications of cirrhosis
The main complications of cirrhosis result from portal hypertension ,
portosystemic shunting and liver failure and include variceal haemorrhage, hepatic
encephalopathy, ascites, renal dysfunction (hepatorenal syndrome) and pulmonary
dysfunction (hepatopulmonary syndrome). We will examine in more details the
pathogenesis of hepatic encephalopathy.
1.12 Chronic Hepatic encephalopathy
Chronic hepatic encephalopathy (CITE) is a complex neuropsychiatric
syndrome that occurs in patients with cirrhosis and has a potential for full reversibility.
It is characterised by global depression of the central nervous system and has different
degrees of severity (Table 1.2). In the majority of patients CHE is subclinical and no
overt signs and symptoms are present. Those patients have altered reaction times and
impaired ability to perform psychometric tests. In 30% of patients the full blown
syndrome is present with alterations in behaviour, mood, personality and disturbances
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in consciousness. CHE is usually episodic and relapsing but some patients exhibit a
chronic protracted course (Jalan et al, 1996).
Table 1.2
West Haven criteria for grading mental state in hepatic encephalopathy
Grade 0 No abnormality detected clinically
Grade 1 Trivial lack of awareness, euphoria, anxiety
Shortened attention span
Impaired performance in addition or substraction
Grade 2 Lethargy, apathy, disorientation for time and space
Obvious personality change
Inappropriate behaviour




Mental state not testable
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1.12.1 Pathogenesis
Many theories regarding the pathogenesis of CHE were popular at
different times but the exact mechanisms remain unclear. We are going to summarise
the most important elements that are thought to play a role in the pathogenesis of this
syndrome.
1.12.2 Alterations in the blood-brain barrier
Patients with CHE exhibit a functional derangement of this protective
mechanism (Kato et al, 1992). There is an increase in the transport of neutral amino
acids and a decrease in the transport of basic amino acids (Ono et al, 1978). This
could be fundamental in the development of CHE because levels of amino acid
neurotransmitters in the brain, such as glutamate, aspartate and glycine are directly
affected and the increased concentration of aromatic amino acids transported across
the blood brain barrier act as substrates for the synthesis of neuroactive substances
such as serotonin, kynurenine, quinolinic acid and tryptamine (Fischer et al, 1971).
Although the mechanism of this derangement is not clear, it is thought that the
disturbance of the blood brain barrier provides the mechanism by which other factors
in CHE may operate.
Changes in energy metabolism occur in the brain in patients with CHE.
There is decreased cerebral blood flow and decreased consumption of glucose and
oxygen. There seems to be a derangement in high energy phosphate bonds as well
(Lockwood et al, 1987). Although energy metabolism in the brain seems to be
deranged, there is so far no direct evidence linking the energy metabolism alterations
to the cause of CHE. It is thought that they could be secondary epiphenomena.
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1.12.3 Ammonia
Like other gut derived toxins ammonia fulfils the criteria for potential
neurotoxins that contribute to CHE. All candidates should be produced in the gut, be
nitrogenous, be found in the portal circulation, be metabolised by the normal liver and
should cross the blood brain barrier (Basile et al, 1991). Ammonia is produced by the
action of gut bacteria on food, by breaking down of dietary proteins, by metabolising
glutamine and other circulating amino acids. It is detoxified in the liver through the
urea cycle and through the synthesis of glutamine from glutamate in the liver, muscle
and brain. In cirrhotics, due to dysfunction of the hepatocytes and portosystemic
shunting, increased concentrations of ammonia in the blood and the CNS have been
demonstrated (Lockwood et al, 1991).
Ammonia diffuses readily into the brain and can induce intracranial
hypertension in animal models (Voorhies et al, 1983). The main pathologic change in
the CNS associated with CHE is the development of Alzheimer's Type II astrocytes
which are characterised by large, pale nuclei, large nucleoli, and an increased number
of intracellular organelles that are involved in the production of metabolites by the cell
(Adams et al, 1953). It is postulated that ammonia plays a pivotal role in that
phenomenon. Ammonia in the brain is detoxified by combination with glutamate and
production of glutamine. The enzyme responsible for this reaction in the brain is
glutamine synthetase and is exclusively found in the astrocytes. Also, upregulation of
glutamate transporter GLT-1 is found on cerebral astrocytes in animal models of
CHE. Ammonia inhibits the channels that pump chloride ions into the cells. This leads
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to increased intracellular concentration of chloride, and inhibition of excitatory
postsynaptic electrical activity (Goldstein, 1984).
Ammonia can also facilitate the uptake of tryptophan in the brain.
Tryptophan is a substrate for the generation of neuroinhibitors like serotonin and
tryptamine which were found to be elevated in CHE and neuroexcitators like
quinolinic acid which was also found to be elevated in CHE. Ammonia is also
implicated in the neurodrepression of CHE via reducing glutamatergic
neurotransmission.
Although ammonia seems to be a key element in the development of CHE
its significance must be put into context. In favour of the ammonia hypothesis is the
fact that hyperammonaemia in other conditions produces a CHE like picture, as well
as the fact that treatment of patients with non-absorbable disaccharides reduces blood
ammonia levels and improves encephalopathy. The hypothesis is also supported by
the fact that feeding ammoniagenic substances to normal volunteers produces
encephalopathy. However-and this contradicts the hypothesis- there is no correlation
between ammonia levels and severity of encephalopathy and CHE can occur with
normal ammonia levels (Jalan et al, 1996).
Based on the ammonia hypothesis various treatment regimes for CHE have
been developed. Patients are given a low protein diet to minimise ammonia
production, lactulose and lactitol that can reduce ammonia available for absorption by
incorporating it into bacterial proteins. They are also prescribed non-absorbable
antibiotics to reduce production of ammonia by gut flora. Another new treatment is
the administration of sodium benzoate that facilitates hippurate synthesis from excess
ammonia (Jalan et al, 1996).
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1.12.4 Glutamate
Besides being an intracellular buffer in astrocytes for ammonia
detoxification, glutamate is also the predominant excitatory neurotransmitter in the
brain. Glutamate concentration is regulated at the synaptic level of the neuron.
Astrocytic glutamate uptake is impaired in CHE (Raabe, 1987). Also glutamate
binding sites in the postsynaptic neuron are down regulated (Norenberg et al, 1985).
Both mechanisms contribute to increased extracellular concentrations of glutamate.
This could be a contributing mechanism to the overall impaired brain function in CHE.
Based on the glutamate hypothesis, a new treatment has been developed
recently to treat exacerbations of CHE. L-Ornithine-L-Aspartate (LOLA) a
dicarboxylate that promotes glutamine synthesis in the hepatocytes and stimulates the
urea cycle has been used in clinical trials with satisfactory results (Lewelling et al,
1991).
1.12.5 GABA and endogenous benzodiazepines.
Another theory that was en vogue during the early 90's was the one
involving ?-aminobutyric acid (GABA), and endogenous benzodiazepines. GABA is
the major inhibitory neurotransmitter in the brain. It is a product of glutamate in the
brain and exerts its action in the brain through GABAa receptors (Jalan et al, 1996).
The activity of these receptors is thought to be regulated by endogenous
benzodiazepines that bind to a closely linked site (Jones et al, 1988). Endogenous
benzodiazepines are increased in the blood and brain of CHE patients (Olasmaa et al,
1990). The evidence of deranged GABA metabolism is not convincing. Flumazenil, a
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benzodiazepine antagonist has been used in the treatment of CHE with disappointing
results (Pommier-Layrargues et al, 1994).
1.12.6 False neurotransmitters.
Noradrenaline, dopamine and serotonin are cerebral neurotransmitters.
Dopamine and noradrenaline seem to be decreased in the brain in CHE whereas
serotonin seems to be increased in the brain in CHE. The net result could therefore be
an increase in neuroinhibition (Jalan et al, 1996). Aromatic amino acids in the brain in
CHE are increased and can block the enzyme tyrosine hydroxylase which is vital for
the production of cathecholamines. However production of other amines such as
tyramine and octopamine is not affected. Those false neurotransmitters could bind to
catecholamine receptors, induce neuroinhibition and further suppression of CNS
function (Fischer et al, 1971).
Based on that theory, branched chain amino acids who compete for
absorption sites with aromatic amino acids have been infused to patients suffering
from CHE. The results so far have been disappointing (Morgan, 1990) .
1.12.7 Manganese
Theories have been developed for a role of manganese in CHE. They are based on
the observation that similar patterns of hyperintesity in the basal ganglia are observed
in patients with chronic liver disease and manganese toxicity using T]-weighed
Magnetic Resonance Imaging (MRI) (Krieger et al, 1995). Increased manganese
concentrations have been observed in the globus pallidus of patients (Pommier-
Layrargues et al, 1995). Blood manganese concentrations have also been reported to
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be increased (Krieger et al, 1995). It has been suggested that increase manganese
concentration in the basal ganglia could be responsible for the extrapyramidal features
of patients with CHE but this has not been supported overwhelmingly.
As this brief synopsis has tried to show there are many theories regarding
the pathogenesis of CHE and many substances have been implicated in it. The
evidence does not support the idea of one substance being only and wholly
responsible for the pathogenesis of CHE and it seems that CHE is a multifactorial
disease and there is scope for further studies and investigation into the role of other
substances in its pathogenesis.
1.13 Fulminant Hepatic Failure
Fulminant hepatic failure (FHF) is a clinical syndrome characterised by
massive hepatocellular dysfunction, in the absence of chronic liver disease, resulting in
hepatic encephalopathy. The failing liver has a potential to regeneration can recovery
can occur without permanent sequela.
1.13.1 Definition
The definition of fulminant hepatic failure is still cause for debate. In the
original definition by Trey and Davidson (1970), encephalopthy has to develop within
8 weeks of the onset of symptoms for the syndrome to be called fulminant hepatic
failure. If encephalopathy presents between 8 and 24 weeks then the syndrome is
defined as late-onset hepatic failure. Various other definitions have been brought
forward during the last thirty years. Recently, the King's College Hospital Group in
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London, proposed a new terminology with the term acute liver failure at its centre.
Patients presenting within 7 days of the onset of symptoms were termed hyper-acute
liver failure, those presenting within 8 -28 days were termed acute liver failure and
those presenting between 29 and 72 days were termed subacute liver failure (O'Grady
et al, 1993). Irrespective of terminology, all studies seem however to agree that the
patients with the most rapid onset of encephalopathy have the best chance of
spontaneous recovery. We have adopted the term fulminant hepatic failure
throughout this thesis to describe the acute liver injury and failure syndrome.
1.13.2 Prognosis and aetiology
Fulminant hepatic failure is fairly uncommon and has a high mortality
approaching 80% in some series (O'Grady et al, 1993). The prognosis depends on
aetiology and concomitant liver disease.
Paracetamol overdose which is the most frequent cause of FHF in the UK
has a rather better prognosis with an overall mortality of around 40% (Plevris et al,
1998). Paracetamol metabolism produces an unstable nucleophilic intermediate N-
acetyl-/?-benzoquinone imine (NAPQI), which damages cells, if produced in amounts
greater than can be detoxified by hepatic protective substances such as glutathione.
Paracetamol hepatotoxicity is more common in alcoholics and in patients taking
enzyme-inducing drugs that induce the cytochrome P450 system, which produces the
toxic metabolite. The antidote N-acetylcysteine (NAC), by acting as a sulfydryl donor
neutralises the toxic compound. There is evidence to suggest that although patients
74
benefit most within lOhrs of the overdose from NAC, late administration is also
beneficial (Harrison et al, 1990).
Hepatitis A is the commonest cause world wide. It has also overall a
better prognosis with survival rates of around 50% although only 0.4% of patients
suffering from acute hepatitis A will develop a fulminant course (Hoofnagle et al,
1995). Although Hepatitis A virus is directly cytotoxic there is also evidence of cell
mediated toxicity in fulminant hepatitis A.
Hepatitis B virus infection is a common cause of FHF in many countries.
It is associated with HBV reactivation, HBe antigen/antibody seroconversion,
coinfection and superinfection with Hepatitis D virus and HBV precore mutant
infection. Other hepatotropic viruses like Hepatitis C Virus, Hepatitis E virus,
Cytomegalovirus, Epstein-Barr virus, Herpes Simplex virus, Varicella-Zoster and
Herpes virus-6 are all rare causes of fulminant hepatic failure (Tibbs et al, 1995).
Other drugs can cause liver damage and most produce their effect on an idiosyncratic
basis. Wilson's disease can produce a fulminant picture and Reye's syndrome is also
characterised by encephalopathy, cerebral oedema and fatty liver (Plevris et al, 1998).
1.13.3 Pathology
The commonest histological finding in FHF, irrespective of aetiology is
severe hepatocyte necrosis. In paracetamol overdose a panacinar eosinophilic
necrosis is observed 2-3 days after the injury (Portmann et al, 1975). The centrizonal
areas are mostly affected, while the periportal areas are commonly preserved.
Cholangioles are proliferating in the damaged areas. Cholestasis is observed in the
remaining hepatocytes and is most prominent after sepsis. Inflammation is often
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lacking until the late stages of the disease. Fatty changes in the hepatocytes are
observed in some causes of FHF. The remaining liver cells have the ability to
regenerate and this has been demonstrated by immunostaining of proliferating cell
nuclear antigen (Koukoulis et al, 1992).
1.14 Clinical course of acute liver failure
The clinical course is that of a progressive multi organ failure. The loss of
functioning hepatocytes has adverse metabolic consequences. The toxins produced by
the liver have systemic effects and the immune system is compromised. We will
briefly describe the multi organ failure concentrating more on the brain, the renal and
cardiovascular manifestations and the coagulopathy.
1.14.1 Cerebral dysfunction
Encephalopathy is the hall mark of FHF. The West Haven criteria were
produced to assess the different degrees of severity as in CHE. As patients progress
to grade III or IV coma, cerebral oedema which is a unique manifestation of fulminant
hepatic failure appears. Cerebral oedema occurs in 70-80% of FHF patients in coma
(Lee, 1993). The pathogenesis of cerebral oedema is not clearly understood. The
most plausible hypothesis implicates ammonia and glutamate. It is thought that
glutamate in the astrocytes of the brain detoxifies ammonia by combining with it and
producing glutamine. The glutamate-glutamine system serves according to this
hypothesis as a buffer system in the astrocytes. Myo-inositol, another astrocytic
compound is thought to buffer the intracellular water content of the astrocytes.
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Excess ammonia exhausts the glutamate-glutamine system particularly as uptake of
extracellular glutamate is impaired in the failing astrocytes. An excess of intracellular
ammonia would also deplete the myo-inositol buffering system and the net result
would be astrocytic swelling in the brain (Goldstein, 1984). Although this theory has
generated a lot of enthusiasm, it remains to be adequately proven in the context of
FHF
Cerebral oedema is the primary cause of death in most FHF patients.
Intracranial pressure (ICP) rises and the clinical signs of it are summarised in Table
1.3. It is also accompanied by reduced cerebral blood flow and reduced cerebral
oxygen consumption. This series of events leads to cerebral herniation and coning
through the foramen magnum and eventually the patient develops apnoea and dies.
The clinical signs can occur late or be absent and intensive monitoring can be
potentially life saving. Intracranial pressure monitoring with an epidural bolt can show
early ICP rising and appropriate therapy with mannitol or thiopentone can be
instituted (Blei, 1991). Oxygen delivery to the brain can be monitored via a jugular
bulb catheter, but this is an invasive and potentially dangerous procedure.
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Table 1.3
Clinical signs of raised intracranial pressure
1 Systolic hypertension (paroxysmal or sustained)
2 Bradycardia
3 Increased muscle tone, opisthotonos, decerebrated posturing
4 Pupillary abnormalities (sluggish or absent response to light)
5 Brain stem respiratory patterns, apnoea
1.14.2 Infection and sepsis
FHF patients are prone to develop infections and generalised sepsis
because their immune system is compromised. Complement concentrations, bacterial
opsonisation, white cell chemoattraction and bacterial killing and Kupffer cell function
are all impaired. Patients are also subject to an array of invasive procedures (Canalese
et al, 1982). Bacterial and fungal infections complicate FHF. The commonest
bacteria are Gram-positive bacteria especially Staphylococcus aureus. The
commonest Gram-negative organism is Escherichia coli. Fungal infections are
particularly dangerous and mainly due to Candida albicans. Typical signs of infection
are absent in those patients. Early use of broad spectrum antibiotics is recommended.
1.14.3 Haemodynamic abnormalities
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FHF is associated with increased cardiac output and reduced peripheral
vascular resistance both systemic and pulmonary (Bihari et al,1985). Clinically
patients are profoundly hypotensive. Oxygen delivery to the tissues increases but the
oxygen extraction ratio and the oxygen consumption decrease, leading to impaired
tissue perfusion, which is the cause of increased lactate production from the hypoxic
cells.
Treatment is by fluid replacement initially and if that proves ineffective then
vasopressive agents such as epinephrine and norepinephrine.
1.14.4 Coagulation abnormalities
Cogulopathy in FHF is the result of inadequate synthesis and increased
consumption of clotting factors and platelet abnormalities. Monitoring of the
coagulopathy through prothrombin time and International Normalised Ratio (INR) is
the best indicator of changing liver function. Severe haemorrhage is rare, so
prophylactic correction of coagulopathy is contraindicated.
1.14.5 Respiratory complications
They are the result of central hyperventilation and respiratory alkalosis as
the patient becomes progressively encephalopathic. When cerebral oedema develops,
worsening hyperventilation may herald sudden apnoea and tentorial herniation.
Endotracheal intubation is usually undertaken in patients in grade III or IV coma and
mechanical ventilation is instituted. This also helps to prevent aspiration of gastric
contents and pulmonary infection (Plevris et al, 1998).
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1.14.6 Renal failure
An oliguric renal failure develops in half of all FHF patients. Acute
tubular necrosis and functional renal failure may be found. Renal blood flow is
reduced and renin and angiotensin are increased (Wilkinson et al, 1977). Renal failure
is treated with either continuous venovenous or high flow haemofiltration as solute
and osmolality changes should be slow to prevent development of cerebral oedema
(Plevris et al, 1998).
1.14.7 Electrolyte and metabolic abnormalities
Hyponatraemia commonly develops as sodium is shifted intracellular^ and
the NaVK+ -ATPase is inhibited. Hypokalaemia and hypophosphataemia can also
occur (Wilkinson et al,1974). Hypoglycaemia is a hall mark of FHF as the liver has
depleted glucagon stores and cannot clear insulin properly. Routinely patients with
FHF are given 10% glucose solutions intravenously.
1.15 Treatment of acute liver failure.
Orthotopic liver transplantation is the most effective means of therapy for
patients with FHF whose prognosis is poor. The results for liver transplantation for
FHF have significantly improved during the last few years and 1-year survival ranges
between 50% and 80% in different centres (McCashland et al,1996). What has
emerged from studies in Europe and the U.S. is that overall success rates are lower in
the setting of FHF than in elective orthotopic liver transplantation (Bismuth et al,
1996). This can be attributed to the poor clinical condition of the patients at the time
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of transplantation, but also to the inferior quality organs accepted due to the critical
condition of the patients.
Patients for transplantation are selected based on the King's College
Hospital criteria (Table 1.4). Those criteria were found to have a good predictive
accuracy as to which patients have a very poor prognosis if managed conservatively
but can be fulfilled days or weeks after the onset of disease (O'Grady et al, 1989).
Although orthotopic liver transplantation is the only hope of survival for these
patients, only a selected few can benefit from such therapy.
In this thesis by using 'H NMR Spectroscopy, in association with
biochemical data we have established criteria that could predict early poor outcome of
patients with acute liver failure both in the paracetamol overdose group and in the non
paracetamol overdose group so that more time can be available in the search for a
suitable donor organ.
Many patients with acute liver failure will never be transplanted anyway as
they deteriorate too quickly, have contraindications to transplantation or the shortage
of organ donors implies that an organ can not be found quickly enough.
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Table 1.4
King's College Hospital criteria for liver transplantation in acute liver
failure
Paracetamol
pH of arterial blood<7.30 (irrespective of the grade of encephalopathy)
or
Prothrombin time >100 sec and serum creatinine > 300 p,mols/L in patients with
grade III or IV encepahlopathy
Non-paracetamol patients
Prothrombin time >100 sec (irrespective of the grade of encephalopathy)
or
Any three of the following variables (irrespective of the grade of encephalopathy)
Age < 10 or > 40 yr
Aetiology- Non A Non B hepatitis, halothane hepatitis, idiosyncratic drug reaction
Duration of jaundice before the onset of encephalopathy > 7 days
Prothrombin time > 50 s
Serum bilirubin > 300 p.mols /L
To overcome these difficulties alternatives to whole organ
transplantation are sought. Auxilliary transplantation is one of them. A partial liver
graft is placed either beside the native liver (heterotopic) or in place of a removed
liver lobe (orthotopic). Although initial results are encouraging it is a technically
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demanding operation which has a high postoperative rate of complications (Chenard-
Neu et al, 1996).
Another alternative in the attempt to bring a stable patient to
transplantation is the total removal of the failing liver or its devascularisation while the
patient awaits for donor organ to become available. There is evidence that this
corrects the cerebral oedema and the haemodynamic abnormalities (Ringe et al,
1993). Initial evidence suggests that this could be of benefit to increasingly unstable
patients for whom there is a high probability for a graft to become available (Plevris et
al, 1998).
Liver transplantation in the FHF setting faces the problem of organ donor
shortage. As the native liver has a potential for full recovery a system that would
provide temporary support for the failing liver in order to allow for regeneration of
the native liver would be ideal (Wang et al,1995). Another interesting theory for
temporary liver support is hepatocyte transplantation of cultured hepatocytes into the
native liver or spleen where they take temporarily over the function of the native liver
until this recovers and the transplanted cells are rejected (Demetriou et al, 1998).
Both those interesting liver support modalities require the availability of
primary porcine hepatocytes on demand as they are mostly used in emergency
circumstances. Primary porcine hepatocytes are thought to be the ideal cell for use in
those modalities. Their optimal culture and preservation conditions though remain
unclear. Those cells should be able to exhibit an active metabolism in culture before
they are used in liver support modalities.
A lot of work has been recently undertaken in our Liver Cell Biology
Laboratory in order to understand the pathophysiology of acute liver failure and to
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develop therapeutic modalities for this syndrome. This thesis is part of the collective





2.1 Cell culture supernatant.
Experiments in cell culture supernatants and plasma samples were performed
using the proton nucleus as the observed nucleus. We have opted for *H NMR
spectroscopy as it enabled us to have detailed fingerprints of low molecular weight
substances in the biofluids investigated. Acquiring and editing a 'H spectrum was
relatively easy and quick and most of the necessary information about amino acids and
intermediates of metabolic pathways and their concentrations was present. Our
spectrometer, a Varian INOVA 600 MHz instrument, gave us enough information
in ID and 2D spectra to enable us to assign and quantitate most of the important
metabolic intermediates.
Specific problems related to the physicochemical properties of the biofluids
investigated were addressed and tackled in this thesis.
2.1.1 Effect of sample temperature.
Although changes in temperature will have an effect on the sharpening of
signals by methylene and methyl groups ( Otvos et al, 1987) this is most prominent
when those peaks are part of a complex macromolecule such as lipoproteins. Using
the peak of the singlet methyl resonance of a known amount of Sodium 3-
(trimethylsilyl 2,2,3,3-2H4) -1 propionate (TSP) at zero ppm as the only variable we
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investigated the effect of temperature changes in peak intensity. Temperature ranged
from 285° K to 317° K. The signal intensity did not change significantly between the
two extremes and we chose the ambient temperature of 298° K as the temperature for
our experiments.
2.1.2 Effect of sample pH.
Samples of plasma have a very constant pH that varies between 7.20 and 7.50
at the maximum. Storage of samples at - 40° C did not influence their pH after
thawing. Although previous studies have postulated that aromatic amino acids are not
NMR visible in neutral pH conditions (Gartland PhD thesis, 1988), our experiments
did not confirm that and the peaks from histidine, tyrosine and phenylalanine were
clearly visible and easily assigned to the relevant amino acids. Their concentrations in
control plasma were the same as the ones obtained by reverse phase High Pressure
Liquid Chromatography (HPLC) performed in our laboratory. This was not true for
citrate as its high affinity to albumin and the binding that results, made citrate
resonances NMR invisible in neutral pH. As titration of samples to pH < 2 for
identification of citrate was time consuming it was thought that not enough
information would be gained to warranty acidification of all samples and all
experiments were performed in neutral pH. Sample pH in the culture supernatant
samples varied between 4.50 and 7.5. As albumin binding of low molecular weight
substances was not an issue, the only problem we faced was the possibility of peaks
shifting with changes in pH. But as the substances were few and the shifting was not
pronounced, there was no signal overlapping due to changes in pH and the intensity of
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the peaks did not change. As a result the experiments were conducted without pH
titration.
2.1.3 Effect of storage and freezing of samples.
There were concerns that freezing of samples might affect the concentrations
of the substances and that storage time might have similar results (Nicholson et al,
1989). All samples were analysed less than six months after acquisition. Both culture
supernatants and plasma samples were analysed fresh and then after six months of
freezing. The results showed that the storage conditions (i.e. freezing at -40° C ) did
not adversely affect the samples and the concentrations of low molecular weight
substances studied were the same.
2.1.4 Effect of anticoagulants and chelating agents.
Plasma is a constituent of blood which is separated from blood after an
addition of an anticoagulant. The most widely used anticoagulants are trisodium
EDTA and Lithium Heparin. EDTA can also be used as a chelating agent that is able
to form complexes with metals present in plasma such as calcium and magnesium.
This would have a beneficial effect also in the intensities and sharpness of peaks from
substances that would form complexes with those metals and become NMR invisible
(Nicholson et al 1983). This is mostly true for citrate which was not studied in our
experiments. As EDTA peaks overlap to an extensive amount to the peaks of glucose
and methylamines it was thought best to collect samples on Lithium Heparin even
though we were adding another metal that could form complexes with low molecular
weight substances.
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2.1.5 Effect of addition of D20 as lock.
D20 is an obligatory addition to all aqueous samples as it provides an internal
lock field for the spectrometer. Literature at present would suggest that addition of
D20 in excess in a sample would result in some resonances being lost. In particular,
the resonances from histidine, acetoacetate and other ketone bodies can be affected
(Lindon et al. 1999). We have experimented with different amounts of D20 and we
observed this phenomenon. For our experiments we had to introduce a minimum
amount of lock so as not to disturb the intensities of the above mentioned substances.
We routinely used 75 pi of D20 as a field lock. This resulted in some loss of
resolution in very low concentrations.
2.1.6 Effect of albumin -ligand binding in plasma samples.
Many plasma components can exist either free in solution or bound
electrostatically to albumin. This is true for lactate, acetate, tyrosine, tryptophan,
phenylalanine and citrate (Nicholson et al. 1993). Bell et al (1989) have shown that
almost 30% of lactate becomes NMR invisible when bound to albumin under
physiological conditions. The addition of ammonium chloride was reported to turn
lactate NMR detectable. We were able to confirm that and in addition there was
significant increase in intensity in the peaks of acetate as well No changes were seen
in the peaks of tyrosine and phenylalanine. Their concentrations were similar to
concentrations obtained by HPLC methods in our laboratory and to published
references for control samples. The addition of ammonium chloride did not have any
effect on tryptophan that remained NMR invisible in plasma. Ammonium chloride
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was added routinely in our samples as a solution of 0.5 mmols/L and the added
volume was lOOpl.
2.2 NMR Spectroscopy monitoring
The concentration of the following substances in the culture supernatants was
measured, using NMR spectroscopy: Acetate, acetoacetate and B-hydroxybutyrate as
those ketone bodies are mainly exported by liver cells (Fuchs et al, 1994; Duee et al,
1994; Gerlach et al, 1996), leucine, isoleucine, phenylalanine and tyrosine as the key
ketogenic amino acids used by the hepatocyte (Gerlach et al, 1996), glucose, alanine,
glycine and threonine concentration as a measure of gluconeogenesis and to monitor
the cells energy requirements (Seglen 1974; Seifter et al, 1994), lactate and pyruvate
as a measure of the active aerobic and anaerobic glycolysis (Seglen, 1974), valine,
isoleucine and methionine concentrations as succinate formation precursors and
possible substrates for the Kreb's cycle (Kinsell et al, 1948; De Blaauw et al, 1998)
and the concentrations of glutamate, glutamine histidine and arginine as indices of
active transamination and urea synthesis (Lang et al, 1990; De Blauw et al, 1998).
Ethanol found within supernatants was also measured. Glycerol, myo-inositol,
methylamine, dimethylamine and TMAO concentrations were measured in plasma
samples.
2.3 Sample preparation for NMR spectroscopy.
Samples were prepared by adding a D20 solution of (75 pi) to culture
supernatants (700 pi) or to plasma samples of the same volume providing an internal
field frequency lock for the spectrometer. Chemical shifts were referenced internally
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to the singlet methyl resonance of Sodium 3-(trimethylsilyl 2,2,3,3-2H4) -1 propionate
(TSP) at zero ppm. We used TSP as an internal reference standard; it is less toxic and
cheaper than formate which some studies suggest as the ideal internal standard.
Furthermore, as the laboratory had significantly more experience with TSP and most
papers in the literature have used TSP we opted for TSP throughout our experiments
2.4 Proton NMR spectroscopy.
2.4.1 Presaturation technique.
'H- NMR spectra were measured on control William's E medium, and
supernatants of culture media. Data were acquired on a Varian INOVA 600 NMR
Spectrometer operating at 600 MHz for protons. All spectra were acquired at
ambient probe temperature (298 ± 0.2 0 K). For each sample 128 transients (FID's)
were acquired into 32K complex data points, over a spectral width of 6 KHz. 30°
pulses were applied with an acquisition time of 4.0 sec, followed by a recovery delay
of 8 s, to allow for complete relaxation and recovery of the magnetisation. Water
signal suppression was achieved by applying a gated secondary irradiation field at the
water resonance frequency during the recovery delay. Spectral assignments were
made by reference to literature values of chemical shifts in various media and
biological fluids (Nicholson et al, 1989, Lindon et al, 1999) and coupling constants.
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2.4.2 CPMG sequence.
The CPMG sequence was used in samples with a plethora of macromolecules
in solution. This was valid for plasma samples that contained albumin and
macromolecules. The CPMG sequence has short spin-spin relaxation times and
attenuates protein resonances enough for low molecular weight substances to be
measured without interference.
90° - t - 180° - x (1st echo) - t -180° - t (2nd echo)
For each sample 256 repeats of the CPMG sequence were acquired into 32K
complex data points over a spectral width of 6 KHz. 90° pulses were applied with an
acquisition time of 3.0 s, followed by a recovery delay of 15 s, to allow for complete
relaxation and recovery of the magnetisation. CPMG was used to enable us to
identify low molecular weight substances in small concentrations but for the
integration process the simple presaturation spectra were used.
The use of the CPMG sequence in plasma samples has some drawbacks that
could jeopardise the validity of the measurements. All observed nuclei should be
equivalent and the spin-spin coupling observed results in a broadening of the lines
studied. We have tried to include as much area under the line as possible by
integrating on the whole line width. As some of the small molecules observed had big
Ti relaxation times the recovery period between pulses was adequate for all molecules
to relax in order to avoid selective saturation of the peaks of those molecules. The
real recovery period in our CPMG experiment was 15 seconds that is 5 times the Ti
relaxation time of the pyruvate molecule.
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2.4.3 J-resolved experiments.
We applied J-resolved experiments to simplify the plasma spectrum and to
enable us to resolve the overlap resonances in the most crowded region of d 3- 4
ppms. It was used in conjunction with COSY experiments to identify overlapping
resonances in a few selected plasma samples.
2.4.4 'H-'H coupling homonuclear COSY experiments .
COSY provided confirmation of the presence of a number of amino acid
resonances in particular branch chain amino acids, threonine and glutamate -
glutamine. Other small molecules are resolved and also polyols as myo - inositol and
connectivities from many lipidic resonances can be observed. COSY was also
performed on selected few plasma samples.
Quantitation of compounds present in the culture supernatants was achieved
by two alternative means, (a) Integrals were measured relative to that of a known
quantity of TSP (10 mg/ml ) present as an internal standard to the solution, (b) When
signals were partially overlapped, peak height measurements were used, taking into
account the appropriate coupling pattern of intensities of the non-overlapped lines.
The computer program used for the integrations was the VARIAN 6.1 in a SOLARIS
environment on a SUN 3.0 data station.
2.5 Reproducibility and variability of NMR experiments.
In order for our method to be valid it had to be reproducible with an
acceptable interassay and intraassay variability. We have compared our results to two
different standards. In the context of cell culture supernatants we have compared the
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concentrations of low molecular weight substances to those in the manufacturer's
product book. We have also compared our results with results on amino acid
concentrations by HPLC. Table 2.1 shows the concentrations of the different
substances present in William's E medium as determined by High performance liquid
Chromatography (HPLC) and as determined by our experimental *H NMR methods.
Coefficients of variation were determined for the two methods for all the substances
stated in table 2.1. They were similar for both methods. Inter-assay variability was
found to be lass than 10% for all the substances measured. The intra-assay variability
of our NMR method was tested and was found to be less than 5%.
TABLE 2.1
Comparison of concentrations of substances present in Wiiliam's
medium as measured by HPLC and NMR spectroscopy
BIOCHEMISTRY NMR
LEUCINE 0.4 ± 0.02 0.44 ± 0.04
ISOLEUCINE 0.27 ± 0.02 0.28 ± 0.01
VALINE 0.30 ± 0.03 0.31 ± 0.03
THREONINE 0.23 ± 0.02 0.21 ± 0.02
LACTATE 0 0
ALANINE 0.41 ± 0.02 0.43 ± 0.03
GLUTAMINE 1.41 ± 0.03 1.38 ± 0.04
GLUTAMATE 0.21 ± 0.02 0.21 ± 0.02
METHIONINE 0.07 ± 0.005 0.07 ± 0.005
PYRUVATE 0.20 ± 0.03 0.18 ± 0.03
GLUCOSE 7.70 ± 0.45 7.93 ± 0.34
TYROSINE 0.19 ±0.02 0.18 ± 0.02
HISTIDINE 0.07 ± 0.01 0.06 ± 0.01




For the plasma samples we tested the concentrations of glucose, creatinine and
lactate against standard automated assays. The inter-assay variabilty for all
measurements using coefficients of variation was less than 10%.
2.6 Intracellular vs extracellular measurements.
We should be aware of the fact that we tested supernatants from cell cultures
and we calculated the concentrations of metabolites in key intracellular pathways.
The question that we had to address is whether cell extracts and measurements of
intracelluar metabolites would provide a more accurate reflection of the processes
studied.
Intracellular concentrations of key metabolites are much smaller than milieu
concentrations. To get spectra that would have peaks above the detection limit for
the substances studied we had to sacrifice 80 million cells every time we were to
sample our cultures. This was not practical and even then the spectra showed
predominant features of glucose and citrate spectra whose concentrations
intracellularly are much higher than those of amino acids. In addition to that
hepatocytes have always been thought of as the factory of the organism where
although everything is assembled and produced , it is then exported in great quantities
to other organs where substances are used or excreted. Ketone bodies are exported to
muscle and kidneys, lactate is excreted whenever possible, urea and by products of
nitrogen and ammonia elimination are excreted in the milieu and amino acids are
constantly remodelled to form proteins or to fuel energy providing pathways. It was
thus thought that differences in concentrations of substances in the supernatant of the
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culture would more accurately reflect the overall metabolic status of the cells over a
period of time.
To study the concentrations of intracellular contents of the cells it was
necessary to freeze dry the cell extracts and to reconstitute them in a smaller volume.
This eliminated volatile substances like the ketone bodies and would result in break
down of the energy rich phosphate bonds in the cell. Contamination with membranes
particles is almost inevitable and membrane lipoproteins made assignments for
substances even more difficult. In addition to that reconstitution used D20 as solvent
and as we showed earlier this resulted in distorsion of peaks and loss of signal
intensities. At the end we opted for the study of cell culture supernatants that would




STUDIES ON FRESHLY ISOLATED HEPATOCYTES
3.1 INTRODUCTION
Fulminant hepatic failure is frequently fatal. The reason for the high mortality
of this disease lies primarily with its fulminant course, and irreversible destruction on
the patient's native liver. Currently, the best treatment option currently is orthotopic
liver transplantation (OLT). Although OLT is highly successful due to a shortage of
organ donors, less than 30 % of patients with fulminant hepatic failure will benefit
from it ( Plevris et al.1998). This is the main reason for the current rush to develop
alternatives to transplantation in those patients. Bioartificial liver support systems
(BALSS) have been discussed previously. Many centres are currently developing
BALSS and the preliminary results have been encouraging (Watanabe et al, 1997;
Flendrig et al, 1997; Samuel, 1998). The key component of these devices is a
substratum of cultured hepatocytes that would temporarily and intermittently replace
the functions of the failing native liver. The choice of hepatocytes is not obvious.
Human hepatocytes are so scarce that it would be unthinkable to develop a system
based on those cells. Immortalised cell lines on the other hand offer an unlimited cell
supply but there are problems with tumourigenicity and dedifferentiation (Newsome et
al, 2000). Mammalian hepatocytes would be a more obvious source. Primary porcine
hepatocytes have been regarded as the cells of choice as they can be readily obtainable
with a sufficient yield and viability. They maintain differentiated functions in culture
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and have high intrinsic metabolic activity (Naik et al, 1997; Donato et al, 1999).
Porcine hepatocytes cultured in William's E medium with the addition of 10%
serum on various substrata and uncoated tissue culture plates showed no differences
between them in differentiated metabolic functions suggesting that substrata are not
necessary to culture PPHs (te Velde et al. 1995). However, culture of PPHs in media
supplemented with serum might be ill- advised if the cells are to be used in BALSS
connected to patients. Serum supplementation would make the transmission of
diseases more probable.
In our tissue culture laboratory we have cultured our cells on biomatrix-free
tissue culture plates, in serum free, chemically defined media containing highly
purified recombinant growth factor, insulin and dexamethasone. Insulin was used to
enhance initial cell attachment (Gerlach et al, 1994). Long epidermal growth factor
stimulates DNS synthesis, cell growth, amino acid transport and protein synthesis
(Michalopoulos et al, 1990). All three hormone contribute to the maintenance of
differentiation and albumin synthesis. Dexamethasone also suppresses fibroblast
growth (Sun et al, 1999)
Different culture media have been used in hepatocyte culture studies (Brodskii
et al, 1989; Scott et al, 1991;Thompson et al, 1993; Coldham et al, 1998; Guzic et al,
1998,). We compared biochemical function and activity of PPHs in four commonly
used culture media, William's E medium, medium 1640, Medium 199 and Hepatocyte
Medium, to assess differences in the function of metabolic pathways of cultured PPHs
between media and also at different time points of the cell culture experiments.
This study provides some insight into the metabolism of amino acids by
hepatocytes in culture. The different amino acids provide substrata for the basic
98
metabolic functions of the cell. Some can only be diverted into one metabolic pathway
while others can feed two or even three different metabolic pathways.
3.1.1 Metabolism of amino acids of interest
We are now going to look into the metabolism of the different amino acids in
detail. Alanine, a key player in the hexose phosphate pathway, can be produced from
threonine and can feed downstream the glucose pathway by transamination with a-
ketoglutarate, producing pyruvate and glutamate. Pyruvate, alanine's a-ketoacid can
either feed the Kreb's cycle through acetyl -CoA production or be transformed to
lactate under anaerobic conditions.
Threonine that enters the cells can only be converted to alanine in order to be
transformed to pyruvate. Other amino acids that can be converted to pyruvate include
glycine, cysteine, serine and tryptophan.
Tyrosine can also feed the hexose phosphate pathway through production of
oxaloacetate by transamination of a-ketoglutarate and production of
phosphoenolepyruvate. The same applies to phenylalanine and aspartate.
Phenylalanine can be converted to acetoacetate and acetyl CoA producing thus ketone
bodies. Aspartate can also be produced from glutamate as substrate to feed the urea
cycle.
Glutamate can either be converted to glutamine or feed the Kreb's cycle
through a-ketoglutarate production or be produced from a-ketoglutarate by accepting
an ammonium ion. Glutamine can only be produced from glutamate and is the
metabolic end product of this pathway. Glutamine is used in DNA synthesis in cells
undergoing mitotic division. Arginine and histidine can be transformed to glutamate
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and that is their only breakdown pathway in the hepatocytes. Proline also needs to be
transformed to glutamate, if it is to be effectively broken down by the hepatocytes.
Acetyl -CoA can, as we mentioned, be produced from phenylalanine and tyrosine but
also from isoleucine and leucine, lysine and tryptophan. This is the only breakdown
pathway for leucine. Of course, in hepatocytes, the major pathway for acetyl -CoA
production is fatty acid oxidation.
Some amino acids, namely isoleucine, valine and methionine can feed the
Kreb's cycle via production of succinate. Production of succinate is the only pathway
for oxidation of valine and methionine.
3.2 Materials and methods
3.2.1 Animals.
Weanling piglets (Large white. < 15 kg) were obtained from the Roslin
Institute (Roslin, Scotland) on the day of isolation having been fed a standard diet and
water ad libitum. All animals were treated in accordance with UK Home Office
Guidelines (Scientific Procedures Act, 1986).
3.2.2 Chemicals
Type IV collagenase (from Clostridium histoliticum j,EGTA, HEPES,
albumin, Long Epidermal Growth Factor, all culture media Williams E, Hepatocyte
medium, medium 199 and RPMI 1640 were from Sigma. Hank's balance salt solution
( HBSS ) buffer, PBS, L- Glutamine, Penicillin - Streptomycin and Amphotericin B
were from ICN. All reagents were of cell culture grade. Other reagents were:
Gentamicin (non- proprietary), Porcine Insulin (Pork Velosulin™, Novo Nordisk,
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Denmark), Dexamethasone (David Bull Labs, England) and Aprotinin (Trasylol™,
Bayer). All chemicals were of Analar grade.
3.2.3 Hepatocyte Isolation
Our method for isolating primary porcine hepatocytes has been described in
detail elsewhere (Nelson et al, 2000). Briefly, piglets were sacrificed using an i.v.
overdose of pentobarbitone sodium, the infrahepatic inferior vena cava was clamped
and the suprahepatic inferior vena cava was cannulated. The liver was retrogradely
perfused in situ with cold saline and excised. It was then transported to the
laboratory on ice and perfused with prewarmed perfusion buffers in 5 steps. The liver
was disrupted using collagenase, sequentially filtered in washing buffer, purified by
sedimentation and centrifugation and the isolated liver cells suspended in Williams E
medium. Cell viability was assessed using the trypan blue exclusion test using a
Neubauer cytometer. Cell viability was assessed by percentage extracellular lactate
dehydrogenase (LDH) activity using the COBAS FARA. Plating efficiency was
assessed by measuring total protein using the COBAS FARA and comparing the
results with baseline values.
3.2.4 Hepatocyte culture
Cells were seeded at a density of 8xl06 viable cells per 90mm plastic culture
dish (Dow Corning, USA) in 8ml of each of the four test media (WE, HM, 199,1640)
at 37 0 C. The culture media consisted of serum free hormonally defined media. The
exact composition of each one of the four media can be found in Table 3.1. We used
serum free media that were supplemented with the following substances: L-EGF 50
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ng/ml, porcine insulin 10pg/ml, dexamethasone lnmol/ml, glutamine 2pmols/ml,
gentamicin 50mg/ml, penicillin 50mg/ml, streptomycin 10 mg/ml, and amphotericin B
2.5pg/ml. The culture dishes were shaken gently to aid cell dispersal and facilitate
attachment, and then placed into a humidified incubator in an atmosphere of 95 % air
and 5% C02. For the initial cell attachment phase the incubator was gassed with 30%
02/5% C02 for 2 hours. On days 2 and 4 the culture dishes were aspirated and fresh
media added.
3.2.5 NMR Spectroscopy
NMR Spectroscopy monitoring was performed as discussed in Chapter 2. No
signals from acetoacetate, B-hydroxybutyrate and glycine were identified and
concentrations of those substances were consequently not measured. Sample
preparation, data acquisition and quantitation of compound concentrations were
performed as discussed in Chapter 2.
3.2.6 Statistical analysis
Comparisons between freshly isolated cells cultured in different media from
the same isolation were made. The values of each experiment were the mean of eight
cultures. Student's t-test was used to compare means of different groups. A p value
of < 0.05 was taken as significant (two-tail test of significance). To compare
between more than two groups we used the Tukey test based on the one factor
independent measures ANOVA. Results are expressed in mmols/L and are corrected
by the number of viable cells per dish.
TABLE 3.1







































































































Figure 3.1 A shows a 600 MHz spectrum obtained from pure William's E
medium and Figure 3.IB shows a spectrum from cell culture supernatant on day 2
from cultures in William's E Medium. Figure 3.2A shows a 600 MHz spectrum
obtained from pure medium 1640 and Figure 3 .2B shows a spectrum from cell culture
supernatant on day 2 from cultures in Medium 1640. Figure 3.3A shows a 600 MHz
spectrum obtained from pure medium 199 and Figure 3.3B shows a spectrum from
cell culture supernatant on day 2 from cultures in Medium 199. Figure 3.4A shows a
600 MHz spectrum obtained from pure Hepatocyte Medium and Figure 3.4B shows a





























Table 3.2 shows the results obtained for the substances involved in anaerobic
glycolysis.
There was consumption of the relevant hexose (glucose in WE, 1640 and 199
media, galactose in HM) in all media and in all days sampled. There was an overall
trend in all media, for the consumption of the hexose to be least in day 2, to increase
by day 4 and then to more or less plateau by day 6. In media 1640 and 199, there was
a statistically significant difference between day 2 and day 4, and day 2 and day 6.
(1640 p<0.015 between 2 and 4 and p<0.005 between 2 and 6. The corresponding
figure for medium 199 was p<0.00005 for both). Medium 1640 exhibited the smallest
overall consumption and HM that contained galactose the greatest hexose
consumption.
Between media there were statistically significant differences between medium
1640 and medium 199 in day 4 (bigger consumption in 199, p<0.0026) and between
medium 199 and WE medium in days 4 and 6 (bigger consumption in 199 p<0.0006
and p<0.0033 respectively.)
There was evidence of a small glucose production in HM. It is possible to
differentiate between glucose and galactose using !H NMR and this result showed
that gluconeogenesis in cells cultured in HM was active.
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3.3.2 LACTATE
There was production of lactate under all conditions by hepatocytes cultured
in all media, on all days sampled. There was an overall trend for the production of
lactate to be least on day 2 and then to increase by day 4. It then dropped by day 6 in
all media apart from WE medium, where it rose to its peak concentration by day 6.
The drop was significant in HM and there was a statistically significant difference
between days 4 and 6 (p<0.022). There were statistically significant differences in
medium 199 between day 2 and 4 (p<0.046) and day 4 and 6 (p<0.017). Looking at
WE medium there was a statistically significant difference between the smallest
production (day 2) and the greatest (day 6) (p<0.031).
Between media there were statistically significant differences between medium
1640 and HM on day 6 (bigger production in HM, p<0.0042), between medium 1640
and medium 199 on day 6 (bigger production in 199, p<0.045), between medium
1640 and WE medium on day 6 (bigger concentration in WE, p<0.048), between HM
and medium 199 on day 2 (bigger concentration in HM, p<0.0029) and between HM
and WE medium on days 2 and 4 ( bigger concentration in HM p<0.0012 and
p<0.012 respectively). Overall the lowest production was observed with medium
1640 and the highest with ELM.
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3.3.3 PYRUVATE
The fate of pyruvate was variable depending on the different culture media. In
those media that did not contain pyruvate as part of their initial composition (media
1640 and 199) there was a net production of pyruvate at all days sampled. When
pyruvate was present initially (media HM and WE ) there was a net consumption of
pyruvate at all days sampled. As a result there were highly significant statistical
differences between medium 1640 and HM on day 2 (p<0.0000), on day 4 (p<0.017),
and day 6 (p<0.0000), between medium 1640 and WE medium on day 2 (p<0.011),
on day 4 (p<0.0033) and on day 6 (p<0.0000), between medium 199 and HM on day
2 (p<0.0000), on day 4 (p<0.0000), and on day 6 (p<0.0000) and between medium
199 and WE medium on day 2 (p<0.00008), on day 4 (p<0.0000) and on day 6
(p<0.0000). If one compares HM and WE medium there was also statistically
significantly more pyruvate consumption in HM by day 4 (p<0.018).
Pyruvate production peaked, in both media exhibiting net pyruvate
production, on day 2 and then plateaued or slightly decreased. In particular, looking
at medium 199, there was a statistically significant difference between days 2 and 4
(p<0.046) and days 2 and 6 (p<0.023). Pyruvate consumption was least, in both
media exhibiting net consumption, in day 2 and peaked by day 4. In particular,
looking at WE medium there was a statistically significant difference between day 2
and day 4 (p<0.008) and day 4 and day 6 (p<0.016).
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TABLE 3.2
Percentage changes from basal concentrations of glucose and glucose
metabolites in the four different media on days 2, 4 and 6.
Initial concentration for glucose is 7.7 mmols/L in WE and 1640 and 3.88 mmols/L in
199. Galactose concentration in HM is initially 3.5 mmols/L. Initial concentration for
pyruvate is 0.2mmols/L in WE and 4.38mmols/L in HM.
DAY 2 DAY 4 DAY6
GLUCOSE
WE -48 ±22 % -60 ± 14% -60± 17 %
1640 -31 ± 28 % -62 ± 15 %* -71 ± 13 %*■
199 -48 ± 15 % -83 ± 13 %** -82 ±11 %*■
HM 0.19 ± 0.12 0.22 ±0.11 0.15 ±0.04
GALACTOSE HM -62 ± 17% -80 ± 8 % -77 ± 7 %
LACTATE
WE 1.07 ±0.53 1.37 ± 0.59 2.12 ±0.48
1640 0.40 ±0.19 0.89 ±0.69 0.87 ±0.41
199 1.07 ± 0.51 2.85 ±2.02* 2.11 ±0.79*
HM 2.78 ± 1.02 3.13 ± 1.37* 2.02 ±0.64
PYRUVATE
WE -50 ± 20 % -85 ± 15 %** -65 ± 15 %*
1640 0.16 ± 0.11 0.13 ±0.05 0.09 ±0.05
199 0.25 ± 0.13 0.09 ± 0.03* 0.08 ± 0.04*
HM -85 ±11 % -94 ± 3 % -91 ± 7 %
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to the
previous day's measurement. Absolute values are in mmols/L
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3.3.4 ALANINE
Table 3.3 shows the results obtained from glucogenic amino acids.
Whether the culture medium contained alanine in the first place was a central
factor to alanine's fate in our experiments. Medium 1640 did not contain any and
although on day 2 there was no production, overall there was a significant production
of alanine. There were statistically significant differences between day 2 and day 4
(p<0.041) and day 2 and day 6 (p<0.0053). WE medium showed a consumption of
alanine in days 2 and 4, peaking at day 4 but remarkably an overall production of
alanine by day 6. There were statistically significant differences between day 2 and 6
(p<0.050) and between day 4 and day 6 (p<0.034). Medium 199 showed the biggest
consumption in day 2 and the least on day 4. Overall there was significant alanine
consumption. HM medium showed a progressively rising alanine consumption that
eventually peaks at day 6
Looking for differences between media there were no significant differences
apart from between medium 1640 and HM on day 6 (p<0.022).
3.3.5 THREONINE
There was consumption of threonine in all media, at all days sampled, apart
from day 2 on medium 1640. There was a small consumption on day 2 in all media,
which peaked eventually on day 6 in all media, apart from medium 199, where
consumption peaked on day 4. There was a statistically significant difference in
medium 1640 between day 2 and day 6 (p<0.015) and between day 4 and day 6
(p<0.035).
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The greatest consumption of threonine was exhibited by medium HM. This
was followed by medium WE , then medium 1640 and then medium 199. There were
statistically significant intermedia differences between HM and medium 199 on day 2
(p<0.014) and on day 6 (p<0.018), between HM and medium 1640 on day 6 (total
consumption in 1640, p<0.0063), between WE medium and mediuml99 on day 6
(p<0.046), between medium 1640 and WE medium on day 6 (p<0.033) and between
1640 medium and 199 medium on day 6 (p<0.018).
3.3.6 ASPARTATE.
Aspartate's fate was also dependent on basal media conditions but only
partially. HM medium does not contain aspartate and there was a small steady
production of aspartate throughout the experiments. Medium WE showed
consumption of aspartate on all days with the smallest on day 6 and the peak on day
4, when there was a total consumption of the existing aspartate. There were
statistically significant differences between day 2 and day 4 (p<0.024) and between
day 4 and day 6 (p<0.0085). Medium 199 showed total consumption of aspartate on
all days. In contrast medium 1640 showed a big production of aspartate on all days
with a peak on day 4.
Between media there were statistically significant differences between medium
1640 and HM on day 6 (p<0.017) (higher production by 1640), between HM and WE
medium on day 4 (p<0.0000), between HM and medium 199 on day 2 (p<0.034), on
day 4 (p<0.00007) and on day 6 (p<0.0000), between media 1640 and WE on day 4
(p<0.033) and day 6 (p<0.0068) and between media 1640 and 199 on day 2
(p<0.024) on day 4 (p<0.038) and on day 6 (p<0.00006).
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TABLE 3.3
Percentage changes from basal concentrations of glucogenic amino acids in the
four different media on days 2, 4 and 6
Initial concentration of alanine is 0.41mmols/L in WE, 0.39mmols/L in 199 and
3.54mmols/L in HM. Initial concentration of threonine is 0.23mmols/L in WE,
0.12mmols/L in 1640, 0.35mmols/L in 199 and 3.53mmols/L in HM. Initial
concentration of aspartate is 0.14mmols/L in WE, and 0.28mmols/L in 199.
ALANINE
WE -76 ±19% -81 ±17%* ±14 ±73%*
1640 0 0.09 ±0.05* 0.09 ±0.04**
199 -79 ± 10 % -43 ± 18 % -64 ± 13 %
HM -26 ±21% -37 ±39% -38 ± 33%
THREONINE
WE -9 ±17% -52 ±30% -52 ±13%
1640 ±8 ±50%* -8 ±42% -100%*
199 -6 ± 17 % -31 ± 40 % -11 ± 34 %
HM -49 ± 19 % -55 ± 22 % -60 ±15 %
ASPARTATE
WE -36 ±45% -100%* -18 ±36%**
1640 ±107 ± 153 % ±247 ± 67 % ±140 ± 73%
199 -100% -100% -100%
HM 0.23 ±0.14 0.23 ±0.11 0.28 ± 0.08
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to the
previous day's measurement. Absolute values are in mmols/L
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3.3.7 ARGININE
Table 3.4 shows the results for the substances involved mostly in urea and
glutamine synthesis and in transamination reactions.
There was consumption of arginine in all media, at all days sampled. Apart
from medium HM all exhibited the greatest consumption by day 6. HM showed the
biggest consumption on day 2 and then consumption plateaued in slightly smaller
levels. The smallest consumption was on day 4 overall apart from WE medium which
showed the smallest consumption on day 2. There was one intramedia statistically
significant difference in medium 1640 between days 4 and 6 (p<0.033). There were
no intermedia statistically significant differences but a trend existed for HM and 1640
media to consume more arginine than media WE and 199
3.3.8 HISTIDINE
There was consumption of histidine in all media at all days sampled. The
emerging pattern was of a peak of consumption on day 4 in all media, with a decline
on day 6. There was a very small consumption on day 2 in medium 1640. There was
one intramedia statistically significant difference, in medium 1640 between days 2 and
4 (p<0.023).
The greatest consumption was shown by medium 199, followed by media HM,
WE and 1640. There were statistically significant intermedia differences between
medium 199 and HM on day 2 (p<0.0000) and day 4 (p<0.0061), between medium
199 and WE medium on day 2 (p<0.00035), between media 199 and 1640 on day 2
(p<0.017) and between HM and WE medium on day 2 (p<0.05).
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3.3.9 GLUTAMATE
Overall, there was production of glutamate on all days in all media, except for
medium HM on days 4 and 6 where there was a net consumption of glutamate. There
were statistically significant differences between day 2 and day 4 (p<0.041) and day 2
and day 6 (p<0.009) in HM. Looking at medium 199 there was a small overall
production of glutamate with a peak on day 2. There were statistically significant
differences between day 2 and day 4 (p<0.048) and between day 2 and day 6
(p<0.024). The production of glutamate was highest in WE medium closely followed
by medium 1640.
There were statistically significant differences between media. They were exhibited
between media WE and 199 on day 2 (p<0.0016) on day 4(p<0.0019) and on day 6
(p<0.00001), between WE medium and HM on day 2 (p<0.00002), on day 4
(p<0.0004) and on day 6 (p<0.0000), between media 1640 and 199 on day 2
(p<0.001), on day 4 (p<0.02) and on day 6 (p<0.027), between medium 1640 and
HM on day 2 (p<0.0001), on day 4 (p<0.0088) and on day 6 (p<0.011) and even
between HM and medium 199 on day 2 (p<0.044) and day 6(p<0.019).
3.3.10 GLUTAMINE
Glutamine was consumed in all media at all time points sampled. All media
contained the same concentration of glutamine as this was added by the study group
and that permitted direct comparisons between media. There was not a trend for
glutamine consumption seen in all media and there were no statistically significant
differences between different days in the same medium.
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HM though showed the highest consumption of glutamine followed by WE
medium, followed by medium 1640 with medium 199 showing the smallest
consumption. There were statistically significant differences between HM and WE
medium on day 2 (p<0.0016) and day 6 (p<0.0032), between HM and medium 1640
on day 2 (p<0.013) and day 6 (p<0.00001), between HM and medium 199 on day 2
(p<0.0023), on day 4 (p<0.0052) and on day 6 (p<0.0000), between media WE and
1640 on day 2 (p<0.05) and day 6 (p<0.005), between media WE and 199 on day 2
(p<0.00008), on day 4 (p<0.0000) and on day 6 (p<0.0000) and between media 1640
and 199 on day 2 (p<0.0001) on day 4 (p<0.02) and on day 6 (p<0.027).
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TABLE 3.4
Precentage changes from basal concentrations of urea and glutamine synthesis
intermediates in the four different media on days 2, 4 and 6
Initial concentration of histidine is 0.07mmols/L in WE, 0.07mmols/L in 1640,
O.lmmols/L in 199 and 1.13mmols/L in HM. Initial concentration of arginine is
0.28mmols/L in WE, 0.21mmols/L in 1640, 0.26mmols/L in 199 and 0.62mmols/L in
HM. Initial concentration of glutamate is 0.21mmols/L in WE, 0.29mmols/L in 1640,
0.63mmols/L in 199 and 0.95mmols/L in HM. Initial concentration of glutamine is
1.4mmols/L for all media.
DAY 2 DAY 4 DAY 6
HISTIDINE
WE -57 ± 29 % -57 ± 29 % -43 ± 57 %
1640 -14 ±43 % -71 ±43 %* -67 ± 14 %
199 -100% -100% -60 ± 40 %
HM -65 ± 10 % -70 ± 12% -67 ± 14 %
ARGININE
WE -57 ±21 % -71 ±25 % -79 ± 11%
1640 -88 ± 6% -82 ± 9 % -100%*
199 -52 ± 3 % -46 ± 10% -43 ±15 %
HM -94 ± 15% -88 ± 5 % -88 ±4.5%
GLUTAMATE
WE ±200 ± 109% ±229±138 % ±324± 157
1640 ±351 ± 120% ±193 ± 152 % ±169±110
199 ±62 ± 50 % ±8 ± 59 %* ±13 ±38 %








± 25 % -40 ± 23
± 3 % -62 ± 22
% -58 ±19%
% -50 ± 25 %
% -31 ±29%
% -95 ± 2 %




Table 3.5 shows the results for substances involved in ketogenesis.
There was consumption of leucine by all media except medium HM. The
consumption was present at all time points sampled in media WE, 1640 and 199. HM
exhibited a very small production of leucine overall on days 2 and 6. There was a peak
for leucine consumption in all media on day 6, but there were no intramedia
statistically significant differences observed.
The biggest consumption was shown by medium 199. Looking at statistically
significant differences between the media, differences were exhibited between HM
and medium 1640 on day 2 (p<0.022), on day 4 (p<0.023) and on day 6 (p<0.0003),
between HM and WE medium on day 2 (p<0.0000), on day 4 (p<0.0044) and on day
6 (p<0.0001), between HM and medium 199 on day 2 (p<0.0000), on day 4
(p<0.00004) and on day 6 (p<0.0000), between media 199 and WE on day 2
(p<0.005), on day 4 (p<0.014) and on day 6 (p<0.00005) and between media 199 and
1640 on day 2 (p<0.017), on day 4 (p<0.0025) and on day 6 (p<0.001).
3.3.12 TYROSINE
There was consumption of tyrosine in all media at all days sampled. The
smallest consumption was on day 2, apart from medium 199, where the smallest
consumption was shown on day 4. There were statistically significant intramedia
differences in medium 199 between day 4 and day 6 (p<0.013).
Medium 1640 exhibited the greatest overall consumption, followed by WE
medium. There were statistically significant differences between media between
medium 1640 and HM on day 2 (p<0.014), on day 4 (p<0.016) and on day 6
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(p<0.0033), between medial640 and 199 on day 2 (p<0.0061), between medial640
and WE on day 6 (p<0.039), between WE medium and HM on day 4 (p<0.04) and
between HM and mediuml99 on day 4 (greater consumption by HM, p<0.01) and on
day 6 ( greater consumption by 199, p<0.0007).
3.3.13 PHENYLALANINE
There was consumption of phenylalanine by all media at all days sampled,
except by medium 1640 on days 2 and 6, where there was a production of
phenylalanine. Consumption of phenylalanine was greatest on day 4 in all media.
Overall there were no statistically significant intermedia differences shown.
HM medium exhibited the greatest overall production of phenylalanine. There
were statistically significant intermedia differences between HM and WE medium on
day 4 (p<0.042), between HM and medium 1640 on day 2 (p<0.011) and on day 6
(p<0.042), between media WE and 1640 on day 2 (p<0.022) and between media 199
and 1640 on day 2 (p<0.011).
3.3.14 ACETATE
Production of acetate was a phenomenon exhibited in all media and at all time
points sampled. There was a pattern emerging with a peak in the production of
acetate by all media on day 4. However, there were no statistically significant
intramedia differences.
The greatest acetate production was shown by medium 199, followed by WE
medium, then by HM and then by mediuml640. There were statistically significant
intermedia differences between medium 199 and HM on day 4 (p<0.025) and on day
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6 (p<0.0086), between medium 199 and 1640 on day 2 (p<0.017), on day 4
(p<0.013)and on day 6 (p<0.0035), between WE medium and HM on day 2
(p<0.045) and on day 4 (p<0.026) and between media WE and 1640 on day 2
(p<0.0058), on day 4 (p<0.0073) and on day 6 (p<0.036).
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TABLE 3.5
Percentage changes from basal concentrations of ketogenic amino acids and
acetate in the four different media on days 2, 4 and 6
Initial concentration of tyrosine is 0.19mmols/L in WE, 0.2mmols/L in 1640,
0.22mmols/L in 199 and 1.16mmols/L in HM. Initial concentration of phenylalanine is
0.14mmols/L in WE, 0.08mmols/L in 1640, 0.21mmols/L in 199 and 1.06mmols/L in
HM. Initial concentration of leucine is 0.4mmols/L in WE, 0.27mmols/L in 1640,
0.64mmols/L in 199 and 0.67mmols/L in HM
DAY 2 DAY 4 DAY 6
TYROSINE
WE -53 ±21 % -63 ±16% -58 ± 26 %
1640 -70 ± 20 % -70 ± 15 % -80 ± 10%
199 -45 ± 9 % -14 ± 14% -62 ± 14%*
HM -34 ± 27 % -31 ± 26 % -34 ± 22 %
PHENYLALANINE
WE -16 ±28% -36 ± 14% 0 ± 21 %
1640 ±37 ± 25 % -13 ±38 % ±13 ±25 %
199 -45 ± 24% -52 ± 3 % -10 ±48 %





HM 0 ± 7%
-53 ± 20% -53 ± 10 %
-34 ± 34% -48 ± 22 %
-63 ± 6% -72 ± 9 %














Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to the
previous day's measurement. Absolute values are in mmols/L
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3.3.15 ISOLEUCINE
Table 3.6 shows the results obtained for substances involved mostly in
aerobic glycolysis and mostly used as succinate precursors.
There was consumption of isoleucine in all media, at all days sampled. There
was a trend for all media to show the smallest consumption by day 2 but there were
no statistically significant intramedia results. Consumption was then increased and
reached its peak at day 4 for media WE and 1640 and at day 6 for media 199 and
HM.
All media consumed fairly similar amounts of isoleucine at all days, the exception
being medium 199, which exhibited a significantly higher consumption than the other
media on day 6. This reached statistical significance when compared with medium
HM (p<0.011) and medium WE (p<0.0007).
3.3.16 VALINE
There was a small consumption of valine by all media, at all days sampled.
The consumption increased as time goes by and it peaked on day 6 for all media,
except for WE medium, where the consumption was constant on all days. There were
no statistically significant intramedia differences observed.
Overall the greatest consumption was shown by HM medium but there were
no statistically significant differences except when comparing HM with WE medium
(significantly smaller by WE) on day 4 ( p<0.016 ) and on day 6 (p<0.00042).
Differences between medium 199 and WE medium reached also statistical significance
on day 6 (less consumption by WE, p<0.0007).
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3.3.17 METHIONINE
There was consumption of methionine in all media at all days sampled. The
consumption peaked on day 6 in all media except in medium WE where methionine
consumption peaked on day 4 to a total consumption of the methionine contained in
the medium. There were no statistically significant intramedia differences however.
Looking at differences between media there was only one present between WE
medium and ITM on day 2 (p<0.033) and on day 4 (p<0.0000). Overall there was an
increase in methionine consumption as time went by culminating at a peak on day 6.
There was a trend for medium WE to exhibit the greatest overall consumption and for
medium HM the smallest.
3.3.18 ETHANOL
Table 3.7 shows the results of ethanol production by the different media.
There was ethanol production in all media at all days sampled. There was a uniform
pattern in all media with a peak production on day 2, a small decrease on day 4 and a
further decrease on day 6, except for medium 199 where production was maximum on
day 4 but minimum on day 6. Looking at statistically significant intramedia
differences these were present in all media. In medium 1640 between day 2 and day 4
(p<0.0044) and between day 4 and day 6 (p<0.039), in medium 199 between day 2
and day 6 (p<0.01), in medium HM between day 2 and day 6 (p<0.034) and in
medium WE between day 2 and day 6 (p<0.027). There were no significant
intramedia differences as all media exhibited the same pattern of ethanol production.
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TABLE 3.6
Percentage chenges from basal concentrations of succinate precursors in the
four different media on days 2, 4 and 6.
Initial concentration of isoleucine is 0.27mmols/L in WE, 0.27mmols/L in 1640,
0.21mmols/L in 199 and 1.33mmols/L in HM. Initial concentration of valine is
0.3mmols/L in WE, 0.12mmols/L in 1640, 0.3mmols/L in 199 and 1.71mmols/L in
HM. Initial concentration of methionine is 0.07mmols/L in WE, 0.07mmols/L in 1640,
0.14mmols/L in 199 and 0.7mmols/L in HM.
DAY 2 DAY 4 DAY 6
ISOLEUCINE
WE -27 ± 26 % -33 ± 30 % -22 ± 22 %
1640 -7 ± 30 % -41 ±26% -37 ± 30 %
199 -34 ± 19% -38 ± 19% -57 ± 10%
HM -22 ± 20 % -35 ±23 % -38 ± 19%
VALINE
WE -27 ± 20 % -27 ± 26 % -20 ± 20 %
1640 -8 ± 25 % -8 ± 25 % -34 ±17%
199 -20 ± 17% -36 ± 20 % -50 ± 7 %
HM -47 ± 16% -51± 18 % -54 ± 15 %
METHIONINE
WE -71± 14 % -100% -43 ± 14 %
1640 -58 ±42 % -29 ± 42 % -58 ± 29 %
199 -36 ± 4 % ±43 ± 5 % -71 ± 21 %
HM -19 ± 16% -6 ± 26 % -20 ± 33 %
Results shown are mean ± SEM.
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TABLE 3.7
Concentrations of ethanol in the four different media on days 2, 4 and 6
(mniols/L)
ETHANOL
DAY 2 DAY 4 DAY 6
WE 11.86 ± 7.02* 5.11 ±2.09 3.19±2.61
1640 8.89 ±4.22 5.21 ± 1.86** 2.87 ±1.60*
199 10.57 ± 4.37* 13.66 ± 11.88* 2.19±0.78
HM 5.22 ±2.15 5.09±3.05 2.56 ±1.17
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to the
previous day's measurement.
3.4 DISCUSSION
This study deals with the following amino acids that can be assigned on NMR
spectroscopy using ID and 2D techniques. Alanine, threonine, aspartate,
phenylalanine, tyrosine, glutamate, glutamine, valine, leucine, isoleucine methionine,
histidine and arginine. Some signals from amino acids were obscured by the water
signal which is remarkably high even when suppressed. Signals from other amino
acids overlap with powerful signals from molecules present in high concentrations like
glucose. Unfortunately, all those amino acids could not be identified.
It is well known that amino acids can be produced by the cell from different
intermediate substances as part of the anabolic process of the cell. But cells are also
constantly breaking down proteins releasing amino acids. The final concentration of
those amino acids will depend on both those processes. It appears that as cell were
under the same experimental conditions, the contribution of protein breakdown to the
final amino acid concentration was equivalent in all culture media.
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This study produces some evidence that the culture medium although it does
not influence the survival of the hepatocytes cultured can influence their metabolic
profile. Researchers who want to enhance or suppress a particular pathway can do so
by changing the concentration of amino acids in solution i.e. the culture medium itself.
3.4.1 William's E Medium
William's E Medium showed a predominantly anaerobic pattern of
metabolism. This was manifested by a high glucose consumption and also a high
production of lactate. There was breakdown of pyruvate and a small consumption of
alanine , aspartate and threonine. The overall consumption of gluconeogenic amino
acids was an indication that gluconeogenesis was active. We have also shown that
WE medium exhibited a moderate consumption of valine, methionine and isoleucine.
This was an indication that the Kreb's cycle for aerobic ATP production was not very
well fed. The glycolysis in cells cultured in WE was far from the ideal scenario of
aerobic metabolism with small lactate production and small pyruvate consumption.
The ketogenic amino acids leucine, isoleucine, phenylalanine and tyrosine exhibited a
moderate to high consumption. The fact that they were used in ketogenesis was
proven by the big production of acetate. High glutamate production indicated that
transamination was very active. High histidine consumption pointed to a production
of glutamate from histidine, while high arginine consumption was indicative of a
functioning urea cycle. A lot of other substrates able to feed the urea cycle were
present in the cells so the small diversion of glutamate to aspartate came as no
surprise. High consumption of glutamine implied that cells were actively using it for
DNA synthesis and cellular division
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3.4.2 Medium 1640
Medium 1640 on the contrary, showed a pattern of aerobic ATP production
with small lactate production ,small increase in pyruvate and alanine concentration,
small threonine consumption and a high glucose consumption. The pattern overall
was of inactive gluconeogenesis. Succinate precursors valine, isoleucine and
methionine exhibited a moderate consumption but the overall pattern of metabolism
supported the view of a well fed Kreb's cycle. There was a small acetyl -CoA
production which was to be expected as there was a small consumption of leucine
and isoleucine and no consumption of phenylalanine. Although we mentioned that
ketogenesis from amino acid break down is only an alternative pathway, it is
indicative of a less active process. There was a very high tyrosine consumption that
could account for some of the acetyl-CoA generation. Aspartate concentration
increased sharply indicating that although aspartate was produced from glutamate it
was not converted to either alanine or arginine. Aspartate was then incorporated
either into the urea cycle or into the Kreb's cycle. The urea cycle was active with a
high histidine consumption and a very high arginine consumption and that would fit
with the high aspartate consumption. Glutamate concentration increased sharply
showing active transamination with a matching glutamine consumption. Glutamine is




Medium 199 exhibited a high glucose consumption accompanied by a high
alanine consumption and a moderate lactate production. As pyruvate was not present
in basal condition there was a small overall pyruvate production. There was also a
small production of threonine. Diversion of aspartate to alanine with production of
pyruvate was indicative of active gluconeogenesis. An active Kreb's cycle was
manifested by a high valine and methionine consumption accompanied by some
isoleucine consumption. All those amino acids can feed the Kreb's cycle through
production of succinate. There was a very high consumption of aspartate with a small
overall production of glutamate indicating that the urea cycle was active. This was
also manifested by the high rate of catabolism of histidine and arginine. The small
production of glutamate was an indication that transamination was less active than in
other media. There was also a small glutamine synthesis indicating that DNA
synthesis has slowed down under those conditions. There was a high acetyl-CoA
production although there is moderate consumption of all four ketogenic amino acids.
As we mentioned earlier the bulk of ketone bodies is produced from fatty acid
oxidation and it seems that this pathway was active under those conditions.
3.4.4 Hepatocyte Medium
There are essential differences in the constitution of Hepatocyte Medium
(HM) and the other three media examined. HM is a very rich medium and the
concentrations of all the amino acids in basal conditions are much higher in HM than
in other media. It also contains galactose as the hexose to be used as fuel for the cell.
HM exhibited a very high galactose consumption with a high lactate production and a
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small alanine consumption. This indicated an anaerobic pattern of metabolism which
was further underlined by a small aspartate production and a small phenylalanine and
tyrosine consumption. The presence of glucose in the supernatants was indicative of
gluconeogenesis. In contrast to other media there was consumption of glutamate
accompanied by a high glutamine consumption indicating a huge DNA synthesis but
not enough transamination, although both histidine and arginine are consumed. All
glutamate produced was transformed to glutamine. There was very small methionine
and isoleucine consumption and although there was moderate valine consumption we
can conclude that a small amount of succinate was produced and that Kreb's cycle
was not very active and well fed. There was moderate production of acetate with all
ketogenic amino acids exhibiting small consumption. Leucine in particular was not
being consumed at all. It is supposed that fatty acid oxidation compensates for the
small amino acid consumption to produce a moderate amount of acetate.
Overall we have evidence to support the hypothesis that the culture medium
plays an important role on how the cultured cells will behave during the experiments.
In WE and HM there was an anaerobic metabolic pattern exhibited which was less
prominent in 199 and turned into aerobic predominantly in medium 1640. The fact
that key substances like pyruvate and alanine were missing in medium 1640 might be
the key to this slow aerobic process exhibited. Also, WE and 1640 exhibited well
functioning transamination reactions with a lot of glutamate production which was
then diverted either to urea synthesis or glutamine. In contrast 199 and HM exhibited
very little transamination. The urea cycle was not performing very well with HM
although in 199 the fact that different amino acids could feed it compensated for the
small transamination. In 199 there was evidence of a small glutamine consumption
135
which shows that its utilisation in DNA synthesis and the division process was not
very successful. The other media showed that DNA synthesis was active to a great
extent. Acetyl -CoA synthesis was present in all media with WE and 199 showing a
lot of acetate production followed by AM and finally 1640 which showed relatively
small acetate production. As both fatty acids and ketogenic amino acids can be the
source for acetate we can only monitor the ketogenic amino acids and we think this is
why , although it seems that ketogenic amino acid consumption by all media was
roughly similar, we observed differences in the final product concentration.
This study produces evidence that it is possible to direct cells towards an
aerobic or anaerobic metabolic pattern. This can be done not only by supplying
enough oxygen but also by changing the concentrations of the amino acids present in
the cell culture medium. Further studies are needed to investigate the mechanisms
that control the flow of substances in hepatocytes in order to have a better
understanding of the above described results.
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CHAPTER 4
STUDIES ON CRYOPRESERVED HEPATOCYTES
4.1 INTRODUCTION
Fulminant hepatic failure (FFfF) is a life - threatening condition that may
require a liver transplant (Plevris et al, 1998). Lack of availability of donor livers
means that these patients will die while awaiting for a liver transplant.
Bioartificial liver support systems (BALSS) have long been regarded as a
desirable therapeutic modality to bridge patients to transplantation or even to allow
for complete regeneration of the patients' livers (Gerlach et al, 1996; Demetriou et al,
1998a). Currently, a few centres around the world have been developing and testing
BAL systems either on animal models of liver failure or patients, with encouraging
results (Sussman et al, 1992; Clement et al, 1996; Janke et al, 1997; Watanabe et
al,1997; Samuel et al, 1997; Ijima et al, 1998). Most available data at present
suggest that BAL systems can, despite their limitations, successfully bridge patients to
transplantation (Sussman et al, 1992; Watanabe et al, 1997; Samuel et al, 1997).
Hepatocyte transplantation is another exciting new modality to treat FHF.
Hepatocytes are infused into the spleen or the portal system of the patient in order to
provide liver support temporarily, allowing for regeneration of the injured liver
(Nakamura et al, 1997; Arkadopoulos et al, 1998; Fox et al, 1998).
Due to the scarcity of human hepatocytes, primary porcine hepatocytes are
currently regarded as the cell of choice for liver support. They are metabolically
active with similar biochemical profile to human hepatocytes and can be obtained in
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the large numbers that are required for BAL treatment and hepatocyte transplantation
(Jauregui et al, 1997; Demetriou et al, 1998b; Clement et al, 1998). Provision of
porcine hepatocytes, on demand, to treat FHF patients is logistically difficult; a
feasible way therefore to have primary porcine hepatocytes available on demand
would be to cryopreserve them and to thaw them as soon as the need arises (Naik et
al, 1997; Sheil et al, 1998). However, although this approach has been used by
several available BAL support systems, data regarding viability and plating efficiency
show that cryopreservation inversely affects those parameters (Chesne et al, 1993;
Naik et al. 1997) Detailed metabolic studies of cryopreserved hepatocytes are lacking.
So far studies evaluating the metabolic functions of cryopreserved hepatocytes
have been limited to monitor enzyme activities, drug and xenobiotic metabolism and
albumin production, because the techniques to measure the production of substrates
from the different biochemical cycles that are ongoing into the hepatocytes are not
widely available(Sun et al, 1990; Kasai et al, 1993; Diener et al, 1993; Koebe et al,
1996, Naik et al, 1997,).
The aim of this study was to systematically investigate the effect of different
protocols of cryopreservation on primary porcine hepatocyte viability and metabolism
using !H Nuclear Magnetic Resonance Spectroscopy.
4.2 MATERIALS AND METHODS
Hepatocyte isolation was performed as previously described in chapter 3
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4.2.1 Cell culture
Both fresh and cryopreserved hepatocytes were seeded at a density of 8.106
cells / plate ( 90 mm standard cell culture dishes) (Corning Inc.). Collagen coated
plates were used to evaluate the effect of collagen coating on viability and plating
efficiency of cryopreserved hepatocytes. 150pl of diluted type 1 ( rat tail) collagen
was used and plates were dried overnight under aseptic conditions before hepatocyte
plating (Sun et al, 1990). The culture media used were supplemented Williams E
medium or Medium 199. Media were used both as culture and as cryopreservation
media to evaluate the effect of different media on cryopreservation. These media
were hormonally defined and supplemented as in Chapter 3. The culture medium was
renewed every day during the culture period. Cultures were maintained under an
atmosphere of 95% air and 5% CO2. They were routinely examined under phase
contrast microscopy before every culture medium renewal. If media were used as
cryopreservation media then 10 % De2MO was used as cytoprotectant (Diener et al,
1993). 10% Foetal bovine serum was also evaluated as an alternative to supplements
for the cryopreservation experiments (Lawrence et al, 1991).
4.2.2 Microcarrier preparation.
Cytodex microbeads were evaluated as an alternative attachment substrate.
Type 3 microbeads were used. They were prepared according to manufacturer's
instructions (Microcarrier cell culture; ptrinciple and methods, Pharmacia LKB
Biotechnology, 1995). Briefly, they were soaked in Phosphate Buffer Solution using
aseptic techniques and were then sterilised in a wet autoclave. After isolation and
purification cells ( 106 cells/ml) were transferred to microbeads suspensions (104
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microcarriers/ml). They were left overnight in the incubator at 37°C to optimise
attachment conditions. They were then cryopreserved using protocol VIII.
4.2.3 Cryopreservation protocols
Eight different cryopreservation protocols were used. They were divided into
slow freezing protocols, quick freezing protocols, stepwise freezing protocols and
protocols for the cryopreservation of plated hepatocytes.
Quick freezing protocols were as follows:
Protocol I: -5°C/min from +4°C to -100°C (Lawrence et al, 1991)
Protocol II: -30°C/min from +4°C to -100°C(Lawrence et al, 1991)
Slow freezing protocols were as follows:
Protocol III: -2°C/min from +4°C to -100°C
Protocol IV: -0.5°C/min from +4°C to -100°C
Stepwise freezing protocols were as follows:
Protocol V: At 4°C for 20 minutes; -l°C/min from 4°C to -4°C; -25l)C/min from -4°C
to -40°C; +10°C/min from -40°C to -12°C; -l°C/min from -12°C to -40°C; -10°C/min
from -40°C to -100HC (Diener et al, 1993).
Protocol VI: -2.5°C/min from 4°C to 0°C; 8 minutes at 0°C; -2°C/min from 0°C to -
8°C; in 10 seconds down from -8°C to -28°C; -2.5°C/min from -28°C to -33°C;
+1.5°C/min from -33°C to -27°C; -2°C/min from -27°C to -60°C; -10°C/min from -
40°C to -100°C (Sun et al, 1990).
Protocol VII: At 4°C for 15 minutes; -l°C/min from +4°C to -5°C; -3°C/min from-5uC
to -12°C; -5°C/min from -12°C to -14°C; -7.5°C/min from -14°C to -20°C; -6.5°C/min
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from -20°C to -25°C; at -25°C for 4 minutes; +3°C/min from -25°C to -20°C; at -20°C
for 2 minutes; -l°C/min from -20°C to -50°C; -10°C/min from -50°C to -100°C.
Cryopreservation protocols used for plated hepatocytes were as follows:
Protocol VIII: -0.3°C/min from +4°C to -100°C.
Protocol IX: At room temperature for 20 min. At 4°C for 30 min. At -30°C for 90
min. Then stored at -70°C.
4.3 Cryopreservation
Cells were cryopreserved either as ordinary suspensions, suspensions attached
to microbeads or attached on plates.
4.3.1 Cell suspensions
After evaluation of the viability of the freshly isolated hepatocytes using the
trypan blue exclusion method, cells were again centrifuged (25g for 5 min) twice and
the pellet resuspended in culture medium. DMSO was introduced slowly over 4
minutes to a final concentration of 10% v/v. The final concentration was 2.106
cells/ml of cryopreservation solution. Suspensions were kept in 2 ml Nunc cryovials
containing approximately 1.5 ml of suspension. They were then cryopreserved using
cryopreservation protocols I- VIII.
Foetal bovine serum (FBS) as an adjunct to the cryopreservation media was evaluated
using protocols I, VI and VIII.
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4.3.2 Plated hepatocytes
They were cultured on standard and collagen coated culture dishes until they
reached confluence at day 2 post isolation. William's E medium and medium 199
were evaluated as incubation media. The supernatant was then aspirated and replaced
with a thin film of culture medium containing 10% v/v De2MO. They were then
cryopreserved using cryopreservation protocols VIII and IX.
All cells were stored in liquid nitrogen (LN2) at -196°C. After 7 days of
cryopreservation in LN2 cells were thawed using the following protocol. They were
gently shaken in a water bath at 37°C. Immediately after liquefaction of the culture
medium, the supernatant was aspirated and cells were centriftiged at 25g for 5
minutes and washed three times with HBSS buffer. Cells suspensions were then
plated on standard Petri dishes or on collagen coated Petri dishes and incubated.
Cells already plated were placed in the incubator after replenishment of the culture
medium. Viability was assessed immediately post thawing using the trypan blue
exclusion test. Morphology and plating efficiency were assessed at 24 h post thawing
using the % LDH test (Marsh et al, 1991.) and morphology of the cells under light
microscopy.
4.3.3 Microcarriers
Cells attached to microcarriers were thawed using the same method. They
were then detached from the microcarriers using trypsin as per the manufacturer's
instructions and plated as per normal cryopreserved cells.
Proton NMR spectroscopy experiments were performed as previously
described in Chapters 2 and 3. Assignments were made for the following substances.
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Glucose, lactate, pyruvate, alanine, glutamate, glutamine, arginine, aspartate, leucine,
isoleucine, valine, tyrosine, histidine, phenylalanine, acetate and ethanol
4.3.4 Statistical analysis
Comparisons between freshly isolated and cryopreserved hepatocyte from the
same isolation were made. Student's t-test was used to compare means of different
groups. A p value of < 0.05 was taken as significant (two-tail test of significance).
To compare between more than two groups we used the Tukey test based on the one
factor independent measures ANOVA. Results are expressed in mmols/L and are




Figure 4.1 shows the contrast phase light microscopic appearance of freshly
isolated cells incubated for 48h and Figure 4.2 the appearance of cryopreserved cells
frozen for 1 week and then plated, after a 24 h incubation. The colonies of
cryopreserved hepatocytes did not show spreading of the cells on the plates and the
cells themselves showed poor morphology with extensive vacuole formation.
4.4.2 Cells cryopreserved on microcarriers
Although Cytodex 3 microcarriers which are the optimal type of
microcarriers for hepatocytes were used and the protocols rigorously observed it was
evident that the attachment of cells on the microcarrier beads was minimal. Light
microscopy of cells incubated with microcarriers revealed a few cells trapped between
microbeads but most cells unattached to the microcarriers. No microbead was
observed covered with hepatocytes which is a sign of optimal attachment. The
viability of hepatocytes cryopreserved on microcarriers was between 5% and 8%
using both cryopreservation protocols. Consequently, experiments on microcarriers
were abandoned early in the study.
Figure 4.1 Inverted phase light microscopy appearances of primary
porcine hepatocytes at 24 h in culture in normal conditions
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Figure 4.2 Inverted phase light microscopy appearances of primary
porcine hepatocytes after 24 h in culture after 7 days in cryopreservation.
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4.4.3 NMR Results.
Figure 4.3 shows a single pulse 600 MHz *H NMR spectrum from cell
supenatants from cultured cryopreserved hepatocytes on plates at 24 h post plating.
Peaks were assigned to low molecular weight substances, as described in Chapter 1.
4.4.4 Effect of foetal bovine serum.
Experiments were conducted on four different isolations. Viability was
significantly better when no FBS was used ( p<0.032) but no difference was found
with regards to plating efficiency (Table 4.1). Glutamate production and glutamine
breakdown were significantly more active in cells cryopreserved without FBS (p<0.05
and p<0.04 respectively) (Figure 4.4). No significant differences were observed in
glutamine, succinate and acetate precursors uptake or in glucose metabolism indices.
Acetate production by cells preserved without FBS was higher when compared with
cells preserved under the same cryopreservation protocol but with FBS. The
differences in protocol VIII reached statistical significance (p<0.03) (Figure 4.4). All
further experiments were conducted using non supplemented media.
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Comparison of viability and plating efficiency in cells cryopreserved with or without
Foetal Bovine Serum using different hepatocyte cryopreservation protocols. .
Abbreviations are as follows: Protocol I (I), Protocol VI (VI), Protocol VIII (VIII),
Cultures with foetal bovine serum (+ FBS), Cultures without foetal bovine serum (-
FBS)
I+FBS I-FBS VI+FBS VI-FBS VIII+FBS VIII-FBS
Viability 40±5.1% 61±3.8%* 43±7.3% 56±6.9% 43±5.0% 52±4.1%
Plat. Eff 12±2. 3% 16±3.1% 10±0.9% 15±3.3% 9±1.2% 13±2%
Results shown are mean ± SEM. * p<0.05 compared to measurements from
the same protocol.
4.4.5 Effect of different culture media on activity of plated hepatocytes
Four different isolations were assessed. William's E and 199 media were
assessed. No significant differences were observed either between cryopreservation
protocols or between different incubation and preservation media. There was a trend
for less lactate production and less glucose uptake in cells incubated with William's E
medium but the results were not significant. All further experiments were conducted
using William's E medium as incubation and cryopreservation medium.
4.4.6 Effect of collagen coating of culture plates
Four different isolations were assessed. Both protocols used for the
cryopreservation of plated hepatocytes were assessed. No significant differences were
observed either between cells on standard cell culture dishes and collagen coated cell
culture dishes, or between protocols,
standard cell culture dishes.
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All further experiments were conducted using
4.4.7 Comparison between different cryopreservation protocols
Protocols I and II ( quick freezing protocols) were compared. Five different
isolations were assessed. No significant differences were observed overall between
the two protocols.
Protocols III and IV ( slow freezing protocols) were compared. Figure 4.5
summarises the results of these experiments (n=5). No significant differences were
observed overall between the two protocols. There was a trend for more acetate
production and less glutamine uptake by the cells using protocol III but the results
were not statistically significant.
Protocols V, VI and VII ( stepwise freezing protocols) were compared. Five
different isolations were assessed. Figure 4.6 summarises the results of these
experiments (n=5). No significant differences were observed overall between the
three protocols. There was a trend for cells cryopreserved by protocol VI to consume
more glucose but the results did not reach statistical significance. There was a trend
for cells cryopreserved by protocol VI to produce less acetate but the results did not
reach statistical significance. There was a trend for cells cryopreserved by protocol
VII to produce less lactate but the results did not reach statistical significance.
Figure4.5
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4.4.8 Comparison between cryopreserved and freshly isolated hepatocytes
To compare the metabolic activity of cryopreserved hepatocytes (CP) and
freshly isolated hepatocytes (FH) all assessed protocols were used. Quick freezing
(QF) protocols (I and II) were combined together as were protocols III and IV (slow
freezing, SF) V, VI and VII (stepwise freezing protocols, STF) and protocols VIII
and IX (stepwise freezing of plated hepatocytes, PH), as no significant differences
between were observed. Standard experimental conditions comprised cell suspended
in William's E medium without FBS supplementation, and plated hepatocytes were
plated on standard cell culture dishes.
Experiments were conducted during ten different isolations. The viability post
thaw was significantly reduced in CP cells compared to FH cells (p<0.05 in all
measurements). Plating efficiency was also significantly reduced in cryopreserved
hepatocytes (p<0.01 in all measurements) (Table 4.2).
TABLE 4.2
Comparisons of viability and plating efficiency between cells cryopreserved under
different protocols and freshly isolated cells. Abbreviations are as follows: Quick
freezing protocols (QF), Slow freezing protocols (SF), Stepwise freezing protocols
(STF), cells frozen on plates (PH), freshly isolated cells (FH)
FH QF SF STF PH
Viability 82±9.4% 56±8.8%* 53±7.6%* 55±8.3%* 62±5%*
Plat.eff. 87±4.3% 13±2.6%** 15±3.6%** 9±2.1%** N/A
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to the
measurements from fresahly isolated hepatocytes.
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4.4.8.1 Glycolysis and gluconeogenesis
Table 4.3 summarises the results of glucose metabolism. All CP cells and FH
cells consume glucose for their energy needs. No significant differences were
observed between CP cells and FH cells. SF hepatocytes consumed more glucose but
the results were not significant. Lactate production was apparent by all cells. FH
cells produced significantly more lactate then CP cells (p<0.0000 in all
measurements). By contrast, pyruvate, which is a normal constituent of William's E
medium, was taken up from the culture medium by all cells. The uptake was
significantly less in FH cells compared to all cryopreservation protocols ( FH vs
QF(p<0.01), FH vs SF (p<0.016), FH vs STF (p<0.0073), FH vs PH (p<0.009)).
Alanine, a central amino acid involved in many metabolic pathways had different fates
depending on the protocol. There was a small overall production of alanine in PH and
QF hepatocytes and a small overall uptake in SF and STF hepatocytes. In FH cells
there was a net consumption of alanine and this was statistically significant compared
with all cryopreservation protocols ( FH vs QF(p<0.0068), FH vs SF (p<0.0084), FH
vs STF (p<0.018), FH vs PH (p<0.0071)). There was a net consumption of
threonine overall by QF, PH and FH cells, the biggest consumption occurring in FH
cells. By contrast, SF and STF cells exhibited a small production of threonine that
was reflected by an increase in the concentration of threonine in culture supernatants.
155
TABLE 4.3
Comparison of glucose metabolism between cells cryopreserved under
different protocols and freshly isolated cells. Abbreviations as in Table 4.2 plus
William's E (Will. E)
Will. E FH QF SF STF PH
Glucose 7.7 5.51±0.76 5.02±0.48 4.57±0.51 5.52±0.68 5.95±0.78
Lactate 0 3.35±0.90 0.15±0.06** 0.22±0.06** 0.12+0.05** 0.18+0.03**
Pyruvate 0.2 0.12±0.04 0.03+0.01** 0.04+0.00* 0.02+0.00** 0.03+0.00**
Alanine 0.71 0.21±0.06 0.78+0.08** 0.66+0.0** 0.60+0.17* 0.76+0.12*
Threonine 0.23 0.11+0.06 0.16+0.10 0.20+0.04 0.25+0.06 0.13+0.02
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to baseline
values. Absolute values are in mmols/L
4.4.8.2 Urea and glutamine synthesis
Table 4.4 summarises the results for glutamate, glutamine histidine and
arginine metabolism. The pattern observed in all supernatants was of glutamine
uptake, accompanied by glutamate release in the medium. This represented intact
transamination activity. Glutamine can also be used in DNA synthesis. Glutamine
uptake by FH cells was significantly less compered to CP cells and reached statstical
significance in all measurements ( FH vs QF(p<0.005), FH vs SF (p<0.0071), FH vs
STF (p<0.025), FH vs PH (p<0.0071)). No significant differences were observed
concerning the release of glutamate back into the medium. Complete consumption of
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histidine was observed in all supernatants. Arginine uptake was also comparable from
all supernatants.
TABLE 4.4
Comparison between concentrations of glutamate synthesis precursors arginine and
histidine, glutamate and glutamine between cells cryopreserved under different
protocols and freshly isolated cells. Abbreviations as in Table 4.3.
WE FH QF SF STF PH
Histidine 0.07 0.02+0.01 0 0 0 0
Arginine 0.28 0.13±0.06 0.12±0.05 0.11±0.04 0.15+0.05 0.13+0.05
Glutamate 0.21 0.86+0.10 0.86+0.14 0.86+0.13 0.71+0.13 0.81+0.11
Glutamine 1.4 0.83+0.13 0.21+0.10** 0.27+0.08** 0.48+0.15* 0.27+0.08**
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to baseline
values. Absolute values are in mmols/L
4.4.8.3 Acetyl-CoA precursors and acetate.
Table 4.5 summarises the results for leucine, phenylalanine and tyrosine
metabolism which are some of the precursors for acetyl CoA and acetate production.
There was net uptake of leucine, from the medium by all cells. Phenylalanine was
consumed mostly by FH cells. There was a smaller consumption of phenylalanine by
CP cells. The results reached statistical significance if we compared FH vs QF
(p<0.025 and FH vs STF (p<0.032). Tyrosine was preferentially consumed by FH
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cells. The results were statistically significant compared with all cryopreservation
protocols ( FH vs QF(p<0.033), FH vs SF (p<0.042), FH vs STF (p<0.029), FFI vs
PH (p<0.02)). Overall minimal amounts of tyrosine were consumed by CP cells.
Acetate production was significantly higher in FH cells compared to CP cells
(p<0.0000 in all measurements).
TABLE 4.5
Comparison between concentrations of acetyl-CoA precursors leucine, phenylalanine
and tyrosine and acetate, between cells cryopreserved under different protocols and
freshly isolated cells. Abbreviations as in Table 4.3.
Will. E FH QF SF STF PH
Leucine 0.4 0.21±0.03 0.31±0.05 0.26±0.02 0.20±0.04 0.33±0.04
Phenylal. 0.14 0.06±0.01 0.14+0.03* 0.11+0.05 0.13+0.07* 0.09+0.04
Tyrosine 0.19 0.07+0.02 0.19+0.06* 0.15+0.03* 0.18+0.03* 0.14+0.04*
Acetate 0 7.82+2.00** 0.19+0.05** 0.23+0.03** 0.14+0.04** 0.15+0.03**
Results shown are mean ± SEM. * p<0.05, ** p<0.01 compared to baseline
values. Absolute values are in mmols/L
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4.4.8.4 Succinate precursors.
Figure 4.7 summarises the results for valine, isoleucine and methionine
metabolism which are the precursors for succinate formation that would then feed
Kreb's cycle. A small net consumption of valine by all cells, was observed. Isoleucine
uptake was very small from most cell supernatants but the supernatants from SF cells
showed no net isoleucine consumptioa. The fate of methionine which is a constituent
substance of the William's E medium seems to be similar in all cultures. There was no
significant uptake of methionine by any culture system.
4.4.8.5 ETHANOL
Figure 4.8 summarises the results for ethanol concentrations. Ethanol was
identified in all culture supernatants. The ethanol concentration was elevated in all
supernatants. It was markedly elevated in PH and FH cells , that is in all cell cultures
which have reached confluence at the time of the experiments
Figure4.7
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4.5 DISCUSSION
This study was undertaken to assess the metabolic functions of cryopreserved
primary porcine hepatocytes with the help of 'H NMR Spectroscopy. These cells
were kept in cryogenic storage in a LN2 atmosphere for 1 week, before being plated.
The culture supernatants were examined at 24 h after plating.
In our study the viability of the CP cells was examined and was found to be
significantly less than that of FH cells. There was a trend for better viability for plated
hepatocytes but was inferior to that of FH cells. It is generally thought that
hepatocytes are very difficult cells to cryopreserve as they seem to be very sensitive to
intracellular ice formation (Darr et al, 1997) and the known cytoprotectants are not of
much help (Toshchakov et al, 1991). This is also reflected by the extremely poor
plating efficiency of the cells preserved in suspensions and by the inability of the
hepatocytes to attach to microcarriers properly.
In this study we examined some of the major metabolic pathways of the CP
hepatocytes and compared them to FH hepatocytes. We are going to examine those
pathways in detail below.
Glucose from the glucose rich William's E medium was consumed by both CP
cells and FH cells. No significant differences were observed either between different
cryopreservation protocols or between CP and FH cells. CP cells seemed to have a
less active glycolytic pathway but the net production of alanine from QF and PH cells
was an indication that pyruvate was transformed to alanine and glycolysis did occur.
There was a very small production of lactate and most of the pyruvate was consumed
by CP cells (Denton et al, 1978). The conversion of pyruvate to alanine suggets that
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there was definitely no active gluconeogenesis present. Results on threonine
concentration were different depending on the cryopreservation protocol used. PH
and QF hepatocytes seemed to consume threonine and by converting it to alanine.
Those results are in agreement with inactive gluconeogenesis and high alanine
concentrations in supernatants of PH and QF cells. There was a negligible uptake of
threonine by SF hepatocytes and there was a net production of threonine in STF cells
supernatants from protein breakdown, which was not directly converted to alanine.
By contrast FH cells seemed to have a more active glycolysis. Although the
abundant lactate production could be a sign of anaerobic metabolism the fact that
alanine was consumed in big quantities proves that pyruvate synthesis was present and
gluconeogenesis was active (Seglen et al, 1974). There was also a significant
threonine uptake which implied that threonine was converted to alanine.
Successful turnaround of nitrogen compounds is another key function of the
hepatocytes. This is reflected in transamination reactions and urea production
through the urea cycle. The central player in transamination reactions is of course
glutamate which accepts the nitroso radical of a-ketoacids during their catabolism
(Fuchs et al, 1994). Net production of glutamate was observed in all culture
supernatants in CP and FH hepatocytes. Glutamine is produced from glutamate when
need for scavanging of ammonium cations is present. It is then used as a nitrogen
donor in the synthesis of purine and pyrimidine bases and hence nucleic acid synthesis
(Lang et al,1990). Glutamate and glutamine are also a useful buffer in acidotic
conditions (Gerlach et al, 1996). Significantly more glutamine was consumed by CP
cells than by FH cells. It is reasonable to conclude then that transamination was
active in CP cells.
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Arginine uptake from the media by both CP and FI cells showed that arginine was
introduced into the urea cycle. All supernatants from cryopreserved cells showed that
histidine from the medium was entirely consumed by the hepatocytes. Histidine
uptake is indicative of an ability of hydroxylation and further transformation of
histidine into glutamate can take place in hepatocytes (De Blaaw et al, 1999). Our
results confirm that transamination occurs and the urea cycle is active in CP cells in
accordance with previous reports (Lawrence et al, 1991; Kasai et al 1993).
Acetate production from the fatty acids via ketogenesis is characteristic of the
hepatocyte (Seifter et al, 1994). Significantly less acetate was produced by the CP
cells indicating a dysfunctioning fatty acid oxidation and ketogenesis. In comparison
FH cells produced and exported significant amounts of acetate. Although studies
have shown defective fatty acid oxidation in new born piglets (Duee et al, 1994), the
fact that FH cells produced acetate confirms that there is no enzyme deficiency in our
piglet population. Looking at ketogenic amino acids leucine was preferentially taken
up by both CP and FH cells. The other ketogenic amino acids isoleucine,
phenylalanine and tyrosine showed a small and comparable uptake by CP cells
cryopreserved by all methods. FH cells consumed more isoleucine, phenylalanine and
tyrosine and this represents evidence of more active ketogenesis by FH cells.
Some of succinate precursors' fate was monitored during our experiments. We
mentioned previously the small uptake of isoleucine. A similar pattern was observed
by valine as all hepatocytes utilised very little valine and there was no difference
between FH and CP cells. The pattern for methionine was of no net methionine
consumption overall by any CP cells. There was a 30% reduction of methionine
concentration in the supernatants of FH cells. Overall those results indicated that
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there was no significant succinate production to feed the Kreb's cycle and this is in
agreement with our hypothesis that Kreb's cycle activity is impaired.
The liver has a very limited capacity to metabolise branch chain amino acids
(BCAAs) as it lacks almost completely the necessary enzymes to metabolise leucine to
a-ketoisocaproate, isoleucine to a-ketofi-methylvalerate and valine to a-
ketoisovalerate in basal conditions. This is true in in vivo situations though and in the
well fed state. It is possible that hepatocytes under stress as they possess the
mechanism for production of the necessary enzymes, they would try and utilise
BCAAs to produce necessary proteins (Fuchs et al, 1994). Our results showed that
CP and FH cells preferentially utilised leucine for protein synthesis or transamination
reactions which is the most abundant BCAA in William's E medium. There was
almost negligible uptake of isoleucine and valine by all cell cultures. The fact that all
BCAA's use the same transporter to enter the cells could account for that observation
as cells try to restore an equilibrium in the extracellular milieu.
Aromatic amino acids present in the culture medium were also taken up by the
hepatocytes. CP cells almost exclusively took up histidine from the medium and little
tyrosine or phenylalanine. FH cells also took up histidine but tyrosine and
phenylalanine as well. Phenylalanine can be converted to tyrosine and lead to the
formation of ketoacids.
High levels of ethanol were observed in all culture supernatants. Their
presence is enigmatic. The obvious theory of contamination by bacteria or fungi is
confounded by the sterility of media on conventional testing. The fact that we used
ethanol in our laboratory as a decontaminant on incubators and laminar flow hoods
was also tested by introducing alcohol free isolations. Cell culture supernatants
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though from those isolations clearly showed evidence of ethanol in the cell culture
supernatant. These observations have previously been reported in biological fluids of
animals (Nicholson et al., 1985; Gosden et al,1990; Foxall et al. 1992) and one
plausible explanation is that some mammalian species under stress conditions have the
ability to produce ethanol under conditions of alcohol dehydrogenase inhibition
We were surprised to find that supplementation of the cryopreservation
medium with FBS, was actually detrimental to the cells. Our results confirm the
observation that FBS made no difference in the functional status of the hepatocytes
(Lawrence et al, 1993). We have also observed that different media and the coating of
plates with collagen did not make any significant difference in accordance with
previous studies (Watts et al, 1996.).
Overall, our results have shown that 'H NMR Spectroscopy at 600MHz is an
accurate tool to monitor the metabolic activity of cryopreserved and freshly isolated
cultured cells. They would be in agreement with the hypothesis that although
cryopreserved hepatocytes are metabolically active, major metabolic pathways are
dysfunctioning as cryogenic storage could significantly impair the function of
temperature sensitive metabolic enzymes. Although cryopreserved cell have been
used as the biological component of BALSS that have recently gone into clinical
trials it is clear that CP cells do not perform as well as FI cells. The fact that these
systems can be performing as only a biological adsorbent detoxifying substances that
could be responsible for the acute liver failure has been proposed (Flendrig et al,
1997) and merits further investigation.
Our results have shown that the up to date cryopreservation protocols do
produce similar results. The fact that new biological cytoprotectants will be on the
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market shortly would guarantee further investigations. Further efforts will go into
the understanding of the freezing process itself in order to optimise cryopreservation




STUDIES ON HYPOTHERMICALLY PRESERVED HEPATOCYTES
5.1 INTRODUCTION
The complex physiological role of the liver and its pivotal role in a diversity of
biochemical pathways is well recognised. Methods to isolate the liver and to study its
metabolic functions in an environment free from the regulatory signals it receives in
vivo have been sought since the early days of modern biomedical research. The
introduction of the two step collagenase perfusion technique for the isolation of liver
parenchymal cells (Barry et al, 1969) has been a major breakthrough for the study of a
variety of liver functions. Extensive progress has been made since, in our ability to
isolate and maintain primary hepatocytes in monolayer cultures for several days
(Gerlach et al, 1994; Sielaff et al, 1995; Koebe et al, 1996; Jauregui et al, 1997).
Primary hepatocytes are widely used in in vitro models of toxicology and
pharmacology. The metabolism of xenobiotics by primary hepatocytes has been
extensively investigated and has been used in recent years to help produce safer drugs
by studying drug metabolism and to reduce the number of in vivo animal toxicology
studies (Strom et al, 1983; Butterworth et al, 1989; Guillouzo et al, 1997).
Increasing demand for isolated hepatocytes has led scientists to experiment
with different animal species. Rat hepatocytes are extensively used for in vitro studies
in toxicology and pharmacology (Paine et al, 1982; Ratanavasanh et al, 1988).
Although primary porcine hepatocytes now seem to be the cells of choice in liver
support systems, the use of human hepatocytes in those systems when treating
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patients has been advocated (Jauregui et al, 1997; Demetriou et al, 1998b; Clement et
al, 1998).
In the previous chapter we have looked at cryopreserved hepatocytes and their
metabolic functions. Overall our results suggest that key metabolic pathways of
cryopreserved hepatocytes are impaired and that cryopreserved hepatocytes are not
ideal for use in BALSS and in hepatocyte transpplantation.
Hypothermic preservation of primary hepatocytes has been suggested as a
means of temporary liver cell storage (Marsh et al, 1991; Poullain et al, 1992; Vara et
al, 1995; Oesch et al, 1995; Sakai et al, 1996; Piatt at al, 1996). Such storage is
important if BALSS are to be commercially developed. Hypothermic storage can
affect hepatocyte viability and plating efficiency (Chesne et al, 1993b; Naik et al,
1997). So far studies evaluating the metabolic functions of hypothermically
preserved hepatocytes have been limited to monitoring enzyme activities, (Marsh et
al, 1991; Poullain et al, 1992; Vara et al, 1995; Sakai et al, 1996; Piatt at al, 1996)
drug and xenobiotic metabolism (Poullain et al, 1992; Oesch et al,1995; Sakai et al,
1996; Piatt at al, 1996) and albumin production (Marsh et al, 1991; Poullain et
al, 1992; Vara et al, 1995; Sakai et al,1996). This is because the techniques to measure
the production of substrates from the different biochemical cycles occurring within the
hepatocytes are not widely available.
The aim of this study was to validate the use of NMR Spectroscopy as a tool
to assess metabolic functions of primary porcine hepatocytes and to monitor major
metabolic pathways in those cells during culture following hypothermic preservation
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5.2 MATERIALS AND METHODS
Hepatocyte isolation was performed as previously described in Chapter 3.
5.2.1 Hypothermic cell preparation
Our hypothermic cell preparation is based on that described by Poullain et
al,(1992). Freshly isolated primary porcine hepatocyte suspensions in Williams E
medium were centrifiiged (25 g for 5 min) and resuspended in Leibovitz L-15 medium
supplemented with antibiotics ( penicillin 50 mg /ml, streptomycin lOmg/ml and
gentamicin 0.1 mg/ml ). Hepatocytes (107 /ml) were stored at 4°C in sealed 3 ml
Nunc Cryovials (Nunc, Denmark) for 48 h under an air atmosphere. At 48 h
hepatocytes were gently resuspended and cell viability was assessed by the trypan blue
exclusion test and plating efficiency by percentage LDH activity. Cells were then
centrifiiged (25 g for 5 min) washed in Hank's Balanced Salt Solution (HBSS) buffer
and then resuspended in Williams E medium before seeding.
5.2.2 Cell culture
Both fresh and hypothermically preserved hepatocytes were seeded at a
density of 8xl06 cells / plate ( 90 mm standard cell culture dishes) (Corning Inc.).
The culture medium used was a supplemented Williams E medium. Supplements
included penicillin, streptomycin, gentamicin, amphoterocin B, porcine insulin, L-
glutamine, dexamethasone and Long Epidermal Growth Factor (L-EGF). The culture
medium was renewed every day during the culture period. Cultures were maintained
under an atmosphere of 95% air and 5% C02at 37 °C. They were routinely examined
using phase contrast microscopy before every culture medium renewal.
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5.2.3 NMR Spectroscopy
NMR Spectroscopy monitoring was performed as discussed in Chapter 2.
Sample preparation, data acquisition and quantitation of compound concentrations
were performed as discussed in Chapter 2.
5.2.4 Statistical analysis
Comparisons between freshly isolated (Fl) and hypothermically preserved
(HP) hepatocytes from the same isolation were made. The values of each experiment
were the mean of six cultures. Results are expressed as mean ± standard error of the
mean.
5.3 RESULTS
Results are expressed as mmols/L. Six different primary porcine hepatocyte
isolations were evaluated. Viability was 78.1 ± 1.2% at isolation, 69 ± 3.4% at 24
hours and 58.9 ± 3.8% at 48hours of hypothermia. Plating efficiency was 87 ± 4%
for freshly isolated (FI) cells and 33.6 ± 7.6% for hypothermically preserved (HP)
cells at 48h.
Both HP and FI hepatocytes were observed using phase contrast microscopes.
There were no morphological differences between the two groups of hepatocytes.
5.3.1 Quantitative NMR data
Figure 5.1 shows single pulse 600 MHz 'H NMR spectra of supenatants






5.3.2 Glycolysis and gluconeogenesis
Figure 5.2 shows the levels of glucose, lactate, pyruvate alanine and threonine
in supernatants of FI cells, HP cells, and supplemented William's E medium for
comparison.
The results showed that there was a net consumption of glucose in both Fl and
HP cell supernatants. If we compared glucose consumption by FI and HP cells there
was significantly more glucose consumed by HP cells (p<0.038) . Lactate was
produced by both HP and FI cells but production of lactate by FI cells was
significantly higher than production by HP cells (p<0.0076). Examination of
pyruvate which is normally a constituent of William's E medium, enabled us to
conclude that there was a consumption of pyruvate by FI cells and a net production of
pyruvate by HP cells. Pyruvate concentration in HP cells supernatants was
significantly higher than in supernatants on FI cell cultures (p<0.01). Alanine, a
central amino acid, involved in many pathways is gluconeogenic and can also be
converted to pyruvate. We observed a significant reduction of alanine concentration
in the supernatants of FI cells compared to William's E medium (p<0.046), but noted
that there was a significant increase in the alanine concentration in the supernatants of
HP cells compared to William's E medium (p<0.009). If we look at threonine which
is an amino acid used by hepatocytes as a substrate for alanine synthesis we observed
that FI cells consumed very little threonine but there was significant reduction of
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5.3.3 Urea and glutamine synthesis
Figure 5.3 shows the levels of glutamine , glutamate, arginine and histidine in
supernatants of FI cells, HP cells and supplemented William's E medium for
comparison.
Glutamine uptake was accompanied by glutamate release in both supernatants.
Glutamine uptake in both FI and HP supernatants was comparable. Glutamate release
was also comparable. This reflects intact transamination capacity by both culture
modalities. Arginine and histidine uptake was significant in both supernatants
(p<0.032 for arginine and p<0.028 for histidine). The amounts consumed were
comparable for both supernatants, which indicates urea cycle activity.
5.3.4 Acetyl-CoA precursors
Figure 5.4 shows the levels of leucine, isoleucine, tyrosine and phenylalanine
in supernatants of FI and HP cells and supplemented William's E medium for
comparison
Leucine, isoleucine, tyrosine and phenylalanine are all ketogenic amino acids
for the hepatocytes. Both FI cells and HP cells utilised preferentially leucine from the
medium, showing a significant reduction in concentration (p<0.003 for FI cells and
p<0.03 for HP cells). Small quantities of isoleucine were also taken up by FI and HP
cells.
Looking at tyrosine we observed that FI cells showed significant uptake of
tyrosine (p<0.04). In contrast,the HP cells showed no uptake of tyrosine and indeed
there was some release of tyrosine from the cells back into the medium which was not
statistically significant. Phenylalanine was not significantly taken up by either FI or
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Figure 5.5 shows the levels of acetate in supernatants of FI and HP cells.
Acetate production was present both in FI and HP cells. There was significant
production of acetate by HP cells but the levels of acetate production in FI cells
weresignificantly higher (p<0.001). This may overall represent some impairment of
ketogenesis in hypothermically preserved cells.
5.3.6 Succinate precursors.
Table 5.6 shows the levels of methionine and valine in supernatants of FI
cells, HP cells and supplemented William's E medium for comparison. Those two
amino acids are glucogenic for the hepatocytes and are used by the hepatocytes to
form succinate which in turn will feed the Krebs cycle and aerobic glycolysis.
FI cells consumed significant quantities of methionine (p<0.001) and on
average all the methionine present in the medium was taken up by the hepatocytes.
HP cells showed no evidence of methionine consumption.
There was a small consumption of valine present in both FI and HP cells.
There was a trend for FI cells to consume more valine but the resulting differences
were not significant.
5.3.6 Ethanol.
Figure 5.7 shows the levels of ethanol in supernatants of FI cells and HP cells.
Supplemented William's E medium does not contain any ethanol, but ethanol was
readily identifiable in NMR spectra from all culture supernatants from either FI cell
cultures or HP cell cultures. The ethanol concentration was elevated in all examined
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supernatants. A trend of higher ethanol concentrations in the supernatants of FI cells
than in supernatants of HP cells was noted but the results were not statistically
significant.
Figure5.5
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This study was undertaken to systematically assess primary porcine hepatocyte
metabolism following hypothermic preservation using 'H NMR Spectroscopy. These
cells were kept in moderate hypothermia at 4 0 C for 48 h, before being plated. The
culture supernatants were examined at 48 h after plating.
Viability was reduced from 78.1 % at isolation to 58.9% after preservation in
hypothermia for 48 h. plating efficiency was also greatly reduced from 87% at
isolation to 33.6% after hypothermic preservation. This represents the effect of
hypothermia induced cell - injury and is in accordance with previous studies on
primary porcine hepatocytes and hepatocytes of other species (Marsh et al, 1991;
Poullain et al, 1992; Vara et al, 1995; Naik et al, 1997).
As the plating efficiency between FI and HP cells varied greatly, it is obvious
that the cell densities on the culture dishes were different. However, phase contrast
microscopy studies did not show differences between the two cell populations. In
addition studies in our laboratory and others comparing metabolic functions of fresh
hepatocytes, over a period of 6 days confirmed that urea and albumin synthesis and
galactose elimination by the cells were not significantly different despite different
levels of cell densities. We thus believe that cell density would not influence the
metabolic functions of hepatocytes.
We have used the Leibovitz L-15 medium as our cryopreservation medium as
literature evidence suggests and our preliminary experiments confirmed that it is
superior to specific hepatocyte culture and preservation media (Marsh et al, 1991,
Poullain et al, 1992).
184
In this study, using NMR Spectroscopy, we have been able to show that major
pathways of carbohydrate and aminoacid metabolism that operate in normal cells are
conserved in hypothermically preserved cells.
Glucose from the glucose rich William's E medium was consumed by HP
cells. The glycolytic was activated and pyruvate was produced. Although William's E
contains pyruvate which FI cells utilised, it appears that HP cells are able to utilise
their glucose more efficiently with net production of pyruvate and a very small
production of lactate. This indicates a predominantly aerobic pattern of glucose
oxidation by HP cells. A net production of alanine and a net consumption of
threonine from the HP cells was on the other hand, suggestive of inactive
gluconeogenesis. In contrast, FI cells utilised their alanine to feed their
gluconeogenetic pathway quickly and they seemed to be unable to efficiently convert
threonine to alanine. Pyruvate is the a-ketoacid that is derived from alanine. Liver
cells possess the enzymatic machinery to interconvert pyruvate and alanine. It has
been shown that if an excess of pyruvate is present intracellularly it can either be
converted to oxaloacetate and enter the Kreb's cycle for efficient energy storage
through production of high energy phosphate bonds, or be converted to lactate for
fast energy release, or be converted to alanine for incorporation into protein synthesis
pathways or be used for gluconeogenesis (Denton et al, 1978; Petersen et al, 1994).
The observed threonine consumption was a sign of threonine conversion to alanine
which is a sign of active gluconeogenesis as alanine can be converted to pyruvate and
further to glucose. Although organic acids from the Kreb's cycle were not present in
supernatants of the cell cultures, future studies designed to examine cell extracts from
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cell cultures may be able to elucidate the question of increase turnover of Kreb's
cycle.
Successful turnaround of nitrogen compounds is another key function of the
hepatocytes. This was reflected in transamination reactions and urea production
through the urea cycle. HP cells in culture, took up glutamine from the glutamine rich
William's E medium and released glutamate into the culture supernatant. Glutamate
and glutamine both play a major role in the transamination reactions involving amino
acids. It has been shown that the observed pattern in the case of HP cells
supernatants reflects transamination activity (Gerlach et al, 1996). Uptake of histidine
from the medium by HP cells shows that the cells utilise histidine to form glutamate.
Uptake of arginine from the media also shows that arginine is introduced into the urea
cycle. Our results confirmed that the urea cycle was active and transamination
reactions occurred in HP hepatocytes. Glutamine uptake also confirmed that cells
were active in DNA synthesis and repair.
Acetate production from fatty acid oxidation is characteristic of a well
functioning hepatocyte (Seglen et al. 1974). Although there was evidence that leucine
was taken up by the HP hepatocytes the other acetyl-CoA precursors studied tyrosine,
phenylalanine and isoleucine showed either minimal uptake or even some release into
the medium (tyrosine). There was some production of acetate from HP hepatocytes
indicating that fatty acid oxidation and ketogenesis took place but compared with FI
cells the concentration of acetate after 48 h was four fold lower. It seems that all the
ketogenic mechanisms from amino acid breakdown in HP cells are impaired.
Valine, isoleucine and methionine are some of the glycolytic aminoacids that
the hepatocytes breakdown to feed the Kreb's cycle through succinate formation.
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The fact that all amino acids showed evidence of minimal uptake is an indication that
the Kreb's cycle is well fed from the hexose phosphate pathway and does not need
amino acid break down for satisfactory turn over.
High levels of ethanol were observed in all culture supernatants. The possible
explanations for this were discussed in Chapter 4.
Overall our results are in agreement with previous reports that HP hepatocytes
maintain their differentiated functions and can be successfully revived after
hypothermia (Marsh et al, 1991; Poullain et al, 1992; Vara et al, 1995; Sakai et
al,1996). These results will enable researchers to use hypothermia as a temporary
storage procedure for porcine hepatocytes. This could apply to the preservation of
hepatocytes from other species like dogs, mice and rats. As porcine hepatocytes are
more difficult to preserve and culture than hepatocytes of other species we can
assume that this technique could be applied to hepatocytes of other species.
Cryopreservation experiments have confirmed our hypothesis (Chesne et al, 1993,
Darr et al, 1997). Although this is not a definitive method of preservation it allows
scientists to maintain these cells in suspension for potential applications such as
BALSS or hepatocyte transplantation. We have been unable to maintain HP cells for
more that 48 h. It was clear that after 72 h viability was greatly reduced. Further
studies on long term culture of HP hepatocytes are required perhaps by altering the
hypothermia medium or the culture medium. Also further studies are needed on other
techniques for hepatocyte storage long term such as preservation of hepatocytes in
three dimensional structures in microgravity environment.
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CHAPTER 6
STUDIES ON HEPATOCYTES CULTURED IN MICROGRAVITY
6.1 INTRODUCTION
During the last few decades our ability to culture isolated cells in vitro has
been the basis for fundamental advances in cell biology. In spite of the amount of
information gained in the traditional cell culture settings, it is believed that
conventional tissue culture in two dimensions may be inadequate to model the
complex cellular interactions that promote tissue specific differentiation. Cells
maintained as homotypic population in 2-D culture quickly lose their differentiated
functions (Kloth et al, 1995). This can be maintained by growing cells under the
necessary environmental conditions for organ like assembly, such as cell- cell
interactions in three dimensions. Three dimensional cell aggregates can be obtained in
suspension cultures but the high levels of fluid shear stress encountered in
conventional stirred fermentors limit the level of tissue specific differentiation of the
aggregated cells (Lelkes et al, 1998).
Experiments in space flight induced microgravity can overcome the high shear
forces. Indeed cells cultured in suspension under those conditions, have shown
significant changes in their functions. These include increased growth rate and
antibiotic resistance in bacteria, increased substrate attachment in human kidney cells
and increased hormone secretion by cultured lymphocytes and macrophages and many
others. Even in the absence of any direct evidence for any specific mechanisms, it has
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become increasingly clear that space flight induced microgravity has profound effects
on cells in vitro (Morrison et al, 1992).
Recently the in vitro generation of simulated microgravity has become
possible with the High Aspect Ratio Vessels (HARV). HARVs offer a revolutionary
approach to study cell functions. HARVs were developed at the National Aeronautics
and Space Administration (NASA) - Johnson Space Center. HARVs allow for the
cultivation of cell in an environment of low shear stress, low turbulence and no gas -
fluid interface (Akins et al, 1997; Baker et al, 1997; Long et al, 1999). The principle
of rotating the culture vessel allows cells to be maintained in perpetual suspension
with the net gravity vector approaching zero all the time.
The key to the utility of the HARV system is that the culture vessel and the
fluid contained therein approximate a solid body during rotation (Goodwin et al,
1997). When cells are added to the HARV they sink to the bottom of the vessel at a
constant rate related to the gravitational field, the difference in density between the
particles and the medium, the size of the particles and other factors. Rotation of the
HARV results in a path for the cells determined by the combination of sedimentation
and movement along with the medium. By increasing the rotation speed we can
prevent the cells from reaching the bottom of the vessel. The cells appear to describe
an elliptical path in the medium relative to the observer. Further increases in the
rotation rate results in the diminution of the elliptical path until the cells become
essentially motionless relative to the medium. At this point the vessel, contents and
medium approximate a solid body. The cells maintain 3D orientations relative to each
other and the surrounding medium in an apparently low shear environment. These
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conditions are similar to those expected to prevail in true microgravity (Goodwin et
al, 1993).
Bioartificial liver support systems can benefit from hepatocytes cultured and
preserved in a suspension environment. The microgravity environment presents an
exciting new modality for continuous cultures of hepatocytes in suspension. They can
be easily transferred out of the rotating vessels and loaded onto the bioreactors for
BALSS treatments on demand.
The aim of this study was to characterise key metabolic functions of PPHs
cultured in a HARV and to assess cell aggregation and maintenance of proliferation of
hepatocytes on 3D structures for the predetermined time period of 21 days.
6.2 MATERIALS AND METHODS
Hepatocyte isolation was performed as previously described
6.2.1 Hepatocyte Culture in Simulated Microgravity
Cells were seeded in the 55 ml-capacity HARV (Cellon-Sarl, Luxembourg)
(Figure 6.1) at a density of 2xl06 viable cells / ml William's medium E at 37°C. The
medium consisted of serum-free, chemically-defined medium supplemented with 50
Glutamine; 50 mg/ml Gentomycin 50 mg/ml Penicillin and lOmg/ml Streptomycin,
ng/ml L-EGF; 10p.g/ml porcine insulin; 1 pmol/L dexamethasone; 2 mmol/L L- The
HARV was connected to the horizontally rotating axle of the RCCS which pumped
incubator gas via a central aperture, across a semi-permeable gas exchange membrane
within the HARV. The RCCS-HARV assembly was placed in a humidified incubator
under a 95% air: 5% CO2 atmosphere. Next day (day 1), the medium from the
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HARV was aspirated and fresh medium added, which was subsequently changed
every 3 days. The optimal rotational speed of the HARV was determined by adjusting
the RCCS rotational speed such that the aggregates maintained a free-fall, quasi-
stationary orbit within the culture vessel. The rotational speed varied according to
both aggregate size and the corresponding sedimentation coefficient, however by day
6 of culture, rotational speed was set between 10-15 rpm.
For changes of supplemented William's E medium a 0.5 cm fill port was used
using a suction aspirator. When changing the medium, the cells were covered by a
small amount of medium to minimise cell damage. Media samples were taken daily via
a syringe attached to tone of the luer-lock syringe ports and stored at -70°C until
NMR analysis.
Morphology was assessed using a Zeiss inverted microscope (Zeiss, Germany)
under phase-contrast on both day 0 and day 21 of culture. Cell purity was determined
by cytospin (x200g, 5 mins) of 5xl05 freshly isolated cells and staining with
haemotoxylin + eosin / Periodic Acid SchifF (PAS), followed by counting cells in 3
separate fields for 3 separate isolations.
6.2.2 NMR spectroscopy.
NMR Spectroscopy monitoring was performed as discussed in Chapter 2.
Sample preparation, data acquisition and quantitation of compound concentrations
were performed as discussed in Chapter 2.




Comparisons between freshly isolated hepatocytes maintained in the HARV
environment from the same isolation were made at different time points of the
experiments. Six consecutive cultures were used as the basis of our experiments. The
concentration results obtained represent the mean of those six experiments. To
compare between groups we used the Tukey test based on the one factor independent
measures ANOVA. The Bonferoni correction was used if more than two groups were
compared. A p value of < 0.05 was taken as significant (two-tail test of
significance). Results are expressed as mean ± standard error of the mean
6.3 RESULTS
Cell viability, determined by trypan blue exclusion following isolation (day 0)
was 85±6%. The cell suspension was composed of single cells and small aggregates
of between 5-20 cells showing bright cytoplasm, sharply defined borders, commonly
with round or polygonal shape and little physical damage (blebbing) under phase
contrast microscopy (Figure 6.2). Hepatocyte purity for fresh cells was 95±3% (n=3)
H&E staining showed gross morphology of cell aggregates at day 13 and 21; PAS
staining revealed hepatocyte glycogen content at each time point.
Figure 6.3 shows a 1 FT NMR sperctrum of the cutlure medium from a
microgravity experiment as cells are in culture for 3 days






Figure 6.3 shows the results for glucose and lactate comparing concentrations
between different days. Figure 6.4 shows the results for pyruvate and glucogenic
amino acids comparing concentrations between different days
6.3.1.1 GLUCOSE.
There is statistically significant consumption of glucose compared to the
baseline value on all days (p<0.01 on all measurements). The biggest consumption is
seen on day 14 and the smallest in day 21. Between days 4 and 10 glucose
consumption plateaued. Overall there were no statistically significant differences
between days as measured by one factor independent measures ANOVA.
6.3.1.2 LACTATE
There was lactate production at all time points sampled. There was a small
production on day 1 which then increased to reach a peak on day 4 and then steadily
decreased up to day 21, when lactate concentration was similar to the one on day 1.
There were statistically significant differences in concentrations between day 4 and
day 1 (p<0.0029). between day 4 and day 21 (p<0.017) and day 7 and day 1
(p<0.033).
Figure6.4
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Pyruvate was consumed on all days apart from day 14 when there was net
pyruvate production from the hepatocytes cultured. The biggest consumption is
manifested in day 1. Pyruvate concentration in the supernatant was also low on day
10. Between days 2 and 10 pyruvate concentration plateaued. The ANOVA test
shows statistical significance between concentrations on different days (F<0.03). The
Tuckey test confirmed that there were statistically significant differences between day
1 and day 14 (p<0.03) and day 10 and day 14 (p<0.02).
6.3.1.4 ALANINE
There was consumption of alanine on days 1, 2, 4 and 10 and alanine
production on days 7, 14 and 21. The lowest alanine concentration was exhibited on
day 2. The maximum alanine concentration was reached on day 21. There were
statistically significant differences in alanine concentration between day 2 and day 14
(p<0.009) and between day 2 and day 21 (p<0.029)
6.3.1.5 THREONINE
There was consumption of threonine at all time points sampled. There was a big
variation of the amount of threonine that was consumed. If we look at the one way
ANOVA test between days the results were highly significant (F<0.00003). Table 6.1
shows the statistically significant differences between concentrations on different days
using the Tukey test. There was a very small consumption of threonine on the first
day, on day 14 and on day 21. Consumption peaked on day 4 and steadily decreased
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thereafter. The pattern of concentrations was opposite to and fitted with that for
lactate.
TABLE 6.1
Statistically significant differences between concentrations of threonine on different
days of the experiments using the Tukey test.
THREONINE
ANOVA SIGNIFICANCE 0.000023
DAY 1 vs DAY 2 p<0.022
DAY 1 vs DAY 7 p<0.00053
DAY 1 vs DAY 10 p<0.002
DAY 2 vs DAY 14 p<0.022
DAY 4 vs DAY 1 p<0.00000012
DAY 4 vs DAY 2 p<0.011
DAY 4 vs DAY 7 p<0.0037
DAY 4 vs DAY 10 p<0.0015
DAY 4 vs DAY 14 p<0.0000028
DAY 4 vs DAY 21 p<0.000039
DAY 7 vs DAY 14 p<0.0033
DAY 10 vs DAY 14 p<0.002
Figure6.5
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Figure 6.5 shows the overall results for histidine and arginine which are two
glutamate precursors in the cell, glutamate and glutamine which is the end product of
this chain and is utilised by the cells in DNA synthesis
6.3.2.1 HISTIDINE.
There was consumption of histidine on all days sampled except for day 1 and
day 21, when consumption was minimal or non-existent, but there was no evidence of
production of histidine. Consumption increased from day 1 reaching a peak on day 7.
Between days 7 and 14 there was consumption of all the histidine which is present in
the medium. One way ANOVA showed that those differences were not statistically
significant.
6.3.2.2 ARGININE
Contrary to the consumption observed with histidine there was production of
arginine at most of the time points sampled apart from days 7 and 10 when there was
minimal consumption. Day 1 showed high production of arginine as was the case on
days 14 and 21, with a peak on concentration on day 14. There were statistically
significant differences between concentrations between day 14 and day 4 (p<0.002).,
between day 14 and day 7 (p<0.0000), between day 14 and day 10(p<0.0007),
between day 21 and day 7 (p<0.02) and between day 1 and day 7 (p<0.037).
Figure6.6
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Glutamate concentration overall exhibited the same patterns as arginine
concentrations. There was production of glutamate at all time points sampled.
Production of glutamate was maximal on day 1 and was comparable to this on days
14 and 21. Between days 2 and 10 there was a small production of glutamate
exhibited and the amounts produced were similar. There was one statistically
significant differences between days between day 1 and day 10 (p<0.031).
6.2.3.4 GLUTAMINE.
There was consumption of glutamine at all time points sampled. The pattern of
concentrations was inverse to that of glutamate. There was a big consumption
manifested on day 1 which decreased to a minimum on day 4. Between day 4 and day
10 it plateaued at the same level. It then increased to reach a maximum peak on day




Figure 6.7 shows the overall results for phenylalanine, tyrosine, leucine and
isoleucine which together with tryptophan and lysine are the acetyl-CoA precursors.
Figure 6.8 shows the overall production of acetate by the cultured cells during the
experiments.
6.3.3.1 PHENYLALANINE.
There was production of phenylalanine by cells as a result of protein
breakdown on all days sampled apart from day 1 when there was minimal
consumption of phenylalanine. The rates of phenylalanine production varied between
days. They showed an increase in concentration from day 1 to day 4 and then
plateaued, with a small decrease on day 21. One way ANOVA showed statistically
significant differences between days (F<0.02). The Tukey test confirmed statistically
significant differences between day 1 and day 7 (p<0.028), between day 1 and day 10
(p<0.0012) and between day 1 and day 14 (p<0.0008).
6.3.3.2 TYROSINE
Tyrosine concentration showed an inverse pattern to the concentrations of
phenylalanine. There was consumption of tyrosine on all days sampled apart from day
1 when there was a small production. Days 10 and 14 showed the biggest uptake of
tyrosine from the medium. The concentration then increased and on day 21 the
uptake was minimum. There were statistically significant differences between
concentrations of tyrosine between day 10 and day 1 (p<0.0001), between day 10 and
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6.3.3.3 LEUCINE
There was significant consumption of leucine compared to the baseline
concentrations of the medium at all days. This has reached statistical significance at
all days (p<0.01 at all time points). Overall over the time scale of the experiments the
concentration of leucine of the supernatant remained stable and there were no
statistically significant differences between the time points sampled.
6.3.3.4 ISOLEUCINE
Overall there were no significant changes from baseline concentrations on
isoleucine concentrations throughout the experiments. They remained relatively
stable with small amounts of isoleucine taken up or released on different days. No
statistically significant differences were exhibited between days as well. Cells in the
RCCS did not use isoleucine for their needs.
6.3.3.5 ACETATE.
There was production of acetate at all time points sampled. Acetate
production was elevated on day 1, reached its peak on day 2 and then decreased on
day 4 to a plateau through to day 10. Then it reached its minimum on day 14 and on
day 21 it was similar to day 14. There were statistically significant differences
between acetate concentrations between day 14 and day 1 (p<0.013), between day 14
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6.3.4 SUCCINATE PRODUCTION
Succinate is an essential intermediate acid of the Kreb's cycle. Valine,
isoleucine and methionine are the amino acids that are transformed to succinate by the
hepatocytes to feed the Kreb's cycle. Figure 6.9 shows the concentrations of those
amino acid s at different time points during our run of experiments.
6.3.4.1 VALINE
There was a small consumption of valine present at all time points sampled.
There were no statistically significant differences neither between concentrations of
valine on different days nor between concentrations of valine sampled and the baseline
concentration of William's E medium. The concentration of valine in the supernatants
remained relatively stable with minimal amounts consumed on every sample.
6.3.4.2 METHIONINE.
The pattern exhibited by methionine was of consumption on days 1, and 21
with production of methionine from protein breakdown between days 4 and 14. The
consumption peaked on day 14 when all the available methionine was consumed by
the hepatocytes. One way ANOVA did not reveal statistically significant differences
between concentrations on different days.
Figure6.9






There was significant ethanol production on all days at all time points sampled
(Figure 6.10). The maximum concentration was exhibited on day 21. Ethanol
concentration started high on day 1 then subsequently diminished to reach a minimum
on day 4 and then increased to its peak on day 21. There was a statistically
significant difference between concentrations between day 1 and day 4 (p<0.02).
Figure6.10
3.5x

















During the last decade, with the advent of the HARV system, many different
types of cells and cell lines have been successfully cultured in simulated microgravity
conditions (Ingram et al, 1997; Jessup et al; 1997).
Our study examined maintenance of the differentiated metabolic functions of primary
porcine hepatocytes in a simulated microgravity environment. We were able to show
that cells in HARVs not only survive for long periods of time but are also able to
maintain key metabolic functions.
Our findings were entirely consistent with those from a recently published
paper (Khaoustov et al, 1999), where the authors showed that human liver cells
cultured in simulated microgravity were viable for 60 days and aggregated to tissue
like structures. They also showed that albumin and urea were produced and glucose
was consumed.
Our study showed that hepatocytes not only consume glucose but they are
able to feed both the Krebs and the Cori cycles. Looking at glucose metabolism in
particular, there was a pattern emerging showing that during the first 7 to 10 days
there was lactate production, pyruvate consumption, alanine consumption and
threonine consumption. This is a pattern observed in cells breaking down glucose
anaerobically for their energy requirements and active gluconeogenesis. From day 10
onwards though this pattern was reversed. There was diminishing lactate production,
pyruvate production, alanine production and diminishing threonine consumption. This
is a pattern observed in cells breaking down their glucose aerobically for their energy
requirements and not very actively using glucogenic amino acids for gluconeogenesis .
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This observation and similar others on key metabolic pathways detailed below have
enabled us to put forward a hypothesis that cells grow quite happily in the RCCS.
After an initial period of acclimatisation at the time point when static cell cultures drift
towards cell death, cell aggregates formed in the RCCS switch from the anaerobic
pattern of metabolism to the more efficient aerobic pattern. They exhibit the same
pattern of metabolism until the end of the experiments.
Looking at glutamine synthesis we observed that glutamate can be produced
either from the urea cycle through arginine breakdown, or directly from histidine or
through transamination from a- ketoglutarate, which produces the bulk of
intracellular glutamate. The results showed that glutamate production closely
followed histidine consumption. This only produces a small proportion of the overall
glutamate production by the cells. We suggest that transamination activity and
production of glutamate overall, was proportional to glutamate production from
histidine.
The hypothesis of cells acclimatising at the microgravity environment for the
first 10 days and then continuing their life cycles in a friendly environment is
suggested by those results. The glutamine consumption pattern being inverse to what
the glutamate production pattern was, suggested that cells post day 7 were consuming
glutamine for their DNA synthesis. They were as such dividing until day 21 when our
experiments were terminated.
Looking at ketogenesis we observed a significantly reduced acetate
production compared to acetate production from freshly isolated cells cultured in
static cultures. We also observed contrary to what has been reported on static
cultures phenylalanine production from protein breakdown. It is well established that
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hepatocytes tend to convert phenylalanine to tyrosine which is further converted to
acetyl- CoA and fumarate. The increased concentration of phenylalanine in the media
and in the cells accelerates the turnover of tyrosine and its conversion to metabolites
more useful to the cell. The results are entirely in keeping with this hypothesis.
Overall the pattern of ketogenesis proves again the theory of cells
acclimatising in the RCCS environment. Ketone bodies are the export products of
liver cells to other organs that need ketone bodies to survive. The microgravity
cultures exhibited high acetate production at the beginning. As only hepatocyte
aggregates existed in the system there was no organ target to export ketone bodies.
Eventually, acetate production diminished and reaching its minimum on day 14 and
remaining small until the end of the experiments.
There is no evidence of a big succinate production as all precursors of
succinate seemed not to be taken up in big quantities. Overall it does not seem that
the Kreb's cycle was fed from succinate production under our experimental
conditions.
Looking at the branch chain amino acids as an entity it becomes clear that cells
use preferentially leucine for their requirements. The most plausible explanation is
that as all three branch chain amino acids are using the same transporter to enter the
hepatocyte , leucine is preferentially taken up because its concentration in the
extracellular milieu is the highest. Until the three branch chain amino acids are in
concentration equilibrium in the medium leucine is almost exclusively taken up and as
a net result the concentrations of the three branch chain amino acids in the
extracellular supernatant are almost identical.
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Overall our results show that primary porcine hepatocyte can be happily
grown in microgravity conditions for up to three weeks. This may have implications
for BALSS as they can provide an active biosubstrate for the systems. We have
shown that this culture modality overcomes the initial disorder in cellular amino acid
metabolism which is critical in long term cultures of porcine hepatocytes (Gerlach et
al, 1996). Further studies are urgently required to scale up this model for growth of
substantial quantities of hepatocytes and studies without time limits would need to be




METABOLIC ABNORMALITIES IN PATIENTS WITH
FULMINANT HEPATIC FAILURE
7.1 INTRODUCTION
Fulminant Hepatic Failure (FHF) is a clinical syndrome characterised by
massive hepatocellular dysfunction, in the absence of chronic liver disease, resulting in
hepatic encephalopathy. It is a fairly uncommon syndrome and has a high mortality
approaching 80% in some series (Schiodt et al, 1999). The prognosis depends on
aetiology and concomitant liver disease. Remarkably, the acutely failing liver has a
potential to regenerate without any permanent sequelae.
The most frequent cause of fulminant hepatic failure in the UK is paracetamol
overdose (POD). The clinical syndrome in patients with FFfF following POD is quite
distinct and differs to other aetiologies. Paracetamol is hepatotoxic but also
nephrotoxic and nephrotoxicity can be a late feature. The time course of fulminant
hepatic failure after POD is usually accelerated and there is evidence that the
metabolic abnormalities occur relatively early. Most series with FHF patients will
consider POD patients separately and they will apply different prognostic criteria to
them.
Other causes include reactions to drugs, viral hepatitis, Wilson's disease, Budd
- Chiari syndrome etc. Hepatitis A is the commonest cause world wide (Plevris et al,
1998).
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The clinical course is that of progressive multi organ failure. There is cerebral
dysfunction with hepatic encephalopathy, coagulation abnormalities, haemodynamic
abnormalities, renal failure and infections superimposed to the liver failure. Unless
Orthotopic Liver Transplantation (OLT) is attempted, the prognosis is grave. OLT
seems to be the only effective means of therapy in those unfortunate patients whose
prognosis is poor. No pharmacological or other modality seem to be as effective as
OLT. In recent series, the 5 year survival rate approaches 85% in patients with FHF
after they receive a liver transplant (Asher et al, 1993; Wei et al, 1997).
Although researchers have described the clinical course of fulminant hepatic
failure in detail, very little is known regarding the pathophysiology of the syndrome on
the cellular level in humans. Most studies looking at biochemical abnormalities of the
liver have been conducted on animals (Newsome et al, 2000). Most studies have
looked at indices of liver necrosis and poor synthetic function and very few have any
data on abnormalities of metabolic pathways on a cellular level in the liver (Blitzer et
al, 1978; Francavilla et al, 1989; Sielaff et al, 1995; Diaz-Buxo et al, 1997; Kalpana
et al, 1999). Some human studies have looked at abnormalities of the brain cells in the
context of fulminant hepatic failure (Strauss et al; 1997, Clemmesen et al, 1999).
Most clinicians are aware that, in humans, glucose levels are low early in the
syndrome and are correcting the hypoglycaemia with glucose infusions. There is also
evidence that lactate is high in severe disease (Jalan et al, 1999). There is therefore
indirect evidence that glycolysis is not efficient and ATP is produced anaerobically.
There are no studies investigating the time course of those abnormalities and there are
no data regarding the performance of other key metabolic pathways in the liver. As
we know from clinical experience, there is progressive deterioration of liver function
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during the course of the disease and we can assume that many metabolic pathways
are affected as the disease evolves.
The aim of our study was to identify abnormalities in key metabolic pathways
in patients with fulminant hepatic failure. We compared key metabolite
concentrations between patients and controls using 'H NMR Spectroscopy. I n a
subsequent subgroup analysis we compared concentrations of those metabolites
between severely affected individuals and moderately affected individuals. Patients
were divided from the beginning in two groups: those with POD and those of other
aetiologies. We also studied the evolution in time concentrations of key metabolites
during the early stages of fulminant hepatic failure in both groups.
7.2 MATERIALS AND METHODS
7.2.1' PATIENTS.
The study was conducted between May 96 and July 99. We studied 34
patients with fulminant hepatic failure caused by paracetamol overdose. We also
studied 34 patients with fulminant hepatic failure caused by other aetiologies. The
aetiologies for the fulminant hepatic failure in those patients are shown in Figure 7.1.
All patients were admitted and cared for at the Scottish Liver Transplant Unit and the
Intensive Care Unit at the Royal Infirmary of Edinmburgh. All patients were
encephalopathic and they presented with an International Normalised Ratio ( INR) of
more than 3.0. Individual characteristics of the patients in the two groups are shown
in Table 7.1 Our control group consisted of 17 healthy volunteers ( 10 males, 7
fermales,mean age (39.8 ± 7.3)) .
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Blood was collected on admission a means of 5.4 hours post admission (range
2-11 hours) for the Day 1 analysis and a means of 52.6 hours (48- 69) for the Day 3
analysis, in lithium heparin tubes. Blood from volunteers was collected a mean of 2
hours post prandially as the differences in amino acid concentrations between sexes
are minimal at that time (Morgan et al, 1982). It was immediately centrifuged at 2000
g for 15 minutes at 4°C. The supernatant was then pippetted and aliquoted in 2.5 ml
vials. The vials were then stored at -40°C until NMR analysis.
Table 7.1
Individual characteristics of patients with fulminant hepatic failure
NON POD FHF POD FHF
AGE 50.7 ±9.3 yrs 38.7 ± 6.4 yrs
MALES 13 11
FEMALES 21 23

































































7.2.2 Sample preparation for NMR spectroscopy
Samples were prepared by adding a D20 solution of (150 pi) to plasma (600
pi) providing thus an internal field frequency lock for the spectrometer. Chemical
shifts were referenced externally to the singlet methyl resonance of Sodium 3-
(trimethylsilyl 2,2,3,3-2H4) -1 propionate (TSP) at zero ppm.
7.2.3 NMR Spectroscopy monitoring
We measured the concentration of the following substances in the plasma
using NMR spectroscopy: Acetate, acetoacetate and B- hydroxybutyrate as they are
the main ketone bodies mainly exported by liver cells (Fuchs at al, 1994; Duee et al,
1994; Gerlach et al, 1996), leucine, isoleucine, phenylalanine and tyrosine
consumption as they are the key ketogenic amino acids used by the hepatocyte
(Gerlach et al, 1996), glucose, alanine and threonine consumption from plasma as a
measure of glycolysis to monitor the cells energy requirements (Seglen, 1974; Sefter
et al, 1994), lactate and pyruvate as a measure of the active aerobic and anaerobic
glycolysis (Seglen, 1974), the consumption of valine, isoleucine and methionine as
succinate formation precursors (De Blaauw et al, 1998) and the concentrations of
glutamate, glutamine, histidine and arginine which are indices of active transamination
and urea synthesis (Lang et al, 1990; De Blaauw et al, 1998). Concentrations of
glycerol were also measured as evidence of on going fatty acid oxidation. We have
also measured the concentrations of methylamine, dimethylamine, trimethylamine and
TMAO as they are thought to be produced by acute injury to hepatocytes. Finally,
myoinositol an essential osmotic buffer was measured as well.
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7.2.4 Proton NMR spectroscopy
NMR Spectroscopy monitoring was performed as discussed in Chapter 2.
Sample preparation, data acquisition and quantitation of compound concentrations
were performed as discussed in Chapter 2. Instead of the presaturation technique to
acquire our data, the CMPG sequence was applied, as this sequence enabled us to
observe a flat baseline in our spectra from plasma samples, by minimising the signals
acquired from macromolecules present in the plasma like proteins and lipoproteins.
Figure 7.2 shows a 1H NMR spectrum from plasma from a normal volunteer
and Figure 7.3 shows a 1H NMR spectrum from plasma of a patient suffering from
fulminant hepatic failure.
7.2.5 Statistical analysis
Separate analysis was performed for fulminant hepatic failure from
paracetamol overdoses and the fulminant hepatic failure caused by other aetiologies.
To compare between groups we used the Student's t-Test for parameters with non-
missing values and the Mann Witney U test for parameters with missing values.
Values are expressed as mean (range and Standard error). A p value of<0.05 was
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7.3 RESULTS
7.3.1 Patients vs controls
We studied patients with fulminant hepatic failure due to aetiologies other
than paracetamol overdose ( group A, 34 patients), patients with fulminant hepatic
failure due to paracetamol overdose ( group B, 34 patients) and sex and age matched
normal controls ( group C, 17subjects ). There was evidence of significant
dysfunction of the major metabolic pathways both in patients whose aetiology was
paracetamol overdose and in patients whose aetiology was not paracetamol overdose
compared to normal controls. We will look at those pathways in detail:
7.3.1.1 GLYCOLYSIS AND GLYCONEOGENESIS
Due to continuous intravenous infusion of glucose it was impossible to
measure directly the concentrations of glucose in patients. The results for lactate and
pyruvate are shown on Figure 7.4. Lactate concentrations in group A were higher
than group B and the results were highly significant statistically (p<0.0000). Lactate
concentrations in group C were also higher with a highly significant statistical result(
p<0.0000).
Pyruvate concentrations in Group A were higher than controls and the results
were statistically significant (p<0.0005 ). Also higher than controls were pyruvate
concentrations in Group B and the results were statistically significant (p<0.018 ).
We have also looked at four glucogenic amino acids. The overall results for
those are shown on Figure 7.5. Alanine which can be converted to pyruvate,
threonine and glycine which are precursors of alanine and aspartate which can be
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converted to phosphoenolpyruvate. Concentrations of alanine were higher in patients
than controls. If we compare group A with group C , the results were statistically
significant ( p<0.014 ) and so were the results of the comparison between group B
and group C (p<0.004).
Concentrations of glycine were higher in patients than controls. If we
compare group A with group C, the results were statistically highly significant (
p<0.0000 ). If we compare group B with group C, the results were statistically highly
significant (p<0.00001).
There were no significant differences in the concentrations of threonine
comparing patients and controls. Concentrations of aspartate were higher in patients
than controls. No aspartate was detected in controls. If we compare group A with
group C, the results were highly significant ( p<0.00007 ). If we compare group B
with group C, the results were highly statistically significant ( p<0.00004).
FIGURE7.4 Glycolysis
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7.3.1.2 BRANCH CHAIN AMINO ACIDS
The overall results for the branch chain amino acids are shown in Figure 7.6.
There were no statistically significant differences in the leucine concentrations
between patients and controls
Overall concentrations of isoleucine were higher in patients than controls. If
we compare group A with group C, the results were statistically significant ( p<0.007
). If we compare group B with group C, the results were also statistically significant
(p<0.013).
The concentrations of valine were lower in patients than controls. If we compare
group A with group C, the results were highly significant ( p<0.0000 ). If we also
compare group B with group C , the results were again highly statistically significant
(p<0.0000).
7.3.1.3 AROMATIC AMINO ACIDS
Overall results for the aromatic amino acids and methionine are shown in
Figure 7.7. Concentrations of tyrosine were higher in patients than controls. If we
compare group A with group C, the results were statistically highly significant (
p<0.0001 ). If we compare group B with group C, the results were statistically highly
significant (p<0.000). Phenylalanine concentrations which is a tyrosine precursor,
were also measured and were found to be higher in patients than controls. If we
compare group A with group C, the results were statistically significant ( p<0.0002 ).
If we compare group B with group C, the results were statistically highly significant
(p<0.0000).
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The concentrations of methionine were higher in patients than controls. In
fact no methionine was detected in any of the samples from the controls. If we
compare group A with group C, the results were statistically significant ( p<0.003 ).
If we compare group B with group C, the results were statistically significant
p<0.016).
FIGURE7.6
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1H NMR Spectroscopy gives us the opportunity to look at ketone bodies
formed in the process of ketogenesis. The abundant ketone bodies in the human body
are acetoacetate, acetate and hydroxybutyrate. They are formed in the liver as a result
of fatty acid oxidation. Overall results for ketone bodies are shown in Figure 7.8. For
all three, concentrations in patients were higher than concentrations in controls. For
acetoacetate, if we compare group A with group C, the results were statistically
highly significant ( p<0.0004 ). If we compare group B with group C, the results
were statistically highly significant (p<0.0003). For acetate, if we compare group A
with group C, the results were statistically significant ( p<0.007 ). If we compare
group B with group C, the results were statistically significant (p<0.004). For
hydroxybutyrate, if we compare group A with group C, the results were statistically
highly significant ( p<0.0000 ). If we compare group B with group C, the results
were statistically significant (p<0.009).
FIGURE7.8
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7.3.1.5 UREA AND GLUTAMINE SYNTHESIS
Urea synthesis is vital in order to get rid of unwanted nitrogen. The urea cycle
takes place exclusively into the liver parenchymal cells and is fed by histidine which is
converted to glutamate, by glutamate itself, and aspartate. By 1H NMR
Spectroscopy we were able to detect all those urea cycle precursors in the plasma of
patients along with arginine and citrulline two amino acids which are directly
implicated in the urea cycle and glutamine which can be an end product for the
metabolism of glutamate. Overall results for these metabolites are shown in Figure
7.9. Looking at histidine concentrations in detail they were highest in patients
suffering fulminant hepatic failure from paracetamol overdose (Group B ), followed
by controls (group C) and the lowest concentrations were observed in patients
suffering fulminant hepatic failure from other aetiologies (Group A). If we compare
group A with group C, the results were statistically highly significant ( p<0.0000). If
we compare group B with group C, the results were statistically significant
(p<0.0006). There were no significant differences in the concentrations of glutamate,
if we compared patients and controls. There were no significant differences in the
concentrations of arginine, comparing patients and controls. Concentrations of
citrulline were higher in patients than controls. If we compare group A with group C,
the results were highly significant ( p<0.0000 ). If we compare group B with group
C, the results were highly statistically significant (p<0.00003). Also concentrations of
glutamine were higher in patients than controls. If we compare group A with group
C, the results were statistically significant ( p<0.0005 ). If we compare group B with





















It was postulated that the production of methylamines is high in the instance of
fulminant hepatic failure. It was thought that this was a way for the body to
metabolise nitrogen which can be toxic in the instance of a non - functioning urea
cycle. Using 1H NMR Spectroscopy we have looked at the production and
concentrations of methylamine, dimethylamine, trimethylamine and trimethylamine
oxide (TMAO). Overall results for the methylamines that we have detected are shown
in Figure 7.10. Concentrations of methylamine were higher in patients than controls.
If we compare group A with group C, the results were statistically significant (
p<0.0002 ). If we compare group B with group C, the results were statistically
significant (p<0.012). There were no significant differences in the concentrations of
dimethylamine or trimethylamine, comparing patients and controls. Concentrations of
TMAO were higher in patients than controls. In fact, no TMAO was detected in the
plasma of control subjects. If we compare group A with group C, the results were
highly significant ( p< 0.0000 ). If we compare group B with group C, the results
were highly statistically significant (p<0.0000).
7.3.1.7 GLYCEROL AND MYOINOSITOL
We have also looked at the concentrations of those two substances. Overall
results are shown in Figure 7.11 for those two substances. Glycerol as a marker of
fatty acid oxidation and myoinositol as a marker of osmotic abnormalities in the living
cells. No statistically significant differences were observed in the concentrations of




























7.3.2 SEVERELY VS MODERATELY AFFECTED PATIENTS
7.3.3 NON-POD FHF.
In total 20 patients with non -POD FHF died or were transplanted. As those
are events that abruptly terminate the disease (censored events) for the purpose of
analysis they constituted Group Al. Fourteen patients survived with maximal
supportive therapy and they did not undergo orthotopic liver tranplantation. For the
purpose of analysis they constituted Group A2.
We looked at the following key metabolic pathways in detail.
7.3.3.1 GLYCOLYSIS AND GLUCONEOGENESIS.
Results concerning the performance of the glycolytic pathway are shown in
Figure 7.12 for Day 1 and in Figure 7.13 in Day 3. There were statistically significant
differences between the two groups both on Dayl and on Day 3. On day 1, lactate
was significantly higher in Group Al (p<0.023 ). Pyruvate was significantly lower in
Group Al (p<0.014). Alanine a glucogenic amino acid was significantly higher in
Group Al (p<0.032). On day 3, lactate was significantly higher in Group Al
(p<0.002 ). Pyruvate was significantly lower in Group Al (p<0.0078). Alanine was
significantly higher in Group Al (p<0.011). No statistically significant differences




















Results concerning the branch chain amino acids are shown in Figure 7.14 for
Day 1 and in Figure 7.15 in Day 3. No difference was observed on Day 1 between
concentrations of leucine. On Day 3, there was a statistically significant difference
observed between the concentrations of leucine, one of the ketogenic amino acids,
which was significantly lower in severely affected patients (p<0.023). Valine was
significantly higher in Group A1 on Day 1. (p<0.022). Valine was significantly higher
in Group A1 also on Day 3. (p<0.039). There were no differences in the
concentration of isoleucine either on Day 1 or on Day 3.
7.3.3.3 AAA
There were no differences in the concentration of the aromatic amino acids
Phenylalanine and Tyrosine either on Day 1 or on Day 3. There were no differences
in the concentration of methionine either on Day 1 or on Day 3.
7.3.3.4 KETOGENESIS
There were no statistically significant differences on Day 1 concerning the
concentrations of acetoacetate, 13-hydroxybutyrate and acetate. Results concerning
the performance of the ketogenic pathway are shown on Figure 7.16 for Day 3. By
Day 3, there were statistically significant differences in the concentrations of
acetoacetate (p<0.007) and acetate (p<0.017). Both were higher in Group A1. There
were no differences in the concentrations of B-hydroxybutyrate.
FIGURE7.14 BCAA
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7.3.3.5 UREA AND GLUTAMINE SYNTHESIS.
The fate of metabolism of nitrogen containing compounds, was the same in the
two groups. There were no statistically significant differences in the concentration of
histidine, glutamate, aspartate or arginine, between the two Groups on both days.
There was a statistically significant difference in the concentration of citrulline on day
1 (p<0.036) and on Day 3 (p<0.022). Citrulline production was higher in Group A2
on both days. Glutamine concentrations were similar in both groups in both days
7.3.3.6 METHYLAMINES PRODUCTION
We did not find any differences in the production of those substances between
the two groups. There were no statistically significant differences in the concentration
of Methylamine, Dimethylamine, Trimethylamine and TMAO, on Day 1 and Day 3
No differences were elicited in the production of glycerol and myoinositol on
both day 1 and Day 3.
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7.3.4 POD FHF
In total 19 patients with POD FHF died or were transplanted. As those are
censored events for the purpose of analysis they constituted Group Bl. Fifteen
patients survived with maximal supportive therapy and they did not undergo
orthotopic liver tranplantation. For the purpose of analysis they constituted Group
B2. We looked at the following key metabolic pathways in detail.
7.3.4.1 GLYCOLYSIS AND GLUCONEOGENESIS.
Results concerning the performance of the glycolytic pathway are shown in
Figure 7.17 for Day 1 and in Figure 7.18 in Day 3. There were statistically significant
differences between the two groups both on Dayl and on Day 3. On day 1, lactate
was significantly higher in Group Bl (p<0.044 ). Pyruvate was significantly higher in
Group Bl (p<0.03). Alanine a glucogenic amino acid was significantly higher in
Group Bl (p<0.048). On day 3, lactate was significantly higher in Group Bl(p<0.016
). Pyruvate was significantly higher in Group Bl (p<0.013). There were no
statistically significant differences in the concentration of Alanine on Day 3. No
statistically significant differences were observed in the concentrations of Threonine
and Methionine.
7.3.4.2 BCAA
There were no differences in the concentration of the branch chain amino
acids Leucine, Isoleucine and Valine either on Day 1 or on Day 3.
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7.3.4.3 AAA
Results concerning the branch chain amino acids are shown in Figure 7.19 for
Day 1 and in Figure 7.20 in Day 3. There were statistically significant differences in
the concentration of phenylalanine on Day 1 (p<0.021). Statistically significant
differences were also shown in the concentration of phenylalanine on Day 3
(p<0.011). On both occasions phenylalanine concentrations were higher on Group B2.
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Results concerning the performance of the ketogenic pathway are shown on
Figure 7.21 for Day 1 and on Figure 7.22 for Day 3. On Day 1, there were
statistically significant differences in the concentrations of B-hydroxybutyrate
(p<0.042) and acetate (p<0.022). Both were higher in Group B2. There were no
differences in the concentrations of acetoacetate. On Day 3, there were statistically
significant differences in the concentrations of acetoacetate (p<0.05) and acetate
(p<0.044). Both were higher on Group B2. There were no differences in the
concentration of the ketogenic amino acids leucine, isoleucine and tyrosine either on
Day 1 or on Day 3.
7.3.4.5 UREA AND GLUTAMINE SYNTHESIS.
The fate of amines was the same in the two groups. There were no
statistically significant differences in the concentration of histidine, glutamate,
aspartate, citrulline or arginine, between the two groups on both days. Glutamine
concentrations were similar in both groups in both days
7.3.4.6 METHYLAMINES PRODUCTION
We did not find any differences in the production of those substances between
the two groups. There were no statistically significant differences in the concentration
of Methylamine, Dimethylamine, Trimethylamine and TMAO, on Day 1 and Day 3
No differences were shown in the concentrations of glycerol and myoinositol
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Little is known about the metabolic changes that take place in the liver and
more specifically intracellularly in that organ during fulminant hepatic failure. We are
all aware of the hypoglycaemia, loss of protein synthesis, and increase in lactate
production in patients with fulminant hepatic failure.
So far some studies on animal models only, have attempted to elucidate
further the abnormalities in key metabolic pathways. Blitzer et al, (1978) in a rabbit
model of fulminant hepatic failure, have shown that the concentrations of most amino
acids is increased in the first 24 h after injury, compared to controls. In particular
they showed that all aromatic amino acids were much increased, methionine was
increased, and there was also a slight increase in the concentrations of branch chain
amino acids. More specifically there was an increase in the concentrations of leucine
with the concentrations of isoleucine and valine remaining almost constant. There
was a huge decrease in the concentration of arginine mainly during the second 24 h.
There was also an elevation of lactate and creatinine concentrations. Sielaff et al.,
(1995) in a dog model has shown that there was an increase in the concentrations of
proline and alanine from the first 24 h, compared to controls. They also showed that
arginine concentration was lower from 12 h onwards compared to controls. They
also showed that the overall concentration of aromatic amino acids was elevated and
the overall concentration of branch chain amino acids was decreased compared with
controls. Other studies in pig and dog models produced similar results (Francavilla et
al, 1989; Diaz-Buxo et al, 1997 ; Kalpana et al, 1999).
In this study using 1H NMR Spectroscopy we were able to identify changes in
the concentration of amino acids and other metabolic substances in the plasma in
257
patients with fulminant hepatic failure. In general we were able to identify changes in
most amino acids in both the setting of fulminant hepatic failure from paracetamol
overdose and in the setting of fulminant hepatic failure from other aetiologies. The
spectra of patients looked different from those of controls (Figures 7.23 and 7.24).
We are now going to look at metabolic pathways in detail and forward a hypothesis as
to why those changes are happening.
Our study confirmed the findings by the animal study by Blitzer et al (1978) in
rabbits, showing increased concentrations of the aromatic amino acids, an increase in
leucine concentrations, a constant concentration of isoleucine and a decreased
concentration of valine. Our results on the aromatic amino acids are in accordance
with the study by Sielaff et al (1995), in dogs. As far as we are aware this is the first
study to look at an extensive amino acid profile in patients suffering from fulminant
hepatic failure
The aromatic amino acids and methionine are primarily metabolised by the
liver and their raised concentrations in fulminant hepatic failure are probably due to
impaired liver metabolism and portosystemic shunting of blood.
The story is more complex for the branch chain amino acids. The normal liver does
not play a major role in the break down of the branch chain amino acids which are
mostly catabolised in the skeletal muscle and kidneys. If we look at branch chain
amino acids individually we find that their metabolic fate after the initials
transamination and decarboxylation can be very different from one to the other.
Leucine is a ketogenic amino acid which can be oxidised to acetyl -CoA. This study
provides evidence that ketogenesis is impaired in fulminant hepatic failure, as is also
the peripheral utilisation of the ketone bodies. Valine can only be gluconeogenic and
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enter the Kreb's cycle and provide towards the production of ATP. As acetyl-CoA is
in short supply Kreb's cycle can be fuelled from alternative sources such as valine.
Isoleucine can be metabolised in both ways thus being either gluconeogenic or
ketogenic in the body. Isoleucine may as well be feeding the Kreb's cycle in fulminant
hepatic failure but not as successfully as valine.
In the case of glucose metabolism similar changes were observed in both
groups of patients. As most patients with fulminant hepatic failure are treated with
continuous intravenous infusions of glucose it was impossible to measure accurately
the effect of fulminant hepatic injury on glucose concentrations accurately. We then
looked at metabolites of glycolysis. There was significant elevation in the
concentrations of lactate and pyruvate in patients compared to controls. This is in
accordance with observations in humans (Strauss et al, 1997) and animal studies
(McMennamy et al, 1965; Blitzer et al, 1978) and shows that although glucose in
broken down, there is preferentially anaerobic glycolysis taking place. This is
supported also by the extremely low concentration of valine in patients compared to
controls, showing that the Kreb's cycle is getting fed by alternative sources to
pyruvate. There is an increase in the concentrations of the glucogenic amino acids
alanine and glycine. We propose that this is a manifestation of impaired
gluconeogenesis and is in accordance with animal studies (Blitzer et al, 1978). Both
alanine and glycine can be transformed to pyruvate and enter the glucogenic pathway
at that point. There was no change in the concentration of threonine which can be an
alanine precursor. We can postulate that this happened because as alanine was not
used there was no need for the absorption of threonine. Aspartate concentrations
were also elevated in patients compared with controls. Aspartate can be transformed
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to phosphoenolpyruvate and enter the glucolytic or neoglucogenic pathway. Elevated
concentrations of aspartate support the view that although there is a lot of pyruvate, it
is not used appropriately and it is mainly shifted to lactate in an effort for ATP
production in an unfavourable environment.
If we look at ketone bodies, which are compounds mainly formed by the liver
but exported to other organs for consumption, there was a significant increase in
concentrations of acetoaceatate, acetate and 3-hydroxybutyrate if we compare
patients with controls. These findings support the hypothesis that the liver early on
during fulminant hepatic failure, is able to produce ketones but the target organs are
unable to metabolise them. This is supported by evidence that ketogenic amino acids
like isoleucine, tyrosine and phenylalanine showed increased concentrations in the
plasma of patients. As ketone bodies are not consumed they seem to exerce a sort of
negative feedback loop to the their own production process.
We were also able to look at the urea cycle and glutamine synthesis. As urea
is undetectable in plasma by 'H NMR Spectroscopy, we have looked at amino acids
that feed the cycle and intermediates of the urea cycle. Concentrations of histidine
were significantly higher in patients than controls. Histidine is a precursor for
glutamate in normal hepatocyte metabolism. Surprisingly, glutamate concentrations
were not elevated whereas glutamine concentrations were. We could conclude from
this observation, that although there was some production of glutamine, liver and
other cells in bad shape due to general critical condition of the patient do not use
glutamine to DNA production. Concentrations of citrulline were elevated and so
were concentrations of arginine. This was in conflict with the results from animal
models(Sielaff et al, 1995, Fahey, 1957) showing that arginine concentrations were
260
greatly reduced early on. From our results we can conclude that as intermediates
from the urea cycle are accumulating not enough urea is produced and the body tries
to find other ways to metabolise ammonia. We have evidence that there is an
increased production on methylamine and an increase in the concentration of TMAO,
which showed that the cells have managed to incorporate ammonia into other
substances.
We did not detect any changes in the concentration of glycerol which favours
the hypothesis that fatty acid oxidation is not impaired early on in fulminant hepatic
failure. Myoinositol concentrations remained unchanged in patients and this could be
a sign that changes in osmolytes in fulminant hepatic failure are happening late on in
the course of the disease.
In the first part of this chapter we have shown that fulminant hepatic failure
produces a vast array of metabolic impairments in patients suffering from it. There
were significant changes compared to controls and there was a pattern emerging for
anaerobic glycolysis and loss of neoglucogenesis impairment of ketogenesis and
possible impairment of urea synthesis.
In the second part of this chapter we looked at differences in metabolic
abnormalities comparing between severely and moderately affected patients from both
groups and we also looked at progression of abnormalities in time to try and identify
possible differences between patients whose aetiology was paracetamol overdose and
those whose aetiology was not, during the course of the disease.
In the second part of this chapter we provide some evidence that metabolic
changes in the setting of fulminant hepatic failure start quite early in the course of the
disease. We also provide evidence to show that aetiology can be a factor determining
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how quickly the derangement of the metabolism will settle in. We provide evidence
that patients with fulminant hepatic failure seem to lose early on the ability for
gluconeogenesis and also are unable to generate energy in the form of ATP by using
aerobic metabolism, with a significant accumulation of lactate as a result. Those who
suffer fulminant hepatic failure due to paracetamol overdose showed evidence of
impaired ketogenesis during the first 24 h post admission. This phenomenon came on
later in patients with fulminant hepatic failure from other aetiologies.
Looking at the glycolytic pathway lactate was high from day 1 in both groups.
It was significantly higher in patients with severe disease in both groups studied. High
lactate was observed in a pig and a dog model of fulminant hepatic failure during the
first 12 h (Diaz-Buxo et al, 1997; Kalpana et al, 1999). Concentrations of alanine
were mirroring those of lactate. They were elevated from day 1 in both groups.
There was also significantly higher alanine concentrations in patients with severe
disease in both groups studied. We believe that this reflects an inability of the
hepatocytes to proceed to gluconeogensis during the course of fulminant hepatic
failure. There were high concentrations of valine in patients with non paracetamol
overdose fulminant hepatic failure. We think that this shows that the Kreb's cycle
does not feed from glucogenic amino acids. There is an obvious difference in the fate
of pyruvate between the two groups. In the non paracetamol overdose fulminant
hepatic failure group it was significantly lower in patients with severe disease. This
can be linked to the high concentrations of lactate, alanine and valine and shows that
although there was a consumption of pyruvate, the cells were unable to further
synthesise pyruvate from glucogenetic mechanisms. In the paracetamol overdose
fulminant hepatic failure group the concentrations of pyruvate in patients with severe
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disease were significantly lower from day 1. This is an obvious change from the other
group and we could explain it as follows. Pyruvate is a central player in glucose
metabolism and as levels of lactate in those patients are generally higher, we postulate
that patients are unable to form new pyruvate through glycolysis, from an early stage
but they are still capable of turning it into lactate and acetyl-coA. So, from our results
we have shown that although there was impairment of glucose metabolism early on in
both groups it was more profoundly affected in patients with severe disease due to
paracetamol overdose. By looking at alanine, lactate and pyruvate concentrations on
the first day post admission we were able to identify with accuracy, those patients that
were going to develop severe liver failure later and this could be a sensitive prognostic
criterion.
If we look at ketogenesis and ketone bodies consumption we have found that
in severe disease the concentrations of ketone bodies were significantly higher by day
3 in non paracetamol overdose patients. On the contraryin the POD group severely
affected patients exhibited lower concentrations of ketone bodies on day 1 and on day
3. In absolute values there was an increase in the concentration of the ketone bodies
on day 3 in all POD patients. A possible explanation is the early impairement of
gluconeogensis prevents the optimal function of the krebs cycle which needs acetyl-
CoA and ketone bodies are able to provide for it. As the situation becomes more
severe the Krebs cycle is defmiftely impaired and does not use acetyl-CoA any more,
thus there is an increase in the concentrations of ketone bodies. We found that the
concentrations of some of the ketogenic amino acids was also higher in patients with
severe disease. In the non POD group isoleucine concentrations were higher by day 3
and in the POD group concentrations of phenylalanine were higher from day 1. Again
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looking at acetate concentrations on the first day post admission we were able to
identify with accuracy, those patients that were going to develop severe liver failure
later.
There were no differences in urea synthesis or glutamine concentrations
according to severity of liver disease. It seems that severity or aetiology did not affect
those two metabolic pathways. As citrulline concentrations were higher in patients
with severe disease in non POD fulminant hepatic failure this might be an clue that
urea synthesis was even more impaired in that setting. In accordance with that
hypothesis no differences between severity were observed in the accumulation of
methylamines and TMAO .
We did not detect any changes in the concentration of glycerol which favours
the hypothesis that fatty acid oxidation is not impaired in fulminant hepatic failure
during the first 72 h. Myoinositol concentrations remained unchanged during the time
course of the study, in patients regardless of severity and aetiology and this could be a
sign that changes in osmolytes in fulminant hepatic failure are happening late on in
the course of the disease.
In conclusion this part of the thesis has shown that patients with severe
paracetamol overdose tend to have more protracted metabolic disturbances earlier
compared to the other groups. As the course of the disease progresses, then patients
with severe non paracetamol overdose exhibited similar metabolic abnormalities to
those with POD and they were quite similar by 72 h. we have also shown that there
are differences between the severely and moderately severely ill patients in both
groups and these indices could be used as early prognostic markers in the setting of
fulminant hepatic failure. Although this is a small scale study it shows clearly that
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metabolic abormalities in patients with liver disease are happenning early in the course




CRITERIA PREDICTIVE OF OUTCOME IN FULMINANT HEPATIC
FAILURE
8.1 INTRODUCTION
In the previous chapter we have shown that there are early biochemical
changes manifested in patients with fulminant hepatic failure. Looking at admission
bloods we have shown that glucose metabolism is affected quite early in all settings of
fulminant hepatic failure. Furthermore, in patients with fulminant hepatic failure
caused by paracetamol overdose it was shown that the ketone bodies production and
break down were significantly impaired.
The only treatment which has been validated in patients with severe fulminant
hepatic failure is orthotopic liver transplantation. The results of orthotopic liver
transplantation in that setting have been steadily improving and reported one and five
year survival rate at different centres ranges between 60 and 80% (Asher et al 1993;
Wei et al, 1997). It is well recognised though that patients transplanted following
fulminant hepatic failure have a stormy post -operative time and the one and three
month survival is less than for patients transplanted for chronic liver failure. This can
be attributed to the poor clinical condition of the patients before the operation but
also to the occasional use of ABO-incompatible or inferior quality grafts due to the
emergency and shortage of donors (Plevris et al, 1998).
In the UK clinicians apply almost universally the King's prognostic criteria to
assess eligibility of patients for otrthotopic liver transplantation. Table 1.4 shows
both sets of criteria; one for patients suffering fulminant hepatic failure after a
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8.2 MATERIALS AND METHODS
8.2.1 PATIENTS
The same patients, as in Chapter 7 were included in our study. Blood
collection was performed as discussed in Chapter 7. Blood was also collected at the
same time for measurement of full blood count, coagulation, liver function tests ,
urea, creatinine and electrolytes and blood gases.
8.2.2 NMR Spectroscopy monitoring
Samples were prepared and quantitation of concentrations of substances were
made as discussed in Chapter 7. Data were acquired as discussed in Chapter 7. We
measured the concentration of the following substances in plasma using NMR
spectroscopy: Acetate, acetoacetate and B- hydroxybutyrate as they are the main
ketone bodies mainly exported by liver cells, glucose, alanine and threonine
concentration in the plasma as a measure of glycolysis and gluconeogenesis to
monitor the cells energy requirements, lactate and pyruvate as a measure of the active
aerobic and anaerobic glycolysis. The concentrations of aromatic amino acids
tyrosine and phenylalanine and methionine and the concentrations of branch chain
amino acids leucine, isoleucine and valine were measured, as they were shown to be
deranged in patients with acute and chronic liver failure and in patients with
encephalopathy (Souters et al, 1987; Morgan et al, 1989). The concentrations of
glutamate, glutamine, histidine and arginine were measured, as indices of active
transamination and urea synthesis. We have also measured concentrations of glycerol
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as evidence of on going fatty acid oxidation. Finally we have measured the
concentrations of methylamine, dimethylamine, trimethylamine and TMAO as they are
thought to be produced by acute injury to hepatocytes. Myoinositol an essential
osmotic buffer was measured as well.
8.2.3 Biochemical data .
We have looked at parameters for liver synthetic function and liver necrosis,
for renal function and for the coagulation cascade. We have also looked at blood
gases results on admission
8.2.4 Statistical analysis.
Separate analysis was performed for fulminant hepatic failure from
paracetamol overdoses and the fulminant hepatic failure caused by other aetiologies.
To compare between groups we used the Student's t-Test for parameters with non-
missing values and the Mann Witney U test for parameters with missing values.
Values are expressed as mean (range and Standard error). A p value of<0.05 was
taken as statistically significant (two- tail test of significance). To construct our
predictive model we used multiple logistic regression analysis with cut off values. We
used multiple logistic regression to identify variables that are independent predictors
of outcome in our population. We then used stepwise forward logistic regression
analysis to create a mathematical equation to predict the outcome of patients with
FHF. Using those values we then calculated the specificity, sensitivity, positive and




In total 20 patients with non -POD FHF died or were transplanted. As those
are censored events for the purpose of analysis they constituted Group A. Fourteen
patients survived with maximal supportive therapy and they did not undergo
orthotopic liver transplantation. For the purpose of analysis they constituted Group
B
I will just reiterate here the significant results found in the previous study on
non POD patients when we looked at amino acids and other key metabolites by NMR
on admission bloods. Lactate was significantly higher in Group A (p<0.023),
pyruvate was significantly lower in Group A (p<0.014), alanine was significantly
higher (p<0.032) and valine was also significantly higher (p<0.022) in Group A. No
other statistically significant results were obtained.
The analysis of the biochemical data showed that no statistically significant
differences between the two groups existed except on two occasions. Bilirubin was
significantly higher in group a (p<0.0053) and albumin was significantly lower in
Group A (p<0.0041). There were no differences in prothrombin time between the
two groups.
We then performed multiple logistic regression analysis to identify the
independent variables to use for our model. We have used the eleven following
variables which were either statistically significant or failed to reach significance but
there was a trend for difference between the two groups. Lactate, pyruvate, alanine,
valine, bilirubin, albumin, prothrombin time, D- dimers, leucine, citrulline and
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histidine. After partial correlation and multiple logistic regression analysis the
following four variables emerged as the only truly independent variables: Lactate,
pyruvate, valine and albumin.
Using stepwise forward logistic regression analysis we were able to create a
mathematical model that predicts the outcome of the fulminant hepatic failure on
admission bloods. The equation constructed for this model is as follows:
0.2 x (Albumin) - 2 x (Lactate) - 36 x (Valine) - 38 x (Pyruvate)
If the result of this equation is < 2 then, we were able to show that our model had a
positive predictive value of 89% , a negative predictive value of 93% , a sensitivity of
94% and a specificity of 86%. We then applied the King's criteria on our population
twice once on admission and once overall as is common practice. We found that on
admission King' criteria had a positive predictive value of 60 % a negative predictive
value of 50%, a sensitivity of 25% and a specificity of 82%. Overall we found that
the positive predictive value of the King's criteria was 85%, their negative predictive
value was 58%, their specificity was 60% and their sensitivity was 85%
8.3.2 Paracetamol Overdose.
In total 19 patients with POD FHF died or were transplanted As those are
censored events for the purpose of analysis they constituted Group A. Fifteen
patients survived with maximal supportive therapy and they did not undergo
orthotopic liver transplantation. For the purpose of analysis they constituted Group
B
I will just reiterate here the significant results found in the previous study on
POD patients when we looked at amino acids and other key metabolites by NMR on
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admission bloods. Lactate was significantly higher in Group a (p<0.044), pyruvate
was significantly higher in Group A (p<0.03)and alanine was significantly higher
(p<0.024) Acetate was significantly lower (p<0.022) in Group A, phenylalanine was
significantly lower in Group A (p<0.011) and B-hydroxybutyrate was also significantly
lower (p<0.05 ) in group A. No other statistically significant results were obtained.
The analysis of the biochemical data showed that there were statistically
significant differences between the two groups. Prothrombin time was significantly
higher in group A (p<0.043) and albumin was significantly lower in Group A
(p<0.034). We also observed statistically significant differences between levels of
Haemoglobin which was lower in Group A (p<0.013), sodium which was higher in
Group A (p<0.035) and calcium which was also lower in Group A (p<0.016).
We then performed multiple logistic regression analysis to identify the
independent variables to use for our model. We have used the eleven variables which
were statistically significant between the two groups. Lactate, pyruvate, alanine,
phenylalanine acetate, B-hydroxybutyrate, albumin, prothrombin time, haemoglobin,
sodium and calcium. After partial correlation and multiple logistic regression analysis,
the following seven variables emerged as the only truly independent variables:
Phenylalanine, pyruvate, alanine, acetate, sodium, haemoglobin and albumin.
Using stepwise forward logistic regression analysis we were able to create a
mathematical model that predicts the outcome of the fulminant hepatic failure on
admission bloods. The equation constructed for this model is as follows:
(Haemoglobin) - 400 x (Pyruvate) - 16 x (Phenylalanine)
If the result of this equation is < 93 then, we were able to show that our model had a
positive predictive value of 89% , a negative predictive value of 100% , a sensitivity
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of 100% and a specificity of 88%. We then applied the King's criteria on our
population twice once on admission and once overall as is common practice. We
found that on admission King' criteria had a positive predictive value of 85 %, a
negative predictive value of 75 % , a sensitivity of 71 % and a specificity of 85%.
Overall, we found that the Positive predictive value of the King's criteria was 94 %,
their negative predictive value was 93 %, their specificity was 94 % and their
sensitivity was 93 %.
8.4 DISCUSSION
In this study we have developed prognostic models that can predict the outcome of
patients who suffer from fulminant hepatic failure on admission to the referring
hospital. We have studied the paracetamol overdose FHF separately as those patients
have a higher incidence of renal failure and metabolic acidosis (O'Grady et al, 1989).
Paracetamol overdose fulminant hepatic failure accounts for 80% of admissions to our
unit. As this study was set out to construct models to predict outcome in fulminant
hepatic failure we decided that the two groups (POD-FHF and non-POD-FHF) should
have similar numbers. Forty two patients were admitted to SLTU suffering from FHF
from aetiologies other than paracetamol overdose. We managed to collect plasma
and study 34 of them. To keep the numbers of patient groups even we also studied
the thirty four paracetamol overdoses that fulfilled the fulminant hepatic failure
criteria which were admitted following our thirty four non-POD-FHFs.
Our study provides a new model for evaluating patients with FHF. It is based
in our previous study which showed that key metabolic pathways in patients with
fulminant hepatic failure are impaired as early as 24 hours after admission to the
tertiary referral centre. We have been fortunate to be able to use 'H NMR
Spectroscopy to identify metabolic abnormalities in patients with fulminant hepatic
failure, by looking at the patients plasma. Our model uses biochemical and dynamic
variables and does not take into account static and therapeutic variables such as age,
sex, aetiology, duration of symptoms and grade of encephalopathy. This might
represent a drawback but the model was developed to show that by using only
biochemical parameters it is possible to formulate a credible predictive model.
We have added the most common biochemical indices to our NMR data to try
and make our model more accurate. Our result were surprising as the most
commonly used biochemical markers either did not show any statistical differences
between severe and moderate disease or they were not selected as independent
variables by our model. This comes as a surprise as prothrombin time was always
thought to be on of the best predictors of outcome in FHF (O'Grady et al, 1989;
Harrison et al, 1990; Takahashi et al, 1994; Anand et al, 1997). One possible
explanation for our results is that we have looked at indices on admission to our unit
and it is well known that prothrombin time is a good marker but probably two or
three days after admission and its values are changing rapidly. The same reasoning
would apply to creatinine as renal failure in POD is a rather late onset. Bilirubin in the
non-POD-FHF situation was an independent variable but our final model excluded
bilirubin as there were other more powerful predictors.
If we look at our non-POD-FHF model the variables included were lactate,
pyruvate, valine and albumin. Admission lactate is known to be a predictor of
outcome in fulminant hepatic failure. (Bernal et al., 1999). It comes as no surprise as
we have shown that anaerobic glycolysis is the norm in fulminant hepatic failure.
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Pyruvate is a central metabolite in the glycolysis and gluconeogenesis pathway. Its
lower values in the non-POD-FHF suggest less production as gluconeogenesis is
impaired and also that more pyruvate is shifted to lactate to meet the energy
requirements of the cells. The higher concentrations of valine in severely affected
patients may suggest that already on admission the disease has affected adversely the
ability of the muscle to metabolise branch chain amino acids. In other words, already
on admission we are faced with a multi-organ disease, that has disabled the basic life
sustaining metabolic pathways of energy production. We do not have an explanation
for the significance and the inclusion of low albumin, other than it may represent a
previous general condition of the patient which was not entirely healthy.
If we look at our POD-FHF model the striking observation is that the most
powerful predictor seem to be admission haemoglobin with a cut-off value of 100g/l.
This is of course an abnormally low level for both sexes. We can offer no explanation
for this finding and we can only look at it as a strange finding that we will try and
clarify in a future study. In contrast to the non-POD-FHF situation we have observed
a significantly higher pyruvate level in severely affected individuals. As lactate in our
study group was significantly elevated in severely affected patients we can
hypothesise that gluconeogenesis is impaired at this point in POD-FHF and more
production of pyruvate is still taking place. However at this point glucose
consumption has inevitably lactate as an end product thus, there is accumulation of
lactate. We have found lower levels of phenylalanine in severely affected POD
patients and this may simply pepresent an early surrogate marker pof severe
encephalopathy in the fulminannt setting. .
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Our study tried to identify prognostic markers of outcome in patients with
FHF on admission bloods. To our knowledge only one previous study has
accomplished that and they looked at patients with FHF due to viral hepatitis
(Bernuau et al, 1991). The currently used King's college criteria, when applied to our
patients, confirmed that they represent a valid set of criteria if applied overall and if
parameters are measured every day. They were less effective in predicting outcome
on admission. It is well recognised that in FITF time is very precious and often
patients on the waiting list die as a donor organ never becomes available. The fact that
our criteria may be able to predict outcome on admission could offer those patients a
time window that could be life saving as they could be placed on a super-urgent
waiting list earlier.
We have used NMR Spectroscopy for the measurement of many of our
variables mainly the amino acids. Although this technique is not familiar to the
medical world, extensive work has proven that it can be used to measure
concentrations of low molecular weight substances in biofluids. Facilities exist in all
major University centres in the UK and even centralised facilities for our purpose
could be envisaged.
In conclusion our study enabled us to construct two models to predict
outcome by measuring concentrations of markers on admission plasma, with a high




METABOLIC ABNORMALITIES IN PATIENTS WITH CHRONIC LIVER
DISEASE AND CHRONIC HEPATIC ENCEPHALOPATHY
9.1 INTRODUCTION
Most chronic liver injuries would result in cirrhosis, which is a combination of
hepatic fibrosis and nodular regenerative hyperplasia. Amongst the many causes of
chronic liver injury, a distinct few account for the majority of cases. Alcohol is the
most common cause in the developed world and Hepatitis B infection in Asia and
Africa. Currently world wide, the proportion of cirrhosis due to chronic Hepatitis C
infection is on the increase (Plevris et al, 1998).
One of the major complications of cirrhosis is chronic hepatic encephalopathy.
This is a complex neuropsychiatry syndrome which has a potential for full
reversibility. It is characterised by global depression of the central nervous system and
has different degrees of severity.(West Haven classification, (Figure 1.3)). The
syndrome is usually episodic and relapsing but some patients exhibit a chronic
protracted course (Jalan et al, 1996).
Cirrhosis is associated with alterations in proteins and amino acids
metabolism, including diminished urea formation (Du Ruisseau et al, 1956) and
hyperammonaemia (Fahey, 1957). Most studies that have looked at amino acid
metabolism in cirrhosis would agree that there seems to be a recognisable pattern in
the plasma amino acid profile with an elevation of aromatic amino acids and
methionine and reduced levels of branch chain amino acids (Morgan et al, 1982;
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Morgan, 1990; Plauth et al, 1990). Although this pattern has been used as the basis
for the false neurotransmitter theory in the pathogenesis of chronic hepatic
encephalopathy (Fischer et al, 1971) not many studies have proved that the pattern
observed in cirrhosis is valid for encephalopathy too (Fischer et al, 1978; Morgan et
al, 1982). Furthermore, it is now well accepted that encephalopathy due to acute
hepatic failure is a different entity and the mechanisms contributing to the CNS
dysfunction in the two diseases might be different.
Most studies have not concentrated in patients with chronic encephalopathy
only. The one study that has, focused on disproving that the BCAA to AAA ratio is
a valid predictor of encephalopathy grading (Morgan et al, 1978).
Other biochemical abnormalities are believed to be present in cirrhotics.
Gluconeogensis is impaired and hyperammonaemia and diminished urea production
makes it necessary for the body to find other pathways for nitrogen elimination (Mc
Cullough et al, 1993).
In this study we have studied amino acid patterns in cirrhosis, ketone bodies,
intermediates of glucose metabolism and urea cycle intermediates and nitrogen by
products. For this purpose we have used !H Nuclear Magnetic Resonance
Spectroscopy which is an easy method for measuring concentrations of low molecular
weight substances in low concentrations in complex biological fluids without
destroying the original samples.
The aim of our study was to investigate amino acid patterns and protein
metabolism, ketogenesis and nitrogen detoxification in patients with cirrhosis and to
compare those findings with patients with cirrhosis during an episode of hepatic
encephalopathy.
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9.2 Materials and Methods
9.2.1 Patients.
We studied patients with stable cirrhosis ( group A, 18 patients), patients with
stable cirrhosis during an episode of hepatic encephalopathy ( group B, 18 patients)
and normal controls( group C, 17 subjects ), the same group we used as controls in
Chapter 7. Individual characteristics of the patients in the two groups are shown in
Table 9.1.
Blood was collected from all three groups two to three hours following a main
meal as differences in the concentration of amino acids between sexes are less
pronounced post prandially, in lithium heparin tubes. It was immediately centrifuged
at 2000 g for 15 minutes at 4°C. The supernatant was then pippetted and aliquoted in
2.5 ml vials. The vials were then stored at -40°C until NMR analysis.
9.2.2 NMR Spectroscopy
Sample preparation for NMR spectroscopy was performed as discussed in
Chapter 7. The same experimental design was used as in Chapter 7 both to acquire
spectra from the plasma of the subjects and also to quantitate the concentrations of
the observed substances. We have measured the concentrations of the same
substances as previously described in Chapter 8.
9.2.3 Statistical analysis
To compare between the three groups we used the three way ANOVA test.
Where the ANOVA test was statistically significant the Tuckey test was performed to
compare between groups. Values are expressed as mean (range and Standard error).
A p value of<0.05 was taken as statistically significant (two- tail test of significance).
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TABLE 9.1
Individual characteristics from patients with cirrhosis and patients with cirrhosis and
chronic hepatic encephalopathy (CHE)
CIRRHOSIS CHE
AGE 54.3 ±8.8 yrs 56.8 ± 6.0 yrs
MALES 9 12
FEMALES 9 6
CHILD'S SCORE 7.8 ±1.6 9.9 ±2.1
PUGH CLASS A 1 1
PUGH CLASS B 11 6
PUGH CLASS C 6 11
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9.3 RESULTS.
Comparisons between the substances observed were made between cirrhotics,
encephalopathic cirrhotics and controls following the three way ANOVA model.
9.3.1 Ketogenesis
Results are summarised in Figure 9.1. We have observed statistically
significant differences by three way ANOVA between controls and patients in all three
ketone bodies measured. Acetate, acetoacetate and B-hydroxybutyrate, were all
significantly higher in patients than controls (p<0.01 in all cases). If we compared
between patients with and without encephalopathy, acetate was significantly lower in
encephalopathies (p<0.01) as was B-hydroxybutyrate (p<0.0002). In contrast
acetoacetate was significantly higher in encephalopathies (p<0.05).
9.3.2 Aromatic amino acids
Results are summarised in Figure 9.2. We have observed statistically
significant differences by three way ANOVA between controls and patients in the two
aromatic amino acids and methionine measured. Tyrosine, phenylalanine and
methionine concentrations were significantly higher in patients than controls (p<0.01
in all cases). If we compared between encephalopathic and non-encephalopathic
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9.3.3 Branch chain amino acids
Results are summarised in Figure 9.3. We have observed statistically
significant differences by three way ANOVA between controls and patients in all three
branch chain amino acids measured. Valine was significantly lower in patients than
controls (p<0.01 in both cases). Leucine was significantly lower if we compared
cirrhotics with controls (p<0.05) and higher if we compared encephalopathies with
controls (p<0.01). Isoleucine was significantly lower if we compared
encephalopathies with controls (p<0.01) but there was no difference between
cirrhotics and controls. If we compare encephalopathic with non- encephalopathic
patients, there were no differences in the concentrations of valine. The concentration
of leucine was significantly higher in encephalopathies (p<0.005) as was the
concentration of isoleucine (p<0.0004).
9.3.4 Glycolysis and gluconeogenesis.
Results are summarised in Figure 9.4 for lactate and pyruvate. We have
observed statistically significant differences by three way ANOVA between controls
and patients in both lactate and pyruvate. Lactate and pyruvate concentrations were
significantly higher in patients than controls (p<0.01 in all cases). There were no
differences present if we compared the two patients groups.
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Figure 9.5 summarises the results for the gluconeogenesis. We have observed
statistically significant differences by three way ANOVA between controls and
patients in all four amino acids measured. Alanine, threonine, glycine and aspartate
concentrations were significantly higher in patients than controls (p<0.01 in all cases
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9.3.5 Urea metabolism and glutamine synthesis
Figure 9.6 summarises the results for the amino acids involved in the urea and
glutamine synthesis. We have observed statistically significant differences by three
way ANOVA between controls and patients in all four amino acids measured.
Glutamine, histidine and arginine concentrations were significantly lower in patients
than controls (p<0.01 in all cases). Glutamate ewas significantly higher in patients
compared to controls (p<0.01 in all cases). If we compared between the two patients
groups, glutamine concentrations were lower in encephalopathic patients (p<0.013).
Glutamate, histidine and arginine concentrations were not significantly different
Figure 9.7 summarises the results for the methylamines. We have observed
statistically significant differences by three way ANOVA between controls and
patients in all three substances measured. Methylamine, dimethylamine and TMAO
concentrations were significantly higher in patients than controls (p<0.01 in all cases).
If we compared between the two patients groups there were no statistically significant
differences in the concentrations of methylamine, dimethylamine, and TMAO.
9.3.6 Glycerol and myoinositol.
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Figure 9.8 summarises the results for those two osmotically active substances.
Glycerol concentrations were significantly higher in patients than controls (p<0.01 in
both cases). Myo-inositol was significantly higher in cirrhotics (p<0.015) but there
were no differences between encephalopathic patients and controls. If we compare
between the two patients' groups, glycerol concentration was very significantly lower
in encephalopathies (p<0.000). Myoinositol concentrations were also significantly
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We should mention here that all spectra from encephalopathy patients
exhibited a novel substance (Figure 9.10 and Figure 9.11) which was not present in
either the cirrhotics (Figure 9.11) or the controls (Figure 7.24). This substance was
present in high concentrations compared to most amino acids (185 -400 pmols/L) .
The 'lT NMR spectrum of this substance which we called EDI-2 exhibited four
broad peaks at 1.56 ppm, at 3.86 ppm, at 4.16 ppm and at 4.53 ppm. By examining
this spectrum, we have hypothesised that EDI-2 is a small molecule that is loosely
bound to a big protein molecule such as albumin which forces it to tumble slowly in
the solution.
Having excluded the possibility that EDI-2 is a drug, a dye, an excipient or
simply an impurity we concentrated on identifying the molecular structure of EDI-2.
To find out about the possible similarities of the spectrum of EDI-2 with the spectra
of other known substances, we examined reference compounds libraries but no
spectrum could be matched with the one from EDI-2. The only spectrum that looked
similar was the spectrum of melatonin.
Melatonin is a hormone that is secreted by the pineal gland and the gut and
induces sleep. The effects of melatonin on the human body resemble the symptoms of
hepatic encephalopathy. It is as if patients with hepatic encephalopathy have an
excessive and inappropriate secretion of melatonin.
As EDI-2 was not melatonin, we postulated that it might be one of
melatonin's precursors or by-products. To investigate this we used High Performance
Liquid Chromatography (HPLC) to purify EDI-2 from the plasma. We then
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compared the peaks from the eluent of the chromatography column, with results from
HPLC of precursors and by-products of melatonin. We were unable to confirm
similarities between EDI-2 and any of the examined substances.
A new round of investigations trying to match EDI-2 and oxindole and its by¬
products are currently underway as part of our attempt to determine the potential role























Our study has confirmed that significant changes occur in plasma
concentrations of amino acids and other key metabolites in patients with cirrhosis in
the presence or not of hepatic encephalopathy. We will now look at some particular
substances in more detail.
Lactate and the amino acids alanine, threonine, glycine and aspartate are major
precursors for gluconeogenesis. Pyruvate is also a central substance in glucose
metabolism. In both cirrhotics and encephalopathies we found that the concentrations
of those substances were uniformly increased. It appears then that gluconeogenesis is
generally impaired in cirrhosis and encephalopathy. This would be in accordance with
previous studies, in experimental models (Seglen 1976; De Blaauw et al, 1997).
Our study showed that the concentrations of ketone bodies were significantly
increased in both groups of patients compared to controls. In encephalopathies
acetoacaetate was even more increased than in cirrhotics but B-hydroxybutyrate and
acetate concentrations were decreased. The fact that all ketogenic amino acids are
increased as well in cirrhosis would favour a hypothesis of impaired ketone bodies
utilisation in the periphery (muscle, brain). The fact that B-hydroxybutyrate and
acetate are significantly decreased in encephalopathic cirrhotics is indicative of an
impaired ketogenesis. We observed though that acetoacetate is increased in
encephalopathies. Acetoacetate is the main product of ketogenesis and then by using
NADH as co-substrate is further metabolised to B-hydroxybutyrate and acetate in the
cellular mitochondria. We can hypothesise that possibly the precarious state of
energy production in encephalopathy makes the availability of NADH for this further
reaction minimal and it is shifted towards energy production from the Kreb's cycle
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which is vital to the hepatocytes instead of finalising a product which is destined for
export to other organs like muscle and brain. This is further consolidated by the fact
that encephalopathies were shown to have a significantly lower glycerol level which is
an indication that fewer triglycerides are broken down and fewer lipids are made
available for oxidation which is the main pathway that would lead to ketone body
production.
Typical changes in plasma amino acid patterns have been found in different
studies in patients (Morgan, 1990; Plauth et al, 1993) and experimental animals in
chronic liver failure (Mc Mennamy et al, 1965; lob et al, 1970). Those changes are
increased concentrations of the aromatic amino acids and methionine and decreased
concentrations of the branch chain amino acids. This pattern was confirmed in
patients in the present study with the exception of isoleucine which was shown to be
non significantly increased in cirrhotics. Overall though there was a statistically
significant decrease in the concentration of the aromatic amino acids in cirrhotics
without encephalopathy.
The aromatic amino acids and methionine are primarily metabolised by the
liver and their raised concentrations in both cirrhotics and encephalopathic cirrhotics
are probably due to impaired liver metabolism and portosystemic shunting of blood.
The story is more complex for the branch chain amino acids and is further
complicated by the findings of this study that in encephalopathies there was a reversal
of the well known pattern with high leucine and isoleucine concentrations. The
normal liver does not play a major role in the break down of the branch chain amino
acids which are mostly broken down in the skeletal muscle and kidneys. It was
postulated that hyperinsulinaemia which is present in cirrhosis may drive branch chain
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amino acids to the muscle and the kidneys where they are broken down (Tessari et al,
1993). Our results do not support this hypothesis particularly in encephalopathy, as
concentrations of leucine and isoleucine are increased in encephalopathy. If we look
at branch chain amino acids individually we find that their metabolic fate, after the
initial transamination and decarboxylation, can be very different from one to the other.
Leucine is a ketogenic amino acid which can be oxidised to acetyl -CoA. This study
provides evidence that ketogenesis is impaired in encephalopathy as is also the
peripheral utilisation of the ketone bodies. Valine can only be a gluconeogenic amino
acid that could enter the Kreb's cycle and provide towards the production of ATP.
As acetyl-CoA is in short supply Kreb's cycle can be fuelled from alternative sources
as valine. Isoleucine can be metabolised in both ways thus being either gluconeogenic
or ketogenic in the body. Isoleucine may as well be feeding the Kreb's cycle in
cirrhosis but not as successfully as valine. We do not have an immediate explanation
as to why the concentration of isoleucine is high in encephalopathic cirrhotics in our
study population. Isoleucine is a ketogenic amino acid and, as the production of
acetoacetate is increased but its catabolism is not, it might be an index of diminished
ketogenesis in encephalopathy.
Hyperammonaemia and diminished urea production are well characterised
phenomena in cirrhotic patients. Our study showed that cirrhotics had decreased
levels of glutamine, histidine and arginine but increased levels of glutamate. This is a
pattern which is in accordance with a previous study which showed a generalised
decrease in those amino acids in chronic liver failure (Plauth et al, 1990). It is in
accordance also with studies in experimental animal models of liver failure (De Jong
et al, 1995). Although other studies in patients suffering acute liver failure confirmed
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a reverse pattern (Fischer et al, 1978), our study in acute liver failure found no
differences in any of those substances between patients and controls. Arginine is an
amino acid that is an intermediary of the urea cycle. Its observed decreased
concentrations are in agreement with a decreased urea cycle as is the decreased
histidine concentrations which is a glutamate precursor. Glutamate- glutamine shuttle
is an alternative way for ammonia detoxification with increased peripheral glutamine
synthesis a pathway for ammonia detoxification. We have also shown that glutamine
concentrations in encephalopathies is similar to controls. Although this might seem
paradoxical there is evidence of increased ammonia production during
encephalopathy, which is implicated in its pathogenesis. The fact that glutamate
synthesis is impaired may provide another point for the hyperammonaemia of
encephalopathy. An alternative pathway to this is the production of amines and
TMAO which can assist in the ammonia detoxification in the presence of urea cycle
impairment.
In conclusion this chapter provides evidence that in stable cirrhosis key
metabolic pathways are impaired and confirms that there is impaired
gluconeogenesis, impaired ketogenesis and ketone bodies break down and impaired
urea cycle. In chronic hepatic encephalopathy there the concentrations of the branch
chain amino acids are almost normal. Encephalopathies seem to have a unique
molecule in their plasma which might be responsible for one of the mechanisms
responsible for the pathogenesis of the syndrome. They also have decreased capacity
for ammonia detoxification and decreased capacity for fatty acid oxidation. Further
studies towards identification of this unique molecule and also towards unification of
the different theories on the pathophysiology of hepatic encephalopathy are
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guaranteed. It will be important to look at intracellular concentrations of key
metabolites in muscle and hepatocytes in patients with cirrhosis in order to measure
interorgan exchange of amino acids and its alterations in chronic liver disease and
when complications of portal hypertension occur.
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